#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Interhemispheric connectivity and hemispheric specialization in schizophrenia patients and their unaffected siblings
#Text=Hemispheric integration and specialization are two prominent organizational principles for macroscopic brain function.
1-1	0-16	Interhemispheric	_	
1-2	17-29	connectivity	_	
1-3	30-33	and	_	
1-4	34-45	hemispheric	_	
1-5	46-60	specialization	_	
1-6	61-63	in	_	
1-7	64-77	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-8	78-86	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[1]	
1-9	87-90	and	_	
1-10	91-96	their	_	
1-11	97-107	unaffected	_	
1-12	108-116	siblings	_	
1-13	117-128	Hemispheric	_	
1-14	129-140	integration	_	
1-15	141-144	and	_	
1-16	145-159	specialization	_	
1-17	160-163	are	_	
1-18	164-167	two	_	
1-19	168-177	prominent	_	
1-20	178-192	organizational	_	
1-21	193-203	principles	_	
1-22	204-207	for	_	
1-23	208-219	macroscopic	_	
1-24	220-225	brain	_	
1-25	226-234	function	_	
1-26	234-235	.	_	

#Text=Impairments of interhemispheric cooperation have been reported in schizophrenia patients, but whether such abnormalities should be attributed to effects of illness or familial risk remains inconclusive.
2-1	236-247	Impairments	_	
2-2	248-250	of	_	
2-3	251-267	interhemispheric	_	
2-4	268-279	cooperation	_	
2-5	280-284	have	_	
2-6	285-289	been	_	
2-7	290-298	reported	_	
2-8	299-301	in	_	
2-9	302-315	schizophrenia	_	
2-10	316-324	patients	_	
2-11	324-325	,	_	
2-12	326-329	but	_	
2-13	330-337	whether	_	
2-14	338-342	such	_	
2-15	343-356	abnormalities	_	
2-16	357-363	should	_	
2-17	364-366	be	_	
2-18	367-377	attributed	_	
2-19	378-380	to	_	
2-20	381-388	effects	_	
2-21	389-391	of	_	
2-22	392-399	illness	_	
2-23	400-402	or	_	
2-24	403-411	familial	_	
2-25	412-416	risk	_	
2-26	417-424	remains	_	
2-27	425-437	inconclusive	_	
2-28	437-438	.	_	

#Text=Moreover, it is unclear how abnormalities in interhemispheric connectivity impact hemispheric specialization.
3-1	439-447	Moreover	_	
3-2	447-448	,	_	
3-3	449-451	it	_	
3-4	452-454	is	_	
3-5	455-462	unclear	_	
3-6	463-466	how	_	
3-7	467-480	abnormalities	_	
3-8	481-483	in	_	
3-9	484-500	interhemispheric	_	
3-10	501-513	connectivity	_	
3-11	514-520	impact	_	
3-12	521-532	hemispheric	_	
3-13	533-547	specialization	_	
3-14	547-548	.	_	

#Text=To address these questions, we performed magnetic resonance imaging (MRI) in a large cohort of 253 participants, including 84 schizophrenia patients, 106 of their unaffected siblings and 63 healthy controls.
4-1	549-551	To	_	
4-2	552-559	address	_	
4-3	560-565	these	_	
4-4	566-575	questions	_	
4-5	575-576	,	_	
4-6	577-579	we	_	
4-7	580-589	performed	_	
4-8	590-598	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[2]	
4-9	599-608	resonance	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[2]	
4-10	609-616	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[2]	
4-11	617-618	(	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[2]	
4-12	618-621	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[2]	
4-13	621-622	)	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[2]	
4-14	623-625	in	_	
4-15	626-627	a	_	
4-16	628-633	large	_	
4-17	634-640	cohort	_	
4-18	641-643	of	_	
4-19	644-647	253	_	
4-20	648-660	participants	_	
4-21	660-661	,	_	
4-22	662-671	including	_	
4-23	672-674	84	_	
4-24	675-688	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]	
4-25	689-697	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[3]	
4-26	697-698	,	_	
4-27	699-702	106	_	
4-28	703-705	of	_	
4-29	706-711	their	_	
4-30	712-722	unaffected	_	
4-31	723-731	siblings	_	
4-32	732-735	and	_	
4-33	736-738	63	_	
4-34	739-746	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
4-35	747-755	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[4]	
4-36	755-756	.	_	

#Text=Interhemispheric connectivity and hemispheric specialization were calculated from resting-state functional connectivity, and compared across groups.
5-1	757-773	Interhemispheric	_	
5-2	774-786	connectivity	_	
5-3	787-790	and	_	
5-4	791-802	hemispheric	_	
5-5	803-817	specialization	_	
5-6	818-822	were	_	
5-7	823-833	calculated	_	
5-8	834-838	from	_	
5-9	839-852	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging	
5-10	853-863	functional	_	
5-11	864-876	connectivity	_	
5-12	876-877	,	_	
5-13	878-881	and	_	
5-14	882-890	compared	_	
5-15	891-897	across	_	
5-16	898-904	groups	_	
5-17	904-905	.	_	

#Text=Results showed that schizophrenia patients exhibit lower interhemispheric connectivity as compared to controls and siblings.
6-1	906-913	Results	_	
6-2	914-920	showed	_	
6-3	921-925	that	_	
6-4	926-939	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
6-5	940-948	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
6-6	949-956	exhibit	_	
6-7	957-962	lower	_	
6-8	963-979	interhemispheric	_	
6-9	980-992	connectivity	_	
6-10	993-995	as	_	
6-11	996-1004	compared	_	
6-12	1005-1007	to	_	
6-13	1008-1016	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
6-14	1017-1020	and	_	
6-15	1021-1029	siblings	_	
6-16	1029-1030	.	_	

#Text=In addition, patients showed higher levels of hemispheric specialization as compared to siblings.
7-1	1031-1033	In	_	
7-2	1034-1042	addition	_	
7-3	1042-1043	,	_	
7-4	1044-1052	patients	_	
7-5	1053-1059	showed	_	
7-6	1060-1066	higher	_	
7-7	1067-1073	levels	_	
7-8	1074-1076	of	_	
7-9	1077-1088	hemispheric	_	
7-10	1089-1103	specialization	_	
7-11	1104-1106	as	_	
7-12	1107-1115	compared	_	
7-13	1116-1118	to	_	
7-14	1119-1127	siblings	_	
7-15	1127-1128	.	_	

#Text=Level of interhemispheric connectivity and hemispheric specialization correlated with duration of illness in patients.
8-1	1129-1134	Level	_	
8-2	1135-1137	of	_	
8-3	1138-1154	interhemispheric	_	
8-4	1155-1167	connectivity	_	
8-5	1168-1171	and	_	
8-6	1172-1183	hemispheric	_	
8-7	1184-1198	specialization	_	
8-8	1199-1209	correlated	_	
8-9	1210-1214	with	_	
8-10	1215-1223	duration	_	
8-11	1224-1226	of	_	
8-12	1227-1234	illness	_	
8-13	1235-1237	in	_	
8-14	1238-1246	patients	_	
8-15	1246-1247	.	_	

#Text=No significant alterations were identified in siblings relative to controls on both measurements.
9-1	1248-1250	No	_	
9-2	1251-1262	significant	_	
9-3	1263-1274	alterations	_	
9-4	1275-1279	were	_	
9-5	1280-1290	identified	_	
9-6	1291-1293	in	_	
9-7	1294-1302	siblings	_	
9-8	1303-1311	relative	_	
9-9	1312-1314	to	_	
9-10	1315-1323	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
9-11	1324-1326	on	_	
9-12	1327-1331	both	_	
9-13	1332-1344	measurements	_	
9-14	1344-1345	.	_	

#Text=Furthermore, alterations in interhemispheric connectivity correlated with changes in hemispheric specialization in patients relative to controls and siblings.
10-1	1346-1357	Furthermore	_	
10-2	1357-1358	,	_	
10-3	1359-1370	alterations	_	
10-4	1371-1373	in	_	
10-5	1374-1390	interhemispheric	_	
10-6	1391-1403	connectivity	_	
10-7	1404-1414	correlated	_	
10-8	1415-1419	with	_	
10-9	1420-1427	changes	_	
10-10	1428-1430	in	_	
10-11	1431-1442	hemispheric	_	
10-12	1443-1457	specialization	_	
10-13	1458-1460	in	_	
10-14	1461-1469	patients	_	
10-15	1470-1478	relative	_	
10-16	1479-1481	to	_	
10-17	1482-1490	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
10-18	1491-1494	and	_	
10-19	1495-1503	siblings	_	
10-20	1503-1504	.	_	

#Text=Taken together, these results suggest that lower interhemispheric connectivity and associated abnormalities in hemispheric specialization are features of established illness, rather than an expression of preexistent familial risk for schizophrenia.
11-1	1505-1510	Taken	_	
11-2	1511-1519	together	_	
11-3	1519-1520	,	_	
11-4	1521-1526	these	_	
11-5	1527-1534	results	_	
11-6	1535-1542	suggest	_	
11-7	1543-1547	that	_	
11-8	1548-1553	lower	_	
11-9	1554-1570	interhemispheric	_	
11-10	1571-1583	connectivity	_	
11-11	1584-1587	and	_	
11-12	1588-1598	associated	_	
11-13	1599-1612	abnormalities	_	
11-14	1613-1615	in	_	
11-15	1616-1627	hemispheric	_	
11-16	1628-1642	specialization	_	
11-17	1643-1646	are	_	
11-18	1647-1655	features	_	
11-19	1656-1658	of	_	
11-20	1659-1670	established	_	
11-21	1671-1678	illness	_	
11-22	1678-1679	,	_	
11-23	1680-1686	rather	_	
11-24	1687-1691	than	_	
11-25	1692-1694	an	_	
11-26	1695-1705	expression	_	
11-27	1706-1708	of	_	
11-28	1709-1720	preexistent	_	
11-29	1721-1729	familial	_	
11-30	1730-1734	risk	_	
11-31	1735-1738	for	_	
11-32	1739-1752	schizophrenia	_	
11-33	1752-1753	.	_	

#Text=Highlights
#Text=Schizophrenia patients show lower interhemispheric connectivity (IC) compared to siblings and controls.
12-1	1754-1764	Highlights	_	
12-2	1765-1778	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
12-3	1779-1787	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[6]	
12-4	1788-1792	show	_	
12-5	1793-1798	lower	_	
12-6	1799-1815	interhemispheric	_	
12-7	1816-1828	connectivity	_	
12-8	1829-1830	(	_	
12-9	1830-1832	IC	_	
12-10	1832-1833	)	_	
12-11	1834-1842	compared	_	
12-12	1843-1845	to	_	
12-13	1846-1854	siblings	_	
12-14	1855-1858	and	_	
12-15	1859-1867	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
12-16	1867-1868	.	_	

#Text=Lower IC is associated with higher hemispheric specialization (HS) in patients.
13-1	1869-1874	Lower	_	
13-2	1875-1877	IC	_	
13-3	1878-1880	is	_	
13-4	1881-1891	associated	_	
13-5	1892-1896	with	_	
13-6	1897-1903	higher	_	
13-7	1904-1915	hemispheric	_	
13-8	1916-1930	specialization	_	
13-9	1931-1932	(	_	
13-10	1932-1934	HS	_	
13-11	1934-1935	)	_	
13-12	1936-1938	in	_	
13-13	1939-1947	patients	_	
13-14	1947-1948	.	_	

#Text=Siblings do not show changes on IC and HS relative to controls.
14-1	1949-1957	Siblings	_	
14-2	1958-1960	do	_	
14-3	1961-1964	not	_	
14-4	1965-1969	show	_	
14-5	1970-1977	changes	_	
14-6	1978-1980	on	_	
14-7	1981-1983	IC	_	
14-8	1984-1987	and	_	
14-9	1988-1990	HS	_	
14-10	1991-1999	relative	_	
14-11	2000-2002	to	_	
14-12	2003-2011	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
14-13	2011-2012	.	_	

#Text=Connectivity metrics (IC, HS) correlate with duration of illness in patients.
15-1	2013-2025	Connectivity	_	
15-2	2026-2033	metrics	_	
15-3	2034-2035	(	_	
15-4	2035-2037	IC	_	
15-5	2037-2038	,	_	
15-6	2039-2041	HS	_	
15-7	2041-2042	)	_	
15-8	2043-2052	correlate	_	
15-9	2053-2057	with	_	
15-10	2058-2066	duration	_	
15-11	2067-2069	of	_	
15-12	2070-2077	illness	_	
15-13	2078-2080	in	_	
15-14	2081-2089	patients	_	
15-15	2089-2090	.	_	

#Text=Introduction
#Text=Two prominent features of macroscopic brain organization are hemispheric integration, characterized as a high level of collaboration between bilateral brain regions, and hemispheric specialization, referring to the association of behavioral traits with a particular side of brain.
16-1	2091-2103	Introduction	_	
16-2	2104-2107	Two	_	
16-3	2108-2117	prominent	_	
16-4	2118-2126	features	_	
16-5	2127-2129	of	_	
16-6	2130-2141	macroscopic	_	
16-7	2142-2147	brain	_	
16-8	2148-2160	organization	_	
16-9	2161-2164	are	_	
16-10	2165-2176	hemispheric	_	
16-11	2177-2188	integration	_	
16-12	2188-2189	,	_	
16-13	2190-2203	characterized	_	
16-14	2204-2206	as	_	
16-15	2207-2208	a	_	
16-16	2209-2213	high	_	
16-17	2214-2219	level	_	
16-18	2220-2222	of	_	
16-19	2223-2236	collaboration	_	
16-20	2237-2244	between	_	
16-21	2245-2254	bilateral	_	
16-22	2255-2260	brain	_	
16-23	2261-2268	regions	_	
16-24	2268-2269	,	_	
16-25	2270-2273	and	_	
16-26	2274-2285	hemispheric	_	
16-27	2286-2300	specialization	_	
16-28	2300-2301	,	_	
16-29	2302-2311	referring	_	
16-30	2312-2314	to	_	
16-31	2315-2318	the	_	
16-32	2319-2330	association	_	
16-33	2331-2333	of	_	
16-34	2334-2344	behavioral	_	
16-35	2345-2351	traits	_	
16-36	2352-2356	with	_	
16-37	2357-2358	a	_	
16-38	2359-2369	particular	_	
16-39	2370-2374	side	_	
16-40	2375-2377	of	_	
16-41	2378-2383	brain	_	
16-42	2383-2384	.	_	

#Text=Proper integration and segregation of the two cerebral hemispheres are crucial for a broad repertoire of cognitive functions including language, visuospatial attention, and manual preference.
17-1	2385-2391	Proper	_	
17-2	2392-2403	integration	_	
17-3	2404-2407	and	_	
17-4	2408-2419	segregation	_	
17-5	2420-2422	of	_	
17-6	2423-2426	the	_	
17-7	2427-2430	two	_	
17-8	2431-2439	cerebral	_	
17-9	2440-2451	hemispheres	_	
17-10	2452-2455	are	_	
17-11	2456-2463	crucial	_	
17-12	2464-2467	for	_	
17-13	2468-2469	a	_	
17-14	2470-2475	broad	_	
17-15	2476-2486	repertoire	_	
17-16	2487-2489	of	_	
17-17	2490-2499	cognitive	_	
17-18	2500-2509	functions	_	
17-19	2510-2519	including	_	
17-20	2520-2528	language	_	
17-21	2528-2529	,	_	
17-22	2530-2542	visuospatial	_	
17-23	2543-2552	attention	_	
17-24	2552-2553	,	_	
17-25	2554-2557	and	_	
17-26	2558-2564	manual	_	
17-27	2565-2575	preference	_	
17-28	2575-2576	.	_	

#Text=Conversely, disturbances of hemispheric coordination may impact cognitive and behavioral functioning and contribute to neuropsychiatric disorders including schizophrenia.
18-1	2577-2587	Conversely	_	
18-2	2587-2588	,	_	
18-3	2589-2601	disturbances	_	
18-4	2602-2604	of	_	
18-5	2605-2616	hemispheric	_	
18-6	2617-2629	coordination	_	
18-7	2630-2633	may	_	
18-8	2634-2640	impact	_	
18-9	2641-2650	cognitive	_	
18-10	2651-2654	and	_	
18-11	2655-2665	behavioral	_	
18-12	2666-2677	functioning	_	
18-13	2678-2681	and	_	
18-14	2682-2692	contribute	_	
18-15	2693-2695	to	_	
18-16	2696-2712	neuropsychiatric	_	
18-17	2713-2722	disorders	_	
18-18	2723-2732	including	_	
18-19	2733-2746	schizophrenia	_	
18-20	2746-2747	.	_	

#Text=Multiple lines of evidence suggest that schizophrenia may involve abnormalities in interhemispheric connectivity and cooperation, which may contribute to central features of the illness such as auditory verbal hallucinations and cognitive deficits.
19-1	2748-2756	Multiple	_	
19-2	2757-2762	lines	_	
19-3	2763-2765	of	_	
19-4	2766-2774	evidence	_	
19-5	2775-2782	suggest	_	
19-6	2783-2787	that	_	
19-7	2788-2801	schizophrenia	_	
19-8	2802-2805	may	_	
19-9	2806-2813	involve	_	
19-10	2814-2827	abnormalities	_	
19-11	2828-2830	in	_	
19-12	2831-2847	interhemispheric	_	
19-13	2848-2860	connectivity	_	
19-14	2861-2864	and	_	
19-15	2865-2876	cooperation	_	
19-16	2876-2877	,	_	
19-17	2878-2883	which	_	
19-18	2884-2887	may	_	
19-19	2888-2898	contribute	_	
19-20	2899-2901	to	_	
19-21	2902-2909	central	_	
19-22	2910-2918	features	_	
19-23	2919-2921	of	_	
19-24	2922-2925	the	_	
19-25	2926-2933	illness	_	
19-26	2934-2938	such	_	
19-27	2939-2941	as	_	
19-28	2942-2950	auditory	_	
19-29	2951-2957	verbal	_	
19-30	2958-2972	hallucinations	_	
19-31	2973-2976	and	_	
19-32	2977-2986	cognitive	_	
19-33	2987-2995	deficits	_	
19-34	2995-2996	.	_	

#Text=Behavioral studies indicate that a bilateral processing advantage that is normally present during language tasks is compromised in schizophrenia patients and studies using event-related potentials (ERP) show evidence of impaired information transfer between the hemispheres during cognitive tasks in schizophrenia.
20-1	2997-3007	Behavioral	_	
20-2	3008-3015	studies	_	
20-3	3016-3024	indicate	_	
20-4	3025-3029	that	_	
20-5	3030-3031	a	_	
20-6	3032-3041	bilateral	_	
20-7	3042-3052	processing	_	
20-8	3053-3062	advantage	_	
20-9	3063-3067	that	_	
20-10	3068-3070	is	_	
20-11	3071-3079	normally	_	
20-12	3080-3087	present	_	
20-13	3088-3094	during	_	
20-14	3095-3103	language	_	
20-15	3104-3109	tasks	_	
20-16	3110-3112	is	_	
20-17	3113-3124	compromised	_	
20-18	3125-3127	in	_	
20-19	3128-3141	schizophrenia	_	
20-20	3142-3150	patients	_	
20-21	3151-3154	and	_	
20-22	3155-3162	studies	_	
20-23	3163-3168	using	_	
20-24	3169-3182	event-related	_	
20-25	3183-3193	potentials	_	
20-26	3194-3195	(	_	
20-27	3195-3198	ERP	_	
20-28	3198-3199	)	_	
20-29	3200-3204	show	_	
20-30	3205-3213	evidence	_	
20-31	3214-3216	of	_	
20-32	3217-3225	impaired	_	
20-33	3226-3237	information	_	
20-34	3238-3246	transfer	_	
20-35	3247-3254	between	_	
20-36	3255-3258	the	_	
20-37	3259-3270	hemispheres	_	
20-38	3271-3277	during	_	
20-39	3278-3287	cognitive	_	
20-40	3288-3293	tasks	_	
20-41	3294-3296	in	_	
20-42	3297-3310	schizophrenia	_	
20-43	3310-3311	.	_	

#Text=Moreover, structural neuroimaging studies report that schizophrenia patients have decreased volume and fiber integrity of the corpus callosum, the major fiber bundle connecting the two hemispheres, and fMRI studies show impaired levels of functional synchronization between homotopic brain regions (i.e., corresponding areas in the left and right hemisphere) at rest.
21-1	3312-3320	Moreover	_	
21-2	3320-3321	,	_	
21-3	3322-3332	structural	_	
21-4	3333-3345	neuroimaging	_	
21-5	3346-3353	studies	_	
21-6	3354-3360	report	_	
21-7	3361-3365	that	_	
21-8	3366-3379	schizophrenia	_	
21-9	3380-3388	patients	_	
21-10	3389-3393	have	_	
21-11	3394-3403	decreased	_	
21-12	3404-3410	volume	_	
21-13	3411-3414	and	_	
21-14	3415-3420	fiber	_	
21-15	3421-3430	integrity	_	
21-16	3431-3433	of	_	
21-17	3434-3437	the	_	
21-18	3438-3444	corpus	_	
21-19	3445-3453	callosum	_	
21-20	3453-3454	,	_	
21-21	3455-3458	the	_	
21-22	3459-3464	major	_	
21-23	3465-3470	fiber	_	
21-24	3471-3477	bundle	_	
21-25	3478-3488	connecting	_	
21-26	3489-3492	the	_	
21-27	3493-3496	two	_	
21-28	3497-3508	hemispheres	_	
21-29	3508-3509	,	_	
21-30	3510-3513	and	_	
21-31	3514-3518	fMRI	_	
21-32	3519-3526	studies	_	
21-33	3527-3531	show	_	
21-34	3532-3540	impaired	_	
21-35	3541-3547	levels	_	
21-36	3548-3550	of	_	
21-37	3551-3561	functional	_	
21-38	3562-3577	synchronization	_	
21-39	3578-3585	between	_	
21-40	3586-3595	homotopic	_	
21-41	3596-3601	brain	_	
21-42	3602-3609	regions	_	
21-43	3610-3611	(	_	
21-44	3611-3614	i.e	_	
21-45	3614-3615	.	_	
21-46	3615-3616	,	_	
21-47	3617-3630	corresponding	_	
21-48	3631-3636	areas	_	
21-49	3637-3639	in	_	
21-50	3640-3643	the	_	
21-51	3644-3648	left	_	
21-52	3649-3652	and	_	
21-53	3653-3658	right	_	
21-54	3659-3669	hemisphere	_	
21-55	3669-3670	)	_	
21-56	3671-3673	at	_	
21-57	3674-3678	rest	_	
21-58	3678-3679	.	_	

#Text=However, important open questions regarding interhemispheric connectivity in schizophrenia remain.
22-1	3680-3687	However	_	
22-2	3687-3688	,	_	
22-3	3689-3698	important	_	
22-4	3699-3703	open	_	
22-5	3704-3713	questions	_	
22-6	3714-3723	regarding	_	
22-7	3724-3740	interhemispheric	_	
22-8	3741-3753	connectivity	_	
22-9	3754-3756	in	_	
22-10	3757-3770	schizophrenia	_	
22-11	3771-3777	remain	_	
22-12	3777-3778	.	_	

#Text=First, it is unclear whether interhemispheric connectivity deficits are primarily related to the effects of the illness or a reflection of (genetic) risk for the disorder.
23-1	3779-3784	First	_	
23-2	3784-3785	,	_	
23-3	3786-3788	it	_	
23-4	3789-3791	is	_	
23-5	3792-3799	unclear	_	
23-6	3800-3807	whether	_	
23-7	3808-3824	interhemispheric	_	
23-8	3825-3837	connectivity	_	
23-9	3838-3846	deficits	_	
23-10	3847-3850	are	_	
23-11	3851-3860	primarily	_	
23-12	3861-3868	related	_	
23-13	3869-3871	to	_	
23-14	3872-3875	the	_	
23-15	3876-3883	effects	_	
23-16	3884-3886	of	_	
23-17	3887-3890	the	_	
23-18	3891-3898	illness	_	
23-19	3899-3901	or	_	
23-20	3902-3903	a	_	
23-21	3904-3914	reflection	_	
23-22	3915-3917	of	_	
23-23	3918-3919	(	_	
23-24	3919-3926	genetic	_	
23-25	3926-3927	)	_	
23-26	3928-3932	risk	_	
23-27	3933-3936	for	_	
23-28	3937-3940	the	_	
23-29	3941-3949	disorder	_	
23-30	3949-3950	.	_	

#Text=Unaffected first-degree relatives of schizophrenia patients are a valuable population to study this question as they share the genetic predisposition and environmental factors for the illness, but are not clinically affected.
24-1	3951-3961	Unaffected	_	
24-2	3962-3974	first-degree	_	
24-3	3975-3984	relatives	_	
24-4	3985-3987	of	_	
24-5	3988-4001	schizophrenia	_	
24-6	4002-4010	patients	_	
24-7	4011-4014	are	_	
24-8	4015-4016	a	_	
24-9	4017-4025	valuable	_	
24-10	4026-4036	population	_	
24-11	4037-4039	to	_	
24-12	4040-4045	study	_	
24-13	4046-4050	this	_	
24-14	4051-4059	question	_	
24-15	4060-4062	as	_	
24-16	4063-4067	they	_	
24-17	4068-4073	share	_	
24-18	4074-4077	the	_	
24-19	4078-4085	genetic	_	
24-20	4086-4100	predisposition	_	
24-21	4101-4104	and	_	
24-22	4105-4118	environmental	_	
24-23	4119-4126	factors	_	
24-24	4127-4130	for	_	
24-25	4131-4134	the	_	
24-26	4135-4142	illness	_	
24-27	4142-4143	,	_	
24-28	4144-4147	but	_	
24-29	4148-4151	are	_	
24-30	4152-4155	not	_	
24-31	4156-4166	clinically	_	
24-32	4167-4175	affected	_	
24-33	4175-4176	.	_	

#Text=Previous studies have reported abnormalities in unaffected relatives in large-scale brain regional interactions during tasks and rest, and a limited number of studies have shown subtle abnormalities in functional, and structural connectivity between homotopic brain regions in patients and relatives.
25-1	4177-4185	Previous	_	
25-2	4186-4193	studies	_	
25-3	4194-4198	have	_	
25-4	4199-4207	reported	_	
25-5	4208-4221	abnormalities	_	
25-6	4222-4224	in	_	
25-7	4225-4235	unaffected	_	
25-8	4236-4245	relatives	_	
25-9	4246-4248	in	_	
25-10	4249-4260	large-scale	_	
25-11	4261-4266	brain	_	
25-12	4267-4275	regional	_	
25-13	4276-4288	interactions	_	
25-14	4289-4295	during	_	
25-15	4296-4301	tasks	_	
25-16	4302-4305	and	_	
25-17	4306-4310	rest	_	
25-18	4310-4311	,	_	
25-19	4312-4315	and	_	
25-20	4316-4317	a	_	
25-21	4318-4325	limited	_	
25-22	4326-4332	number	_	
25-23	4333-4335	of	_	
25-24	4336-4343	studies	_	
25-25	4344-4348	have	_	
25-26	4349-4354	shown	_	
25-27	4355-4361	subtle	_	
25-28	4362-4375	abnormalities	_	
25-29	4376-4378	in	_	
25-30	4379-4389	functional	_	
25-31	4389-4390	,	_	
25-32	4391-4394	and	_	
25-33	4395-4405	structural	_	
25-34	4406-4418	connectivity	_	
25-35	4419-4426	between	_	
25-36	4427-4436	homotopic	_	
25-37	4437-4442	brain	_	
25-38	4443-4450	regions	_	
25-39	4451-4453	in	_	
25-40	4454-4462	patients	_	
25-41	4463-4466	and	_	
25-42	4467-4476	relatives	_	
25-43	4476-4477	.	_	

#Text=In the current study, we examine homotopic interhemispheric functional connectivity in a large cohort of schizophrenia patients and their nonpsychotic siblings to assess how interhemispheric connectivity alterations relate to risk for schizophrenia.
26-1	4478-4480	In	_	
26-2	4481-4484	the	_	
26-3	4485-4492	current	_	
26-4	4493-4498	study	_	
26-5	4498-4499	,	_	
26-6	4500-4502	we	_	
26-7	4503-4510	examine	_	
26-8	4511-4520	homotopic	_	
26-9	4521-4537	interhemispheric	_	
26-10	4538-4548	functional	_	
26-11	4549-4561	connectivity	_	
26-12	4562-4564	in	_	
26-13	4565-4566	a	_	
26-14	4567-4572	large	_	
26-15	4573-4579	cohort	_	
26-16	4580-4582	of	_	
26-17	4583-4596	schizophrenia	_	
26-18	4597-4605	patients	_	
26-19	4606-4609	and	_	
26-20	4610-4615	their	_	
26-21	4616-4628	nonpsychotic	_	
26-22	4629-4637	siblings	_	
26-23	4638-4640	to	_	
26-24	4641-4647	assess	_	
26-25	4648-4651	how	_	
26-26	4652-4668	interhemispheric	_	
26-27	4669-4681	connectivity	_	
26-28	4682-4693	alterations	_	
26-29	4694-4700	relate	_	
26-30	4701-4703	to	_	
26-31	4704-4708	risk	_	
26-32	4709-4712	for	_	
26-33	4713-4726	schizophrenia	_	
26-34	4726-4727	.	_	

#Text=Another open question is what the consequence of reduced interhemispheric connectivity may be for hemispheric specialization characterized by intrinsic connectivity.
27-1	4728-4735	Another	_	
27-2	4736-4740	open	_	
27-3	4741-4749	question	_	
27-4	4750-4752	is	_	
27-5	4753-4757	what	_	
27-6	4758-4761	the	_	
27-7	4762-4773	consequence	_	
27-8	4774-4776	of	_	
27-9	4777-4784	reduced	_	
27-10	4785-4801	interhemispheric	_	
27-11	4802-4814	connectivity	_	
27-12	4815-4818	may	_	
27-13	4819-4821	be	_	
27-14	4822-4825	for	_	
27-15	4826-4837	hemispheric	_	
27-16	4838-4852	specialization	_	
27-17	4853-4866	characterized	_	
27-18	4867-4869	by	_	
27-19	4870-4879	intrinsic	_	
27-20	4880-4892	connectivity	_	
27-21	4892-4893	.	_	

#Text=Traditionally, hemispheric specialization studies have focused on functional or anatomical asymmetry of homotopic brain regions.
28-1	4894-4907	Traditionally	_	
28-2	4907-4908	,	_	
28-3	4909-4920	hemispheric	_	
28-4	4921-4935	specialization	_	
28-5	4936-4943	studies	_	
28-6	4944-4948	have	_	
28-7	4949-4956	focused	_	
28-8	4957-4959	on	_	
28-9	4960-4970	functional	_	
28-10	4971-4973	or	_	
28-11	4974-4984	anatomical	_	
28-12	4985-4994	asymmetry	_	
28-13	4995-4997	of	_	
28-14	4998-5007	homotopic	_	
28-15	5008-5013	brain	_	
28-16	5014-5021	regions	_	
28-17	5021-5022	.	_	

#Text=More recently, studies have extended the concept of hemispheric specialization to include connectivity asymmetry, by investigating functional interaction patterns of brain regions in the two hemispheres.
29-1	5023-5027	More	_	
29-2	5028-5036	recently	_	
29-3	5036-5037	,	_	
29-4	5038-5045	studies	_	
29-5	5046-5050	have	_	
29-6	5051-5059	extended	_	
29-7	5060-5063	the	_	
29-8	5064-5071	concept	_	
29-9	5072-5074	of	_	
29-10	5075-5086	hemispheric	_	
29-11	5087-5101	specialization	_	
29-12	5102-5104	to	_	
29-13	5105-5112	include	_	
29-14	5113-5125	connectivity	_	
29-15	5126-5135	asymmetry	_	
29-16	5135-5136	,	_	
29-17	5137-5139	by	_	
29-18	5140-5153	investigating	_	
29-19	5154-5164	functional	_	
29-20	5165-5176	interaction	_	
29-21	5177-5185	patterns	_	
29-22	5186-5188	of	_	
29-23	5189-5194	brain	_	
29-24	5195-5202	regions	_	
29-25	5203-5205	in	_	
29-26	5206-5209	the	_	
29-27	5210-5213	two	_	
29-28	5214-5225	hemispheres	_	
29-29	5225-5226	.	_	

#Text=One such measurement is the hemispheric autonomy index, which calculates the difference in connectivity strength of a brain region with ipsilateral areas versus contralateral areas during rest.
30-1	5227-5230	One	_	
30-2	5231-5235	such	_	
30-3	5236-5247	measurement	_	
30-4	5248-5250	is	_	
30-5	5251-5254	the	_	
30-6	5255-5266	hemispheric	_	
30-7	5267-5275	autonomy	_	
30-8	5276-5281	index	_	
30-9	5281-5282	,	_	
30-10	5283-5288	which	_	
30-11	5289-5299	calculates	_	
30-12	5300-5303	the	_	
30-13	5304-5314	difference	_	
30-14	5315-5317	in	_	
30-15	5318-5330	connectivity	_	
30-16	5331-5339	strength	_	
30-17	5340-5342	of	_	
30-18	5343-5344	a	_	
30-19	5345-5350	brain	_	
30-20	5351-5357	region	_	
30-21	5358-5362	with	_	
30-22	5363-5374	ipsilateral	_	
30-23	5375-5380	areas	_	
30-24	5381-5387	versus	_	
30-25	5388-5401	contralateral	_	
30-26	5402-5407	areas	_	
30-27	5408-5414	during	_	
30-28	5415-5419	rest	_	
30-29	5419-5420	.	_	

#Text=Studies have shown that regions with high autonomy values (i.e. preferably connecting to ipsilateral areas) in the left hemisphere overlap with regions showing asymmetrical activation during language tasks, and that regional autonomy index values correlate with verbal and visuospatial behavioral scores in healthy subjects.
31-1	5421-5428	Studies	_	
31-2	5429-5433	have	_	
31-3	5434-5439	shown	_	
31-4	5440-5444	that	_	
31-5	5445-5452	regions	_	
31-6	5453-5457	with	_	
31-7	5458-5462	high	_	
31-8	5463-5471	autonomy	_	
31-9	5472-5478	values	_	
31-10	5479-5480	(	_	
31-11	5480-5483	i.e	_	
31-12	5483-5484	.	_	
31-13	5485-5495	preferably	_	
31-14	5496-5506	connecting	_	
31-15	5507-5509	to	_	
31-16	5510-5521	ipsilateral	_	
31-17	5522-5527	areas	_	
31-18	5527-5528	)	_	
31-19	5529-5531	in	_	
31-20	5532-5535	the	_	
31-21	5536-5540	left	_	
31-22	5541-5551	hemisphere	_	
31-23	5552-5559	overlap	_	
31-24	5560-5564	with	_	
31-25	5565-5572	regions	_	
31-26	5573-5580	showing	_	
31-27	5581-5593	asymmetrical	_	
31-28	5594-5604	activation	_	
31-29	5605-5611	during	_	
31-30	5612-5620	language	_	
31-31	5621-5626	tasks	_	
31-32	5626-5627	,	_	
31-33	5628-5631	and	_	
31-34	5632-5636	that	_	
31-35	5637-5645	regional	_	
31-36	5646-5654	autonomy	_	
31-37	5655-5660	index	_	
31-38	5661-5667	values	_	
31-39	5668-5677	correlate	_	
31-40	5678-5682	with	_	
31-41	5683-5689	verbal	_	
31-42	5690-5693	and	_	
31-43	5694-5706	visuospatial	_	
31-44	5707-5717	behavioral	_	
31-45	5718-5724	scores	_	
31-46	5725-5727	in	_	
31-47	5728-5735	healthy	_	
31-48	5736-5744	subjects	_	
31-49	5744-5745	.	_	

#Text=We hypothesize that impaired interhemispheric connectivity may cause the two hemispheres to function more autonomously, favoring within over between-hemisphere interregional cooperation.
32-1	5746-5748	We	_	
32-2	5749-5760	hypothesize	_	
32-3	5761-5765	that	_	
32-4	5766-5774	impaired	_	
32-5	5775-5791	interhemispheric	_	
32-6	5792-5804	connectivity	_	
32-7	5805-5808	may	_	
32-8	5809-5814	cause	_	
32-9	5815-5818	the	_	
32-10	5819-5822	two	_	
32-11	5823-5834	hemispheres	_	
32-12	5835-5837	to	_	
32-13	5838-5846	function	_	
32-14	5847-5851	more	_	
32-15	5852-5864	autonomously	_	
32-16	5864-5865	,	_	
32-17	5866-5874	favoring	_	
32-18	5875-5881	within	_	
32-19	5882-5886	over	_	
32-20	5887-5905	between-hemisphere	_	
32-21	5906-5919	interregional	_	
32-22	5920-5931	cooperation	_	
32-23	5931-5932	.	_	

#Text=To test this hypothesis, we examine how interhemispheric connectivity deficits in schizophrenia patients and their unaffected siblings relate to hemispheric specialization as quantified by the hemispheric autonomy index.
33-1	5933-5935	To	_	
33-2	5936-5940	test	_	
33-3	5941-5945	this	_	
33-4	5946-5956	hypothesis	_	
33-5	5956-5957	,	_	
33-6	5958-5960	we	_	
33-7	5961-5968	examine	_	
33-8	5969-5972	how	_	
33-9	5973-5989	interhemispheric	_	
33-10	5990-6002	connectivity	_	
33-11	6003-6011	deficits	_	
33-12	6012-6014	in	_	
33-13	6015-6028	schizophrenia	_	
33-14	6029-6037	patients	_	
33-15	6038-6041	and	_	
33-16	6042-6047	their	_	
33-17	6048-6058	unaffected	_	
33-18	6059-6067	siblings	_	
33-19	6068-6074	relate	_	
33-20	6075-6077	to	_	
33-21	6078-6089	hemispheric	_	
33-22	6090-6104	specialization	_	
33-23	6105-6107	as	_	
33-24	6108-6118	quantified	_	
33-25	6119-6121	by	_	
33-26	6122-6125	the	_	
33-27	6126-6137	hemispheric	_	
33-28	6138-6146	autonomy	_	
33-29	6147-6152	index	_	
33-30	6152-6153	.	_	

#Text=Material and methods
#Text=Participants
#Text=A total of 253 participants, including 84 schizophrenia patients, 106 of their unaffected siblings and 63 healthy controls, were recruited at the University Medical Center Utrecht between September 2004 and April 2008, as part of the Genetic Risk and Outcome of Psychosis (GROUP) study.
34-1	6154-6162	Material	http://www.case.edu/ProvCaRe/provcare#StudyMethod[7]	
34-2	6163-6166	and	http://www.case.edu/ProvCaRe/provcare#StudyMethod[7]	
34-3	6167-6174	methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod[7]	
34-4	6175-6187	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-5	6188-6189	A	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-6	6190-6195	total	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-7	6196-6198	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-8	6199-6202	253	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-9	6203-6215	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-10	6215-6216	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-11	6217-6226	including	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-12	6227-6229	84	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-13	6230-6243	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]	
34-14	6244-6252	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]	
34-15	6252-6253	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-16	6254-6257	106	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-17	6258-6260	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-18	6261-6266	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-19	6267-6277	unaffected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-20	6278-6286	siblings	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-21	6287-6290	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-22	6291-6293	63	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-23	6294-6301	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[10]	
34-24	6302-6310	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[10]	
34-25	6310-6311	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-26	6312-6316	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-27	6317-6326	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-28	6327-6329	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-29	6330-6333	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-30	6334-6344	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-31	6345-6352	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-32	6353-6359	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-33	6360-6367	Utrecht	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-34	6368-6375	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-35	6376-6385	September	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-36	6386-6390	2004	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-37	6391-6394	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-38	6395-6400	April	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-39	6401-6405	2008	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-40	6405-6406	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-41	6407-6409	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-42	6410-6414	part	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-43	6415-6417	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-44	6418-6421	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-45	6422-6429	Genetic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-46	6430-6434	Risk	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-47	6435-6438	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-48	6439-6446	Outcome	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-49	6447-6449	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-50	6450-6459	Psychosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-51	6460-6461	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-52	6461-6466	GROUP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-53	6466-6467	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-54	6468-6473	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
34-55	6473-6474	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=The GROUP study was conducted by four university psychiatric centers and their affiliated mental health care institutions in the Netherlands.
35-1	6475-6478	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-2	6479-6484	GROUP	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-3	6485-6490	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-4	6491-6494	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-5	6495-6504	conducted	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-6	6505-6507	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-7	6508-6512	four	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-8	6513-6523	university	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-9	6524-6535	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-10	6536-6543	centers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-11	6544-6547	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-12	6548-6553	their	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-13	6554-6564	affiliated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-14	6565-6571	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-15	6572-6578	health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-16	6579-6583	care	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-17	6584-6596	institutions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-18	6597-6599	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-19	6600-6603	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-20	6604-6615	Netherlands	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
35-21	6615-6616	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=The medical ethics committee of the University Medical Center Utrecht approved the current study.
36-1	6617-6620	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-2	6621-6628	medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-3	6629-6635	ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-4	6636-6645	committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-5	6646-6648	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-6	6649-6652	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-7	6653-6663	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-8	6664-6671	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-9	6672-6678	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-10	6679-6686	Utrecht	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-11	6687-6695	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-12	6696-6699	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-13	6700-6707	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-14	6708-6713	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
36-15	6713-6714	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=All subjects provided written informed consent prior to participation.
37-1	6715-6718	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-2	6719-6727	subjects	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-3	6728-6736	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-4	6737-6744	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-5	6745-6753	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-6	6754-6761	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-7	6762-6767	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-8	6768-6770	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-9	6771-6784	participation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
37-10	6784-6785	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	

#Text=For all participants, presence or absence of current and lifetime psychopathology was established using the Comprehensive Assessment of Symptoms and History (CASH).
38-1	6786-6789	For	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-2	6790-6793	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-3	6794-6806	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-4	6806-6807	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-5	6808-6816	presence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-6	6817-6819	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-7	6820-6827	absence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-8	6828-6830	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-9	6831-6838	current	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-10	6839-6842	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-11	6843-6851	lifetime	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-12	6852-6867	psychopathology	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-13	6868-6871	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-14	6872-6883	established	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-15	6884-6889	using	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-16	6890-6893	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
38-17	6894-6907	Comprehensive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-18	6908-6918	Assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-19	6919-6921	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-20	6922-6930	Symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-21	6931-6934	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-22	6935-6942	History	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-23	6943-6944	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-24	6944-6948	CASH	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-25	6948-6949	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]|http://maven.renci.org/NeuroBridge/neurobridge#ComprehensiveAssessmentofSymptomsandHistory[13]	
38-26	6949-6950	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	

#Text=This semi-structured interview is designed to obtain comprehensive information on current and past signs and symptoms of major psychiatric disorders, premorbid functioning, sociodemographic status, treatment, and course of illness.
39-1	6951-6955	This	_	
39-2	6956-6971	semi-structured	_	
39-3	6972-6981	interview	_	
39-4	6982-6984	is	_	
39-5	6985-6993	designed	_	
39-6	6994-6996	to	_	
39-7	6997-7003	obtain	_	
39-8	7004-7017	comprehensive	_	
39-9	7018-7029	information	_	
39-10	7030-7032	on	_	
39-11	7033-7040	current	_	
39-12	7041-7044	and	_	
39-13	7045-7049	past	_	
39-14	7050-7055	signs	_	
39-15	7056-7059	and	_	
39-16	7060-7068	symptoms	_	
39-17	7069-7071	of	_	
39-18	7072-7077	major	_	
39-19	7078-7089	psychiatric	_	
39-20	7090-7099	disorders	_	
39-21	7099-7100	,	_	
39-22	7101-7110	premorbid	_	
39-23	7111-7122	functioning	_	
39-24	7122-7123	,	_	
39-25	7124-7140	sociodemographic	_	
39-26	7141-7147	status	_	
39-27	7147-7148	,	_	
39-28	7149-7158	treatment	_	
39-29	7158-7159	,	_	
39-30	7160-7163	and	_	
39-31	7164-7170	course	_	
39-32	7171-7173	of	_	
39-33	7174-7181	illness	_	
39-34	7181-7182	.	_	

#Text=Patients were included if they met Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) criteria for schizophrenia or schizoaffective disorder.
40-1	7183-7191	Patients	_	
40-2	7192-7196	were	_	
40-3	7197-7205	included	_	
40-4	7206-7208	if	_	
40-5	7209-7213	they	_	
40-6	7214-7217	met	_	
40-7	7218-7228	Diagnostic	_	
40-8	7229-7232	and	_	
40-9	7233-7244	Statistical	_	
40-10	7245-7251	Manual	_	
40-11	7252-7254	of	_	
40-12	7255-7261	Mental	_	
40-13	7262-7271	Disorders	_	
40-14	7272-7278	fourth	_	
40-15	7279-7286	edition	_	
40-16	7287-7288	(	_	
40-17	7288-7294	DSM-IV	_	
40-18	7294-7295	)	_	
40-19	7296-7304	criteria	_	
40-20	7305-7308	for	_	
40-21	7309-7322	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
40-22	7323-7325	or	_	
40-23	7326-7341	schizoaffective	http://maven.renci.org/NeuroBridge/neurobridge#SchizoaffectiveDisorder	
40-24	7342-7350	disorder	_	
40-25	7350-7351	.	_	

#Text=Symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS).
41-1	7352-7359	Symptom	_	
41-2	7360-7368	severity	_	
41-3	7369-7372	was	_	
41-4	7373-7381	assessed	_	
41-5	7382-7387	using	_	
41-6	7388-7391	the	_	
41-7	7392-7400	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	
41-8	7401-7404	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	
41-9	7405-7413	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	
41-10	7414-7422	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	
41-11	7423-7428	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	
41-12	7429-7430	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	
41-13	7430-7435	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	
41-14	7435-7436	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	
41-15	7436-7437	.	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[14]	

#Text=The dosage of antipsychotic medication patients were taking at the time of scanning were converted to a chlorpromazine equivalent dosage.
42-1	7438-7441	The	_	
42-2	7442-7448	dosage	http://maven.renci.org/NeuroBridge/neurobridge#MedicationStatus[15]	
42-3	7449-7451	of	http://maven.renci.org/NeuroBridge/neurobridge#MedicationStatus[15]	
42-4	7452-7465	antipsychotic	http://maven.renci.org/NeuroBridge/neurobridge#MedicationStatus[15]	
42-5	7466-7476	medication	http://maven.renci.org/NeuroBridge/neurobridge#MedicationStatus[15]	
42-6	7477-7485	patients	_	
42-7	7486-7490	were	_	
42-8	7491-7497	taking	_	
42-9	7498-7500	at	_	
42-10	7501-7504	the	_	
42-11	7505-7509	time	_	
42-12	7510-7512	of	_	
42-13	7513-7521	scanning	_	
42-14	7522-7526	were	_	
42-15	7527-7536	converted	_	
42-16	7537-7539	to	_	
42-17	7540-7541	a	_	
42-18	7542-7556	chlorpromazine	_	
42-19	7557-7567	equivalent	_	
42-20	7568-7574	dosage	_	
42-21	7574-7575	.	_	

#Text=Demographic and clinical information of the three groups of participants (controls, siblings, schizophrenia N = 63, 106, 84).
43-1	7576-7587	Demographic	_	
43-2	7588-7591	and	_	
43-3	7592-7600	clinical	_	
43-4	7601-7612	information	_	
43-5	7613-7615	of	_	
43-6	7616-7619	the	_	
43-7	7620-7625	three	_	
43-8	7626-7632	groups	_	
43-9	7633-7635	of	_	
43-10	7636-7648	participants	_	
43-11	7649-7650	(	_	
43-12	7650-7658	controls	_	
43-13	7658-7659	,	_	
43-14	7660-7668	siblings	_	
43-15	7668-7669	,	_	
43-16	7670-7683	schizophrenia	_	
43-17	7684-7685	N	_	
43-18	7685-7686	 	_	
43-19	7686-7687	=	_	
43-20	7687-7688	 	_	
43-21	7688-7690	63	_	
43-22	7690-7691	,	_	
43-23	7692-7695	106	_	
43-24	7695-7696	,	_	
43-25	7697-7699	84	_	
43-26	7699-7700	)	_	
43-27	7700-7701	.	_	

#Text=Table 1\t \t
#Text=\tControls\tSiblings\tPatients\tStatisticsa\t \tAge\t29.16 ± 7.59\t29.50 ± 7.65\t29.86 ± 5.27\tF(2,250) = 0.18, p = .83\t \tSex (M / F)\t29/34\t49 / 57\t70/14\tχ(2)2 = 31.95, p < .001\t \tIQ\t113.76 ± 15.66\t105.96 ± 17.10\t95.99 ± 15.21\tF(2,250) = 20.54, p < .001\t \tHandedness (right / left / mixed)\t44/8/1\t94/6/6\t70/5/4\tχ(2)2 = 5.63, p = .23\t \tScanner (#1 / #2)\t28 / 28\t59 / 47\t49 / 33\tχ(2)2 = 1.28, p = .53\t \tIllness duration (years)b\t–\t–\t5.91 (4.12)\t–\t \tChlorpromazine dosage (mg/day)\t–\t–\t300 (200, 600)\t–\t \tPANSS total\t–\t–\t48.38 ± 14.89\t–\t \tPANSS positive\t–\t–\t11.58 ± 5.42\t–\t \tPANSS negative\t–\t–\t12.23 ± 4.35\t–\t \tPANSS general psychopathology\t–\t–\t24.57 ± 7.05\t–\t \t
#Text=Group comparison of continuous variables (Age, IQ) are tested with one-way analysis of variance (ANOVA).
44-1	7702-7707	Table	_	
44-2	7708-7709	1	_	
44-3	7714-7722	Controls	_	
44-4	7723-7731	Siblings	_	
44-5	7732-7740	Patients	_	
44-6	7741-7752	Statisticsa	_	
44-7	7755-7758	Age	_	
44-8	7759-7764	29.16	_	
44-9	7764-7765	 	_	
44-10	7765-7766	±	_	
44-11	7766-7767	 	_	
44-12	7767-7771	7.59	_	
44-13	7772-7777	29.50	_	
44-14	7777-7778	 	_	
44-15	7778-7779	±	_	
44-16	7779-7780	 	_	
44-17	7780-7784	7.65	_	
44-18	7785-7790	29.86	_	
44-19	7790-7791	 	_	
44-20	7791-7792	±	_	
44-21	7792-7793	 	_	
44-22	7793-7797	5.27	_	
44-23	7798-7799	F	_	
44-24	7799-7800	(	_	
44-25	7800-7805	2,250	_	
44-26	7805-7806	)	_	
44-27	7806-7807	 	_	
44-28	7807-7808	=	_	
44-29	7808-7809	 	_	
44-30	7809-7813	0.18	_	
44-31	7813-7814	,	_	
44-32	7815-7816	p	_	
44-33	7816-7817	 	_	
44-34	7817-7818	=	_	
44-35	7818-7819	 	_	
44-36	7819-7822	.83	_	
44-37	7825-7828	Sex	_	
44-38	7829-7830	(	_	
44-39	7830-7831	M	_	
44-40	7832-7833	/	_	
44-41	7834-7835	F	_	
44-42	7835-7836	)	_	
44-43	7837-7839	29	_	
44-44	7839-7840	/	_	
44-45	7840-7842	34	_	
44-46	7843-7845	49	_	
44-47	7846-7847	/	_	
44-48	7848-7850	57	_	
44-49	7851-7853	70	_	
44-50	7853-7854	/	_	
44-51	7854-7856	14	_	
44-52	7857-7858	χ	_	
44-53	7858-7859	(	_	
44-54	7859-7860	2	_	
44-55	7860-7861	)	_	
44-56	7861-7862	2	_	
44-57	7862-7863	 	_	
44-58	7863-7864	=	_	
44-59	7864-7865	 	_	
44-60	7865-7870	31.95	_	
44-61	7870-7871	,	_	
44-62	7872-7873	p	_	
44-63	7873-7874	 	_	
44-64	7874-7875	<	_	
44-65	7875-7876	 	_	
44-66	7876-7880	.001	_	
44-67	7883-7885	IQ	_	
44-68	7886-7892	113.76	_	
44-69	7892-7893	 	_	
44-70	7893-7894	±	_	
44-71	7894-7895	 	_	
44-72	7895-7900	15.66	_	
44-73	7901-7907	105.96	_	
44-74	7907-7908	 	_	
44-75	7908-7909	±	_	
44-76	7909-7910	 	_	
44-77	7910-7915	17.10	_	
44-78	7916-7921	95.99	_	
44-79	7921-7922	 	_	
44-80	7922-7923	±	_	
44-81	7923-7924	 	_	
44-82	7924-7929	15.21	_	
44-83	7930-7931	F	_	
44-84	7931-7932	(	_	
44-85	7932-7937	2,250	_	
44-86	7937-7938	)	_	
44-87	7938-7939	 	_	
44-88	7939-7940	=	_	
44-89	7940-7941	 	_	
44-90	7941-7946	20.54	_	
44-91	7946-7947	,	_	
44-92	7948-7949	p	_	
44-93	7949-7950	 	_	
44-94	7950-7951	<	_	
44-95	7951-7952	 	_	
44-96	7952-7956	.001	_	
44-97	7959-7969	Handedness	_	
44-98	7970-7971	(	_	
44-99	7971-7976	right	_	
44-100	7977-7978	/	_	
44-101	7979-7983	left	_	
44-102	7984-7985	/	_	
44-103	7986-7991	mixed	_	
44-104	7991-7992	)	_	
44-105	7993-7995	44	_	
44-106	7995-7996	/	_	
44-107	7996-7997	8	_	
44-108	7997-7998	/	_	
44-109	7998-7999	1	_	
44-110	8000-8002	94	_	
44-111	8002-8003	/	_	
44-112	8003-8004	6	_	
44-113	8004-8005	/	_	
44-114	8005-8006	6	_	
44-115	8007-8009	70	_	
44-116	8009-8010	/	_	
44-117	8010-8011	5	_	
44-118	8011-8012	/	_	
44-119	8012-8013	4	_	
44-120	8014-8015	χ	_	
44-121	8015-8016	(	_	
44-122	8016-8017	2	_	
44-123	8017-8018	)	_	
44-124	8018-8019	2	_	
44-125	8019-8020	 	_	
44-126	8020-8021	=	_	
44-127	8021-8022	 	_	
44-128	8022-8026	5.63	_	
44-129	8026-8027	,	_	
44-130	8028-8029	p	_	
44-131	8029-8030	 	_	
44-132	8030-8031	=	_	
44-133	8031-8032	 	_	
44-134	8032-8035	.23	_	
44-135	8038-8045	Scanner	_	
44-136	8046-8047	(	_	
44-137	8047-8049	#1	_	
44-138	8050-8051	/	_	
44-139	8052-8054	#2	_	
44-140	8054-8055	)	_	
44-141	8056-8058	28	_	
44-142	8059-8060	/	_	
44-143	8061-8063	28	_	
44-144	8064-8066	59	_	
44-145	8067-8068	/	_	
44-146	8069-8071	47	_	
44-147	8072-8074	49	_	
44-148	8075-8076	/	_	
44-149	8077-8079	33	_	
44-150	8080-8081	χ	_	
44-151	8081-8082	(	_	
44-152	8082-8083	2	_	
44-153	8083-8084	)	_	
44-154	8084-8085	2	_	
44-155	8085-8086	 	_	
44-156	8086-8087	=	_	
44-157	8087-8088	 	_	
44-158	8088-8092	1.28	_	
44-159	8092-8093	,	_	
44-160	8094-8095	p	_	
44-161	8095-8096	 	_	
44-162	8096-8097	=	_	
44-163	8097-8098	 	_	
44-164	8098-8101	.53	_	
44-165	8104-8111	Illness	_	
44-166	8112-8120	duration	_	
44-167	8121-8122	(	_	
44-168	8122-8127	years	_	
44-169	8127-8128	)	_	
44-170	8128-8129	b	_	
44-171	8130-8131	–	_	
44-172	8132-8133	–	_	
44-173	8134-8138	5.91	_	
44-174	8139-8140	(	_	
44-175	8140-8144	4.12	_	
44-176	8144-8145	)	_	
44-177	8146-8147	–	_	
44-178	8150-8164	Chlorpromazine	_	
44-179	8165-8171	dosage	_	
44-180	8172-8173	(	_	
44-181	8173-8175	mg	_	
44-182	8175-8176	/	_	
44-183	8176-8179	day	_	
44-184	8179-8180	)	_	
44-185	8181-8182	–	_	
44-186	8183-8184	–	_	
44-187	8185-8188	300	_	
44-188	8189-8190	(	_	
44-189	8190-8193	200	_	
44-190	8193-8194	,	_	
44-191	8195-8198	600	_	
44-192	8198-8199	)	_	
44-193	8200-8201	–	_	
44-194	8204-8209	PANSS	_	
44-195	8210-8215	total	_	
44-196	8216-8217	–	_	
44-197	8218-8219	–	_	
44-198	8220-8225	48.38	_	
44-199	8225-8226	 	_	
44-200	8226-8227	±	_	
44-201	8227-8228	 	_	
44-202	8228-8233	14.89	_	
44-203	8234-8235	–	_	
44-204	8238-8243	PANSS	_	
44-205	8244-8252	positive	_	
44-206	8253-8254	–	_	
44-207	8255-8256	–	_	
44-208	8257-8262	11.58	_	
44-209	8262-8263	 	_	
44-210	8263-8264	±	_	
44-211	8264-8265	 	_	
44-212	8265-8269	5.42	_	
44-213	8270-8271	–	_	
44-214	8274-8279	PANSS	_	
44-215	8280-8288	negative	_	
44-216	8289-8290	–	_	
44-217	8291-8292	–	_	
44-218	8293-8298	12.23	_	
44-219	8298-8299	 	_	
44-220	8299-8300	±	_	
44-221	8300-8301	 	_	
44-222	8301-8305	4.35	_	
44-223	8306-8307	–	_	
44-224	8310-8315	PANSS	_	
44-225	8316-8323	general	_	
44-226	8324-8339	psychopathology	_	
44-227	8340-8341	–	_	
44-228	8342-8343	–	_	
44-229	8344-8349	24.57	_	
44-230	8349-8350	 	_	
44-231	8350-8351	±	_	
44-232	8351-8352	 	_	
44-233	8352-8356	7.05	_	
44-234	8357-8358	–	_	
44-235	8362-8367	Group	_	
44-236	8368-8378	comparison	_	
44-237	8379-8381	of	_	
44-238	8382-8392	continuous	_	
44-239	8393-8402	variables	_	
44-240	8403-8404	(	_	
44-241	8404-8407	Age	_	
44-242	8407-8408	,	_	
44-243	8409-8411	IQ	_	
44-244	8411-8412	)	_	
44-245	8413-8416	are	_	
44-246	8417-8423	tested	_	
44-247	8424-8428	with	_	
44-248	8429-8436	one-way	_	
44-249	8437-8445	analysis	_	
44-250	8446-8448	of	_	
44-251	8449-8457	variance	_	
44-252	8458-8459	(	_	
44-253	8459-8464	ANOVA	_	
44-254	8464-8465	)	_	
44-255	8465-8466	.	_	

#Text=Nominal variables (sex, handedness, scanner) were compared using chi-square statistics.
45-1	8467-8474	Nominal	_	
45-2	8475-8484	variables	_	
45-3	8485-8486	(	_	
45-4	8486-8489	sex	_	
45-5	8489-8490	,	_	
45-6	8491-8501	handedness	_	
45-7	8501-8502	,	_	
45-8	8503-8510	scanner	_	
45-9	8510-8511	)	_	
45-10	8512-8516	were	_	
45-11	8517-8525	compared	_	
45-12	8526-8531	using	_	
45-13	8532-8542	chi-square	_	
45-14	8543-8553	statistics	_	
45-15	8553-8554	.	_	

#Text=Distribution of illness duration and medication is skewed, therefore median and inter-quartile range was reported.
46-1	8555-8567	Distribution	_	
46-2	8568-8570	of	_	
46-3	8571-8578	illness	_	
46-4	8579-8587	duration	_	
46-5	8588-8591	and	_	
46-6	8592-8602	medication	_	
46-7	8603-8605	is	_	
46-8	8606-8612	skewed	_	
46-9	8612-8613	,	_	
46-10	8614-8623	therefore	_	
46-11	8624-8630	median	_	
46-12	8631-8634	and	_	
46-13	8635-8649	inter-quartile	_	
46-14	8650-8655	range	_	
46-15	8656-8659	was	_	
46-16	8660-8668	reported	_	
46-17	8668-8669	.	_	

#Text=Patients and siblings originated from 120 unique families and included 48 patient-sibling pairs or triplets.
47-1	8670-8678	Patients	_	
47-2	8679-8682	and	_	
47-3	8683-8691	siblings	_	
47-4	8692-8702	originated	_	
47-5	8703-8707	from	_	
47-6	8708-8711	120	_	
47-7	8712-8718	unique	_	
47-8	8719-8727	families	_	
47-9	8728-8731	and	_	
47-10	8732-8740	included	_	
47-11	8741-8743	48	_	
47-12	8744-8759	patient-sibling	_	
47-13	8760-8765	pairs	_	
47-14	8766-8768	or	_	
47-15	8769-8777	triplets	_	
47-16	8777-8778	.	_	

#Text=The control group comprised 63 subjects from 57 families.
48-1	8779-8782	The	_	
48-2	8783-8790	control	_	
48-3	8791-8796	group	_	
48-4	8797-8806	comprised	_	
48-5	8807-8809	63	_	
48-6	8810-8818	subjects	_	
48-7	8819-8823	from	_	
48-8	8824-8826	57	_	
48-9	8827-8835	families	_	
48-10	8835-8836	.	_	

#Text=A family identification code (family ID) was assigned to every subject to keep track of their pedigrees.
49-1	8837-8838	A	_	
49-2	8839-8845	family	_	
49-3	8846-8860	identification	_	
49-4	8861-8865	code	_	
49-5	8866-8867	(	_	
49-6	8867-8873	family	_	
49-7	8874-8876	ID	_	
49-8	8876-8877	)	_	
49-9	8878-8881	was	_	
49-10	8882-8890	assigned	_	
49-11	8891-8893	to	_	
49-12	8894-8899	every	_	
49-13	8900-8907	subject	_	
49-14	8908-8910	to	_	
49-15	8911-8915	keep	_	
49-16	8916-8921	track	_	
49-17	8922-8924	of	_	
49-18	8925-8930	their	_	
49-19	8931-8940	pedigrees	_	
49-20	8940-8941	.	_	

#Text=Siblings and healthy controls were excluded for any current or previous psychotic disorder.
50-1	8942-8950	Siblings	_	
50-2	8951-8954	and	_	
50-3	8955-8962	healthy	_	
50-4	8963-8971	controls	_	
50-5	8972-8976	were	_	
50-6	8977-8985	excluded	_	
50-7	8986-8989	for	_	
50-8	8990-8993	any	_	
50-9	8994-9001	current	_	
50-10	9002-9004	or	_	
50-11	9005-9013	previous	_	
50-12	9014-9023	psychotic	_	
50-13	9024-9032	disorder	_	
50-14	9032-9033	.	_	

#Text=In addition, controls were examined with the Family Interview for Genetic Studies, to exclude a family history of psychotic disorders (in first- or second-degree relatives).
51-1	9034-9036	In	_	
51-2	9037-9045	addition	_	
51-3	9045-9046	,	_	
51-4	9047-9055	controls	_	
51-5	9056-9060	were	_	
51-6	9061-9069	examined	_	
51-7	9070-9074	with	_	
51-8	9075-9078	the	_	
51-9	9079-9085	Family	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies[16]	
51-10	9086-9095	Interview	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies[16]	
51-11	9096-9099	for	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies[16]	
51-12	9100-9107	Genetic	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies[16]	
51-13	9108-9115	Studies	http://maven.renci.org/NeuroBridge/neurobridge#DiagnosticInterviewforGeneticStudies[16]	
51-14	9115-9116	,	_	
51-15	9117-9119	to	_	
51-16	9120-9127	exclude	_	
51-17	9128-9129	a	_	
51-18	9130-9136	family	_	
51-19	9137-9144	history	_	
51-20	9145-9147	of	_	
51-21	9148-9157	psychotic	_	
51-22	9158-9167	disorders	_	
51-23	9168-9169	(	_	
51-24	9169-9171	in	_	
51-25	9172-9177	first	_	
51-26	9177-9178	-	_	
51-27	9179-9181	or	_	
51-28	9182-9195	second-degree	_	
51-29	9196-9205	relatives	_	
51-30	9205-9206	)	_	
51-31	9206-9207	.	_	

#Text=Exclusion criteria for all participants included a history of head trauma or major medical or neurological illness.
52-1	9208-9217	Exclusion	_	
52-2	9218-9226	criteria	_	
52-3	9227-9230	for	_	
52-4	9231-9234	all	_	
52-5	9235-9247	participants	_	
52-6	9248-9256	included	_	
52-7	9257-9258	a	_	
52-8	9259-9266	history	_	
52-9	9267-9269	of	_	
52-10	9270-9274	head	_	
52-11	9275-9281	trauma	_	
52-12	9282-9284	or	_	
52-13	9285-9290	major	_	
52-14	9291-9298	medical	_	
52-15	9299-9301	or	_	
52-16	9302-9314	neurological	_	
52-17	9315-9322	illness	_	
52-18	9322-9323	.	_	

#Text=All participants were between 18 and 60 years of age at the time of inclusion.
53-1	9324-9327	All	_	
53-2	9328-9340	participants	_	
53-3	9341-9345	were	_	
53-4	9346-9353	between	_	
53-5	9354-9356	18	_	
53-6	9357-9360	and	_	
53-7	9361-9363	60	_	
53-8	9363-9364	 	_	
53-9	9364-9369	years	_	
53-10	9370-9372	of	_	
53-11	9373-9376	age	_	
53-12	9377-9379	at	_	
53-13	9380-9383	the	_	
53-14	9384-9388	time	_	
53-15	9389-9391	of	_	
53-16	9392-9401	inclusion	_	
53-17	9401-9402	.	_	

#Text=Demographics and clinical information are described in Table 1.
54-1	9403-9415	Demographics	_	
54-2	9416-9419	and	_	
54-3	9420-9428	clinical	_	
54-4	9429-9440	information	_	
54-5	9441-9444	are	_	
54-6	9445-9454	described	_	
54-7	9455-9457	in	_	
54-8	9458-9463	Table	_	
54-9	9464-9465	1	_	
54-10	9465-9466	.	_	

#Text=Data acquisition
#Text=MRI scans were acquired on two 1.5 T Philips Achieva scanners at the University Medical Center Utrecht, with the same acquisition protocol.
55-1	9467-9471	Data	_	
55-2	9472-9483	acquisition	_	
55-3	9484-9487	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[17]	
55-4	9488-9493	scans	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[17]	
55-5	9494-9498	were	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[17]	
55-6	9499-9507	acquired	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[17]	
55-7	9508-9510	on	_	
55-8	9511-9514	two	_	
55-9	9515-9518	1.5	_	
55-10	9518-9519	 	_	
55-11	9519-9520	T	_	
55-12	9521-9528	Philips	_	
55-13	9529-9536	Achieva	_	
55-14	9537-9545	scanners	_	
55-15	9546-9548	at	_	
55-16	9549-9552	the	_	
55-17	9553-9563	University	_	
55-18	9564-9571	Medical	_	
55-19	9572-9578	Center	_	
55-20	9579-9586	Utrecht	_	
55-21	9586-9587	,	_	
55-22	9588-9592	with	_	
55-23	9593-9596	the	_	
55-24	9597-9601	same	_	
55-25	9602-9613	acquisition	_	
55-26	9614-9622	protocol	_	
55-27	9622-9623	.	_	

#Text=The scanner information was included as a covariate in further group-comparisons.
56-1	9624-9627	The	_	
56-2	9628-9635	scanner	_	
56-3	9636-9647	information	_	
56-4	9648-9651	was	_	
56-5	9652-9660	included	_	
56-6	9661-9663	as	_	
56-7	9664-9665	a	_	
56-8	9666-9675	covariate	_	
56-9	9676-9678	in	_	
56-10	9679-9686	further	_	
56-11	9687-9704	group-comparisons	_	
56-12	9704-9705	.	_	

#Text=For each subject, resting-state functional magnetic resonance imaging (fMRI) time series were acquired with a three dimensional (3D) echo shifting with a train of observations (PRESTO) acquisition scheme.
57-1	9706-9709	For	_	
57-2	9710-9714	each	_	
57-3	9715-9722	subject	_	
57-4	9722-9723	,	_	
57-5	9724-9737	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[18]	
57-6	9738-9748	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[18]	
57-7	9749-9757	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[18]	
57-8	9758-9767	resonance	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[18]	
57-9	9768-9775	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[18]	
57-10	9776-9777	(	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[18]	
57-11	9777-9781	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[18]	
57-12	9781-9782	)	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[18]	
57-13	9783-9787	time	_	
57-14	9788-9794	series	_	
57-15	9795-9799	were	_	
57-16	9800-9808	acquired	_	
57-17	9809-9813	with	_	
57-18	9814-9815	a	_	
57-19	9816-9821	three	_	
57-20	9822-9833	dimensional	_	
57-21	9834-9835	(	_	
57-22	9835-9837	3D	_	
57-23	9837-9838	)	_	
57-24	9839-9843	echo	_	
57-25	9844-9852	shifting	_	
57-26	9853-9857	with	_	
57-27	9858-9859	a	_	
57-28	9860-9865	train	_	
57-29	9866-9868	of	_	
57-30	9869-9881	observations	_	
57-31	9882-9883	(	_	
57-32	9883-9889	PRESTO	_	
57-33	9889-9890	)	_	
57-34	9891-9902	acquisition	_	
57-35	9903-9909	scheme	_	
57-36	9909-9910	.	_	

#Text=The PRESTO protocol combines the echo shifting technique with multiple gradient echoes per excitation to allow for a repetition time shorter than echo time.
58-1	9911-9914	The	_	
58-2	9915-9921	PRESTO	_	
58-3	9922-9930	protocol	_	
58-4	9931-9939	combines	_	
58-5	9940-9943	the	_	
58-6	9944-9948	echo	_	
58-7	9949-9957	shifting	_	
58-8	9958-9967	technique	_	
58-9	9968-9972	with	_	
58-10	9973-9981	multiple	_	
58-11	9982-9990	gradient	_	
58-12	9991-9997	echoes	_	
58-13	9998-10001	per	_	
58-14	10002-10012	excitation	_	
58-15	10013-10015	to	_	
58-16	10016-10021	allow	_	
58-17	10022-10025	for	_	
58-18	10026-10027	a	_	
58-19	10028-10038	repetition	_	
58-20	10039-10043	time	_	
58-21	10044-10051	shorter	_	
58-22	10052-10056	than	_	
58-23	10057-10061	echo	_	
58-24	10062-10066	time	_	
58-25	10066-10067	.	_	

#Text=The acquisition parameters were: TR / TE = 21.1 / 31.1 ms; flip angle = 90°; field of view = 256 × 256 mm2, voxel size = 4 × 4 × 4 mm3, 900 time frames, consisting of 32 slices covering whole brain.
59-1	10068-10071	The	_	
59-2	10072-10083	acquisition	_	
59-3	10084-10094	parameters	_	
59-4	10095-10099	were	_	
59-5	10099-10100	:	_	
59-6	10101-10103	TR	_	
59-7	10104-10105	/	_	
59-8	10106-10108	TE	_	
59-9	10108-10109	 	_	
59-10	10109-10110	=	_	
59-11	10110-10111	 	_	
59-12	10111-10115	21.1	_	
59-13	10116-10117	/	_	
59-14	10118-10122	31.1	_	
59-15	10122-10123	 	_	
59-16	10123-10125	ms	_	
59-17	10125-10126	;	_	
59-18	10127-10131	flip	_	
59-19	10132-10137	angle	_	
59-20	10137-10138	 	_	
59-21	10138-10139	=	_	
59-22	10139-10140	 	_	
59-23	10140-10142	90	_	
59-24	10142-10143	°	_	
59-25	10143-10144	;	_	
59-26	10145-10150	field	_	
59-27	10151-10153	of	_	
59-28	10154-10158	view	_	
59-29	10158-10159	 	_	
59-30	10159-10160	=	_	
59-31	10160-10161	 	_	
59-32	10161-10164	256	_	
59-33	10164-10165	 	_	
59-34	10165-10166	×	_	
59-35	10166-10167	 	_	
59-36	10167-10170	256	_	
59-37	10170-10171	 	_	
59-38	10171-10174	mm2	_	
59-39	10174-10175	,	_	
59-40	10176-10181	voxel	_	
59-41	10182-10186	size	_	
59-42	10186-10187	 	_	
59-43	10187-10188	=	_	
59-44	10188-10189	 	_	
59-45	10189-10190	4	_	
59-46	10190-10191	 	_	
59-47	10191-10192	×	_	
59-48	10192-10193	 	_	
59-49	10193-10194	4	_	
59-50	10194-10195	 	_	
59-51	10195-10196	×	_	
59-52	10196-10197	 	_	
59-53	10197-10198	4	_	
59-54	10198-10199	 	_	
59-55	10199-10202	mm3	_	
59-56	10202-10203	,	_	
59-57	10204-10207	900	_	
59-58	10208-10212	time	_	
59-59	10213-10219	frames	_	
59-60	10219-10220	,	_	
59-61	10221-10231	consisting	_	
59-62	10232-10234	of	_	
59-63	10235-10237	32	_	
59-64	10238-10244	slices	_	
59-65	10245-10253	covering	_	
59-66	10254-10259	whole	_	
59-67	10260-10265	brain	_	
59-68	10265-10266	.	_	

#Text=In addition, a T1-weighted scan was collected as anatomical reference with the following scanning parameters: TR/TE = 30/4.6 ms; flip angle = 30°; field of view = 256 × 256 mm2, voxel size = 1 × 1 × 1.2 mm3.
60-1	10267-10269	In	_	
60-2	10270-10278	addition	_	
60-3	10278-10279	,	_	
60-4	10280-10281	a	_	
60-5	10282-10284	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[19]	
60-6	10284-10285	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[19]	
60-7	10285-10293	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[19]	
60-8	10294-10298	scan	_	
60-9	10299-10302	was	_	
60-10	10303-10312	collected	_	
60-11	10313-10315	as	_	
60-12	10316-10326	anatomical	_	
60-13	10327-10336	reference	_	
60-14	10337-10341	with	_	
60-15	10342-10345	the	_	
60-16	10346-10355	following	_	
60-17	10356-10364	scanning	_	
60-18	10365-10375	parameters	_	
60-19	10375-10376	:	_	
60-20	10377-10379	TR	_	
60-21	10379-10380	/	_	
60-22	10380-10382	TE	_	
60-23	10382-10383	 	_	
60-24	10383-10384	=	_	
60-25	10384-10385	 	_	
60-26	10385-10387	30	_	
60-27	10387-10388	/	_	
60-28	10388-10391	4.6	_	
60-29	10391-10392	 	_	
60-30	10392-10394	ms	_	
60-31	10394-10395	;	_	
60-32	10396-10400	flip	_	
60-33	10401-10406	angle	_	
60-34	10406-10407	 	_	
60-35	10407-10408	=	_	
60-36	10408-10409	 	_	
60-37	10409-10411	30	_	
60-38	10411-10412	°	_	
60-39	10412-10413	;	_	
60-40	10414-10419	field	_	
60-41	10420-10422	of	_	
60-42	10423-10427	view	_	
60-43	10427-10428	 	_	
60-44	10428-10429	=	_	
60-45	10429-10430	 	_	
60-46	10430-10433	256	_	
60-47	10433-10434	 	_	
60-48	10434-10435	×	_	
60-49	10435-10436	 	_	
60-50	10436-10439	256	_	
60-51	10439-10440	 	_	
60-52	10440-10443	mm2	_	
60-53	10443-10444	,	_	
60-54	10445-10450	voxel	_	
60-55	10451-10455	size	_	
60-56	10455-10456	 	_	
60-57	10456-10457	=	_	
60-58	10457-10458	 	_	
60-59	10458-10459	1	_	
60-60	10459-10460	 	_	
60-61	10460-10461	×	_	
60-62	10461-10462	 	_	
60-63	10462-10463	1	_	
60-64	10463-10464	 	_	
60-65	10464-10465	×	_	
60-66	10465-10466	 	_	
60-67	10466-10469	1.2	_	
60-68	10469-10470	 	_	
60-69	10470-10473	mm3	_	
60-70	10473-10474	.	_	

#Text=Data preprocessing
#Text=Resting-state fMRI data were preprocessed using the Data Processing and Analysis for Brain Imaging (DPABI) toolbox on MATLAB v.
61-1	10475-10479	Data	_	
61-2	10480-10493	preprocessing	_	
61-3	10494-10507	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[20]	
61-4	10508-10512	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[20]	
61-5	10513-10517	data	_	
61-6	10518-10522	were	_	
61-7	10523-10535	preprocessed	_	
61-8	10536-10541	using	_	
61-9	10542-10545	the	_	
61-10	10546-10550	Data	_	
61-11	10551-10561	Processing	_	
61-12	10562-10565	and	_	
61-13	10566-10574	Analysis	_	
61-14	10575-10578	for	_	
61-15	10579-10584	Brain	_	
61-16	10585-10592	Imaging	_	
61-17	10593-10594	(	_	
61-18	10594-10599	DPABI	_	
61-19	10599-10600	)	_	
61-20	10601-10608	toolbox	_	
61-21	10609-10611	on	_	
61-22	10612-10618	MATLAB	_	
61-23	10619-10620	v	_	
61-24	10620-10621	.	_	

#Text=R2016a (Mathworks).
62-1	10622-10628	R2016a	_	
62-2	10629-10630	(	_	
62-3	10630-10639	Mathworks	_	
62-4	10639-10640	)	_	
62-5	10640-10641	.	_	

#Text=For every subject, the first 10 functional volumes were removed to allow for signal stabilization.
63-1	10642-10645	For	_	
63-2	10646-10651	every	_	
63-3	10652-10659	subject	_	
63-4	10659-10660	,	_	
63-5	10661-10664	the	_	
63-6	10665-10670	first	_	
63-7	10671-10673	10	_	
63-8	10674-10684	functional	_	
63-9	10685-10692	volumes	_	
63-10	10693-10697	were	_	
63-11	10698-10705	removed	_	
63-12	10706-10708	to	_	
63-13	10709-10714	allow	_	
63-14	10715-10718	for	_	
63-15	10719-10725	signal	_	
63-16	10726-10739	stabilization	_	
63-17	10739-10740	.	_	

#Text=The rest of the functional images were realigned, co-registered with their individual anatomic image, and corrected for nuisance variables (six rigid realignment parameters, signal drift, averaged signal from white matter and cerebrospinal fluid) using a linear regression model.
64-1	10741-10744	The	_	
64-2	10745-10749	rest	_	
64-3	10750-10752	of	_	
64-4	10753-10756	the	_	
64-5	10757-10767	functional	_	
64-6	10768-10774	images	_	
64-7	10775-10779	were	_	
64-8	10780-10789	realigned	_	
64-9	10789-10790	,	_	
64-10	10791-10804	co-registered	_	
64-11	10805-10809	with	_	
64-12	10810-10815	their	_	
64-13	10816-10826	individual	_	
64-14	10827-10835	anatomic	_	
64-15	10836-10841	image	_	
64-16	10841-10842	,	_	
64-17	10843-10846	and	_	
64-18	10847-10856	corrected	_	
64-19	10857-10860	for	_	
64-20	10861-10869	nuisance	_	
64-21	10870-10879	variables	_	
64-22	10880-10881	(	_	
64-23	10881-10884	six	_	
64-24	10885-10890	rigid	_	
64-25	10891-10902	realignment	_	
64-26	10903-10913	parameters	_	
64-27	10913-10914	,	_	
64-28	10915-10921	signal	_	
64-29	10922-10927	drift	_	
64-30	10927-10928	,	_	
64-31	10929-10937	averaged	_	
64-32	10938-10944	signal	_	
64-33	10945-10949	from	_	
64-34	10950-10955	white	_	
64-35	10956-10962	matter	_	
64-36	10963-10966	and	_	
64-37	10967-10980	cerebrospinal	_	
64-38	10981-10986	fluid	_	
64-39	10986-10987	)	_	
64-40	10988-10993	using	_	
64-41	10994-10995	a	_	
64-42	10996-11002	linear	_	
64-43	11003-11013	regression	_	
64-44	11014-11019	model	_	
64-45	11019-11020	.	_	

#Text=Band-pass filtering (0.01–0.1 Hz) was applied to fMRI time-series to reduce effects of low-frequency drifts and high-frequency noise.
65-1	11021-11030	Band-pass	_	
65-2	11031-11040	filtering	_	
65-3	11041-11042	(	_	
65-4	11042-11046	0.01	_	
65-5	11046-11047	–	_	
65-6	11047-11050	0.1	_	
65-7	11050-11051	 	_	
65-8	11051-11053	Hz	_	
65-9	11053-11054	)	_	
65-10	11055-11058	was	_	
65-11	11059-11066	applied	_	
65-12	11067-11069	to	_	
65-13	11070-11074	fMRI	_	
65-14	11075-11086	time-series	_	
65-15	11087-11089	to	_	
65-16	11090-11096	reduce	_	
65-17	11097-11104	effects	_	
65-18	11105-11107	of	_	
65-19	11108-11121	low-frequency	_	
65-20	11122-11128	drifts	_	
65-21	11129-11132	and	_	
65-22	11133-11147	high-frequency	_	
65-23	11148-11153	noise	_	
65-24	11153-11154	.	_	

#Text=Subsequently, the functional scans were spatially normalized to MNI space using a symmetric group-specific T1 template, and resampled to 3 × 3 × 3 mm3 voxels.
66-1	11155-11167	Subsequently	_	
66-2	11167-11168	,	_	
66-3	11169-11172	the	_	
66-4	11173-11183	functional	_	
66-5	11184-11189	scans	_	
66-6	11190-11194	were	_	
66-7	11195-11204	spatially	_	
66-8	11205-11215	normalized	_	
66-9	11216-11218	to	_	
66-10	11219-11222	MNI	_	
66-11	11223-11228	space	_	
66-12	11229-11234	using	_	
66-13	11235-11236	a	_	
66-14	11237-11246	symmetric	_	
66-15	11247-11261	group-specific	_	
66-16	11262-11264	T1	_	
66-17	11265-11273	template	_	
66-18	11273-11274	,	_	
66-19	11275-11278	and	_	
66-20	11279-11288	resampled	_	
66-21	11289-11291	to	_	
66-22	11292-11293	3	_	
66-23	11293-11294	 	_	
66-24	11294-11295	×	_	
66-25	11295-11296	 	_	
66-26	11296-11297	3	_	
66-27	11297-11298	 	_	
66-28	11298-11299	×	_	
66-29	11299-11300	 	_	
66-30	11300-11301	3	_	
66-31	11301-11302	 	_	
66-32	11302-11305	mm3	_	
66-33	11306-11312	voxels	_	
66-34	11312-11313	.	_	

#Text=Spatial smoothing was applied to normalized images with a 4 mm full-width half-maximum (FWHM) Gaussian kernel.
67-1	11314-11321	Spatial	_	
67-2	11322-11331	smoothing	_	
67-3	11332-11335	was	_	
67-4	11336-11343	applied	_	
67-5	11344-11346	to	_	
67-6	11347-11357	normalized	_	
67-7	11358-11364	images	_	
67-8	11365-11369	with	_	
67-9	11370-11371	a	_	
67-10	11372-11373	4	_	
67-11	11373-11374	 	_	
67-12	11374-11376	mm	_	
67-13	11377-11387	full-width	_	
67-14	11388-11400	half-maximum	_	
67-15	11401-11402	(	_	
67-16	11402-11406	FWHM	_	
67-17	11406-11407	)	_	
67-18	11408-11416	Gaussian	_	
67-19	11417-11423	kernel	_	
67-20	11423-11424	.	_	

#Text=In view of recent findings on the influence of in-scanner head motion on fMRI signals, images with excessive movement (frame-wise displacement >0.5 mm) and 1 backward and 2 forward scans relative to the marked frame, were scrubbed.
68-1	11425-11427	In	_	
68-2	11428-11432	view	_	
68-3	11433-11435	of	_	
68-4	11436-11442	recent	_	
68-5	11443-11451	findings	_	
68-6	11452-11454	on	_	
68-7	11455-11458	the	_	
68-8	11459-11468	influence	_	
68-9	11469-11471	of	_	
68-10	11472-11482	in-scanner	_	
68-11	11483-11487	head	_	
68-12	11488-11494	motion	_	
68-13	11495-11497	on	_	
68-14	11498-11502	fMRI	_	
68-15	11503-11510	signals	_	
68-16	11510-11511	,	_	
68-17	11512-11518	images	_	
68-18	11519-11523	with	_	
68-19	11524-11533	excessive	_	
68-20	11534-11542	movement	_	
68-21	11543-11544	(	_	
68-22	11544-11554	frame-wise	_	
68-23	11555-11567	displacement	_	
68-24	11568-11569	>	_	
68-25	11569-11572	0.5	_	
68-26	11572-11573	 	_	
68-27	11573-11575	mm	_	
68-28	11575-11576	)	_	
68-29	11577-11580	and	_	
68-30	11581-11582	1	_	
68-31	11583-11591	backward	_	
68-32	11592-11595	and	_	
68-33	11596-11597	2	_	
68-34	11598-11605	forward	_	
68-35	11606-11611	scans	_	
68-36	11612-11620	relative	_	
68-37	11621-11623	to	_	
68-38	11624-11627	the	_	
68-39	11628-11634	marked	_	
68-40	11635-11640	frame	_	
68-41	11640-11641	,	_	
68-42	11642-11646	were	_	
68-43	11647-11655	scrubbed	_	
68-44	11655-11656	.	_	

#Text=The scrubbing procedure negated group-differences in head motion (before scrubbing χ(2)2 = 6.20, p = .04 and after scrubbing χ(2)2 = 4.09, p = .13, Supplementary Table 1), and did not lead to differences on the number of images rejected among the three subject groups (χ(2)2 = 3.54, p = .17).
69-1	11657-11660	The	_	
69-2	11661-11670	scrubbing	_	
69-3	11671-11680	procedure	_	
69-4	11681-11688	negated	_	
69-5	11689-11706	group-differences	_	
69-6	11707-11709	in	_	
69-7	11710-11714	head	_	
69-8	11715-11721	motion	_	
69-9	11722-11723	(	_	
69-10	11723-11729	before	_	
69-11	11730-11739	scrubbing	_	
69-12	11740-11741	χ	_	
69-13	11741-11742	(	_	
69-14	11742-11743	2	_	
69-15	11743-11744	)	_	
69-16	11744-11745	2	_	
69-17	11745-11746	 	_	
69-18	11746-11747	=	_	
69-19	11747-11748	 	_	
69-20	11748-11752	6.20	_	
69-21	11752-11753	,	_	
69-22	11754-11755	p	_	
69-23	11755-11756	 	_	
69-24	11756-11757	=	_	
69-25	11757-11758	 	_	
69-26	11758-11761	.04	_	
69-27	11762-11765	and	_	
69-28	11766-11771	after	_	
69-29	11772-11781	scrubbing	_	
69-30	11782-11783	χ	_	
69-31	11783-11784	(	_	
69-32	11784-11785	2	_	
69-33	11785-11786	)	_	
69-34	11786-11787	2	_	
69-35	11787-11788	 	_	
69-36	11788-11789	=	_	
69-37	11789-11790	 	_	
69-38	11790-11794	4.09	_	
69-39	11794-11795	,	_	
69-40	11796-11797	p	_	
69-41	11797-11798	 	_	
69-42	11798-11799	=	_	
69-43	11799-11800	 	_	
69-44	11800-11803	.13	_	
69-45	11803-11804	,	_	
69-46	11805-11818	Supplementary	_	
69-47	11819-11824	Table	_	
69-48	11825-11826	1	_	
69-49	11826-11827	)	_	
69-50	11827-11828	,	_	
69-51	11829-11832	and	_	
69-52	11833-11836	did	_	
69-53	11837-11840	not	_	
69-54	11841-11845	lead	_	
69-55	11846-11848	to	_	
69-56	11849-11860	differences	_	
69-57	11861-11863	on	_	
69-58	11864-11867	the	_	
69-59	11868-11874	number	_	
69-60	11875-11877	of	_	
69-61	11878-11884	images	_	
69-62	11885-11893	rejected	_	
69-63	11894-11899	among	_	
69-64	11900-11903	the	_	
69-65	11904-11909	three	_	
69-66	11910-11917	subject	_	
69-67	11918-11924	groups	_	
69-68	11925-11926	(	_	
69-69	11926-11927	χ	_	
69-70	11927-11928	(	_	
69-71	11928-11929	2	_	
69-72	11929-11930	)	_	
69-73	11930-11931	2	_	
69-74	11931-11932	 	_	
69-75	11932-11933	=	_	
69-76	11933-11934	 	_	
69-77	11934-11938	3.54	_	
69-78	11938-11939	,	_	
69-79	11940-11941	p	_	
69-80	11941-11942	 	_	
69-81	11942-11943	=	_	
69-82	11943-11944	 	_	
69-83	11944-11947	.17	_	
69-84	11947-11948	)	_	
69-85	11948-11949	.	_	

#Text=The Harvard-Oxford atlas was applied to whole-brain functional data in order to parcellate the brain into 112 bilateral regions (48 cortical and 8 subcortical regions per hemisphere).
70-1	11950-11953	The	_	
70-2	11954-11968	Harvard-Oxford	_	
70-3	11969-11974	atlas	_	
70-4	11975-11978	was	_	
70-5	11979-11986	applied	_	
70-6	11987-11989	to	_	
70-7	11990-12001	whole-brain	_	
70-8	12002-12012	functional	_	
70-9	12013-12017	data	_	
70-10	12018-12020	in	_	
70-11	12021-12026	order	_	
70-12	12027-12029	to	_	
70-13	12030-12040	parcellate	_	
70-14	12041-12044	the	_	
70-15	12045-12050	brain	_	
70-16	12051-12055	into	_	
70-17	12056-12059	112	_	
70-18	12060-12069	bilateral	_	
70-19	12070-12077	regions	_	
70-20	12078-12079	(	_	
70-21	12079-12081	48	_	
70-22	12082-12090	cortical	_	
70-23	12091-12094	and	_	
70-24	12095-12096	8	_	
70-25	12097-12108	subcortical	_	
70-26	12109-12116	regions	_	
70-27	12117-12120	per	_	
70-28	12121-12131	hemisphere	_	
70-29	12131-12132	)	_	
70-30	12132-12133	.	_	

#Text=Region names, abbreviations, anatomic classification (frontal, temporal, parietal, occipital lobe, cingulate cortex and subcortical regions) and functional hierarchy (primary sensorimotor regions, unimodal, heteromodal association areas, (para)limbic and subcortical regions) are referenced in Supplementary Table 2.
71-1	12134-12140	Region	_	
71-2	12141-12146	names	_	
71-3	12146-12147	,	_	
71-4	12148-12161	abbreviations	_	
71-5	12161-12162	,	_	
71-6	12163-12171	anatomic	_	
71-7	12172-12186	classification	_	
71-8	12187-12188	(	_	
71-9	12188-12195	frontal	_	
71-10	12195-12196	,	_	
71-11	12197-12205	temporal	_	
71-12	12205-12206	,	_	
71-13	12207-12215	parietal	_	
71-14	12215-12216	,	_	
71-15	12217-12226	occipital	_	
71-16	12227-12231	lobe	_	
71-17	12231-12232	,	_	
71-18	12233-12242	cingulate	_	
71-19	12243-12249	cortex	_	
71-20	12250-12253	and	_	
71-21	12254-12265	subcortical	_	
71-22	12266-12273	regions	_	
71-23	12273-12274	)	_	
71-24	12275-12278	and	_	
71-25	12279-12289	functional	_	
71-26	12290-12299	hierarchy	_	
71-27	12300-12301	(	_	
71-28	12301-12308	primary	_	
71-29	12309-12321	sensorimotor	_	
71-30	12322-12329	regions	_	
71-31	12329-12330	,	_	
71-32	12331-12339	unimodal	_	
71-33	12339-12340	,	_	
71-34	12341-12352	heteromodal	_	
71-35	12353-12364	association	_	
71-36	12365-12370	areas	_	
71-37	12370-12371	,	_	
71-38	12372-12373	(	_	
71-39	12373-12377	para	_	
71-40	12377-12378	)	_	
71-41	12378-12384	limbic	_	
71-42	12385-12388	and	_	
71-43	12389-12400	subcortical	_	
71-44	12401-12408	regions	_	
71-45	12408-12409	)	_	
71-46	12410-12413	are	_	
71-47	12414-12424	referenced	_	
71-48	12425-12427	in	_	
71-49	12428-12441	Supplementary	_	
71-50	12442-12447	Table	_	
71-51	12448-12449	2	_	
71-52	12449-12450	.	_	

#Text=The functional hierarchy subdivision scheme is based on previous studies.
72-1	12451-12454	The	_	
72-2	12455-12465	functional	_	
72-3	12466-12475	hierarchy	_	
72-4	12476-12487	subdivision	_	
72-5	12488-12494	scheme	_	
72-6	12495-12497	is	_	
72-7	12498-12503	based	_	
72-8	12504-12506	on	_	
72-9	12507-12515	previous	_	
72-10	12516-12523	studies	_	
72-11	12523-12524	.	_	

#Text=Regional time-series were averaged across voxels, and cross-correlated for each pair of brain regions using Pearson's correlation.
73-1	12525-12533	Regional	_	
73-2	12534-12545	time-series	_	
73-3	12546-12550	were	_	
73-4	12551-12559	averaged	_	
73-5	12560-12566	across	_	
73-6	12567-12573	voxels	_	
73-7	12573-12574	,	_	
73-8	12575-12578	and	_	
73-9	12579-12595	cross-correlated	_	
73-10	12596-12599	for	_	
73-11	12600-12604	each	_	
73-12	12605-12609	pair	_	
73-13	12610-12612	of	_	
73-14	12613-12618	brain	_	
73-15	12619-12626	regions	_	
73-16	12627-12632	using	_	
73-17	12633-12642	Pearson's	_	
73-18	12643-12654	correlation	_	
73-19	12654-12655	.	_	

#Text=Correlation coefficients were converted to z scores using Fisher's z transformation, serving as a measure of functional connectivity strength between two regions.
74-1	12656-12667	Correlation	_	
74-2	12668-12680	coefficients	_	
74-3	12681-12685	were	_	
74-4	12686-12695	converted	_	
74-5	12696-12698	to	_	
74-6	12699-12700	z	_	
74-7	12701-12707	scores	_	
74-8	12708-12713	using	_	
74-9	12714-12722	Fisher's	_	
74-10	12723-12724	z	_	
74-11	12725-12739	transformation	_	
74-12	12739-12740	,	_	
74-13	12741-12748	serving	_	
74-14	12749-12751	as	_	
74-15	12752-12753	a	_	
74-16	12754-12761	measure	_	
74-17	12762-12764	of	_	
74-18	12765-12775	functional	_	
74-19	12776-12788	connectivity	_	
74-20	12789-12797	strength	_	
74-21	12798-12805	between	_	
74-22	12806-12809	two	_	
74-23	12810-12817	regions	_	
74-24	12817-12818	.	_	

#Text=Interhemispheric connectivity
#Text=The level of functional connectivity between 56 regions in one hemisphere and their corresponding areas in the other hemisphere is used here as the measure of interhemispheric connectivity.
75-1	12819-12835	Interhemispheric	_	
75-2	12836-12848	connectivity	_	
75-3	12849-12852	The	_	
75-4	12853-12858	level	_	
75-5	12859-12861	of	_	
75-6	12862-12872	functional	_	
75-7	12873-12885	connectivity	_	
75-8	12886-12893	between	_	
75-9	12894-12896	56	_	
75-10	12897-12904	regions	_	
75-11	12905-12907	in	_	
75-12	12908-12911	one	_	
75-13	12912-12922	hemisphere	_	
75-14	12923-12926	and	_	
75-15	12927-12932	their	_	
75-16	12933-12946	corresponding	_	
75-17	12947-12952	areas	_	
75-18	12953-12955	in	_	
75-19	12956-12959	the	_	
75-20	12960-12965	other	_	
75-21	12966-12976	hemisphere	_	
75-22	12977-12979	is	_	
75-23	12980-12984	used	_	
75-24	12985-12989	here	_	
75-25	12990-12992	as	_	
75-26	12993-12996	the	_	
75-27	12997-13004	measure	_	
75-28	13005-13007	of	_	
75-29	13008-13024	interhemispheric	_	
75-30	13025-13037	connectivity	_	
75-31	13037-13038	.	_	

#Text=Interhemispheric connections between homotopic regions are among the strongest functional associations in cortical-cortical interactions and have reliably been identified in both healthy and clinical populations.
76-1	13039-13055	Interhemispheric	_	
76-2	13056-13067	connections	_	
76-3	13068-13075	between	_	
76-4	13076-13085	homotopic	_	
76-5	13086-13093	regions	_	
76-6	13094-13097	are	_	
76-7	13098-13103	among	_	
76-8	13104-13107	the	_	
76-9	13108-13117	strongest	_	
76-10	13118-13128	functional	_	
76-11	13129-13141	associations	_	
76-12	13142-13144	in	_	
76-13	13145-13162	cortical-cortical	_	
76-14	13163-13175	interactions	_	
76-15	13176-13179	and	_	
76-16	13180-13184	have	_	
76-17	13185-13193	reliably	_	
76-18	13194-13198	been	_	
76-19	13199-13209	identified	_	
76-20	13210-13212	in	_	
76-21	13213-13217	both	_	
76-22	13218-13225	healthy	_	
76-23	13226-13229	and	_	
76-24	13230-13238	clinical	_	
76-25	13239-13250	populations	_	
76-26	13250-13251	.	_	

#Text=As a supplementary analysis, group-differences in heterotopic interhemispheric connectivity and left and right intrahemispheric connectivity were examined in the same manner as homotopic interhemispheric connectivity.
77-1	13252-13254	As	_	
77-2	13255-13256	a	_	
77-3	13257-13270	supplementary	_	
77-4	13271-13279	analysis	_	
77-5	13279-13280	,	_	
77-6	13281-13298	group-differences	_	
77-7	13299-13301	in	_	
77-8	13302-13313	heterotopic	_	
77-9	13314-13330	interhemispheric	_	
77-10	13331-13343	connectivity	_	
77-11	13344-13347	and	_	
77-12	13348-13352	left	_	
77-13	13353-13356	and	_	
77-14	13357-13362	right	_	
77-15	13363-13379	intrahemispheric	_	
77-16	13380-13392	connectivity	_	
77-17	13393-13397	were	_	
77-18	13398-13406	examined	_	
77-19	13407-13409	in	_	
77-20	13410-13413	the	_	
77-21	13414-13418	same	_	
77-22	13419-13425	manner	_	
77-23	13426-13428	as	_	
77-24	13429-13438	homotopic	_	
77-25	13439-13455	interhemispheric	_	
77-26	13456-13468	connectivity	_	
77-27	13468-13469	.	_	

#Text=Moreover, to assess the consistency of interhemispheric connectivity measurements between studies, we performed an additional analysis examining the correlation in regional interhemispheric connectivity in controls between this study and the study of.
78-1	13470-13478	Moreover	_	
78-2	13478-13479	,	_	
78-3	13480-13482	to	_	
78-4	13483-13489	assess	_	
78-5	13490-13493	the	_	
78-6	13494-13505	consistency	_	
78-7	13506-13508	of	_	
78-8	13509-13525	interhemispheric	_	
78-9	13526-13538	connectivity	_	
78-10	13539-13551	measurements	_	
78-11	13552-13559	between	_	
78-12	13560-13567	studies	_	
78-13	13567-13568	,	_	
78-14	13569-13571	we	_	
78-15	13572-13581	performed	_	
78-16	13582-13584	an	_	
78-17	13585-13595	additional	_	
78-18	13596-13604	analysis	_	
78-19	13605-13614	examining	_	
78-20	13615-13618	the	_	
78-21	13619-13630	correlation	_	
78-22	13631-13633	in	_	
78-23	13634-13642	regional	_	
78-24	13643-13659	interhemispheric	_	
78-25	13660-13672	connectivity	_	
78-26	13673-13675	in	_	
78-27	13676-13684	controls	_	
78-28	13685-13692	between	_	
78-29	13693-13697	this	_	
78-30	13698-13703	study	_	
78-31	13704-13707	and	_	
78-32	13708-13711	the	_	
78-33	13712-13717	study	_	
78-34	13718-13720	of	_	
78-35	13720-13721	.	_	

#Text=Hemispheric specialization
#Text=Hemispheric specialization is calculated here as the difference in connectivity strength between intrahemispheric and heterotopic interhemispheric connections of each brain region.
79-1	13722-13733	Hemispheric	_	
79-2	13734-13748	specialization	_	
79-3	13749-13760	Hemispheric	_	
79-4	13761-13775	specialization	_	
79-5	13776-13778	is	_	
79-6	13779-13789	calculated	_	
79-7	13790-13794	here	_	
79-8	13795-13797	as	_	
79-9	13798-13801	the	_	
79-10	13802-13812	difference	_	
79-11	13813-13815	in	_	
79-12	13816-13828	connectivity	_	
79-13	13829-13837	strength	_	
79-14	13838-13845	between	_	
79-15	13846-13862	intrahemispheric	_	
79-16	13863-13866	and	_	
79-17	13867-13878	heterotopic	_	
79-18	13879-13895	interhemispheric	_	
79-19	13896-13907	connections	_	
79-20	13908-13910	of	_	
79-21	13911-13915	each	_	
79-22	13916-13921	brain	_	
79-23	13922-13928	region	_	
79-24	13928-13929	.	_	

#Text=Homotopic interhemispheric connections were not used in the calculation of hemispheric specialization so that we could examine relationship between hemispheric specialization and interhemispheric connectivity in the following analysis.
80-1	13930-13939	Homotopic	_	
80-2	13940-13956	interhemispheric	_	
80-3	13957-13968	connections	_	
80-4	13969-13973	were	_	
80-5	13974-13977	not	_	
80-6	13978-13982	used	_	
80-7	13983-13985	in	_	
80-8	13986-13989	the	_	
80-9	13990-14001	calculation	_	
80-10	14002-14004	of	_	
80-11	14005-14016	hemispheric	_	
80-12	14017-14031	specialization	_	
80-13	14032-14034	so	_	
80-14	14035-14039	that	_	
80-15	14040-14042	we	_	
80-16	14043-14048	could	_	
80-17	14049-14056	examine	_	
80-18	14057-14069	relationship	_	
80-19	14070-14077	between	_	
80-20	14078-14089	hemispheric	_	
80-21	14090-14104	specialization	_	
80-22	14105-14108	and	_	
80-23	14109-14125	interhemispheric	_	
80-24	14126-14138	connectivity	_	
80-25	14139-14141	in	_	
80-26	14142-14145	the	_	
80-27	14146-14155	following	_	
80-28	14156-14164	analysis	_	
80-29	14164-14165	.	_	

#Text=A positive value of hemispheric specialization indicates that a region or hemisphere is preferentially connected to other regions within its own hemisphere, whereas a negative value suggests that a region or hemisphere is more strongly connected to regions in the contralateral hemisphere.
81-1	14166-14167	A	_	
81-2	14168-14176	positive	_	
81-3	14177-14182	value	_	
81-4	14183-14185	of	_	
81-5	14186-14197	hemispheric	_	
81-6	14198-14212	specialization	_	
81-7	14213-14222	indicates	_	
81-8	14223-14227	that	_	
81-9	14228-14229	a	_	
81-10	14230-14236	region	_	
81-11	14237-14239	or	_	
81-12	14240-14250	hemisphere	_	
81-13	14251-14253	is	_	
81-14	14254-14268	preferentially	_	
81-15	14269-14278	connected	_	
81-16	14279-14281	to	_	
81-17	14282-14287	other	_	
81-18	14288-14295	regions	_	
81-19	14296-14302	within	_	
81-20	14303-14306	its	_	
81-21	14307-14310	own	_	
81-22	14311-14321	hemisphere	_	
81-23	14321-14322	,	_	
81-24	14323-14330	whereas	_	
81-25	14331-14332	a	_	
81-26	14333-14341	negative	_	
81-27	14342-14347	value	_	
81-28	14348-14356	suggests	_	
81-29	14357-14361	that	_	
81-30	14362-14363	a	_	
81-31	14364-14370	region	_	
81-32	14371-14373	or	_	
81-33	14374-14384	hemisphere	_	
81-34	14385-14387	is	_	
81-35	14388-14392	more	_	
81-36	14393-14401	strongly	_	
81-37	14402-14411	connected	_	
81-38	14412-14414	to	_	
81-39	14415-14422	regions	_	
81-40	14423-14425	in	_	
81-41	14426-14429	the	_	
81-42	14430-14443	contralateral	_	
81-43	14444-14454	hemisphere	_	
81-44	14454-14455	.	_	

#Text=The method used to compute hemispheric specialization using intrinsic functional connectivity has been described in previous studies using a voxel-based analysis.
82-1	14456-14459	The	_	
82-2	14460-14466	method	_	
82-3	14467-14471	used	_	
82-4	14472-14474	to	_	
82-5	14475-14482	compute	_	
82-6	14483-14494	hemispheric	_	
82-7	14495-14509	specialization	_	
82-8	14510-14515	using	_	
82-9	14516-14525	intrinsic	_	
82-10	14526-14536	functional	_	
82-11	14537-14549	connectivity	_	
82-12	14550-14553	has	_	
82-13	14554-14558	been	_	
82-14	14559-14568	described	_	
82-15	14569-14571	in	_	
82-16	14572-14580	previous	_	
82-17	14581-14588	studies	_	
82-18	14589-14594	using	_	
82-19	14595-14596	a	_	
82-20	14597-14608	voxel-based	_	
82-21	14609-14617	analysis	_	
82-22	14617-14618	.	_	

#Text=Statistical analysis
#Text=Effects of group and covariates on interhemispheric connectivity and hemispheric specialization were assessed using linear-mixed effect models.
83-1	14619-14630	Statistical	_	
83-2	14631-14639	analysis	_	
83-3	14640-14647	Effects	_	
83-4	14648-14650	of	_	
83-5	14651-14656	group	_	
83-6	14657-14660	and	_	
83-7	14661-14671	covariates	_	
83-8	14672-14674	on	_	
83-9	14675-14691	interhemispheric	_	
83-10	14692-14704	connectivity	_	
83-11	14705-14708	and	_	
83-12	14709-14720	hemispheric	_	
83-13	14721-14735	specialization	_	
83-14	14736-14740	were	_	
83-15	14741-14749	assessed	_	
83-16	14750-14755	using	_	
83-17	14756-14768	linear-mixed	_	
83-18	14769-14775	effect	_	
83-19	14776-14782	models	_	
83-20	14782-14783	.	_	

#Text=For interhemispheric connectivity, fixed-effects include: group status (controls, siblings, patients), age, sex, handedness (right / left / mixed), scanner (#1 / #2) and head motion.
84-1	14784-14787	For	_	
84-2	14788-14804	interhemispheric	_	
84-3	14805-14817	connectivity	_	
84-4	14817-14818	,	_	
84-5	14819-14832	fixed-effects	_	
84-6	14833-14840	include	_	
84-7	14840-14841	:	_	
84-8	14842-14847	group	_	
84-9	14848-14854	status	_	
84-10	14855-14856	(	_	
84-11	14856-14864	controls	_	
84-12	14864-14865	,	_	
84-13	14866-14874	siblings	_	
84-14	14874-14875	,	_	
84-15	14876-14884	patients	_	
84-16	14884-14885	)	_	
84-17	14885-14886	,	_	
84-18	14887-14890	age	_	
84-19	14890-14891	,	_	
84-20	14892-14895	sex	_	
84-21	14895-14896	,	_	
84-22	14897-14907	handedness	_	
84-23	14908-14909	(	_	
84-24	14909-14914	right	_	
84-25	14915-14916	/	_	
84-26	14917-14921	left	_	
84-27	14922-14923	/	_	
84-28	14924-14929	mixed	_	
84-29	14929-14930	)	_	
84-30	14930-14931	,	_	
84-31	14932-14939	scanner	_	
84-32	14940-14941	(	_	
84-33	14941-14943	#1	_	
84-34	14944-14945	/	_	
84-35	14946-14948	#2	_	
84-36	14948-14949	)	_	
84-37	14950-14953	and	_	
84-38	14954-14958	head	_	
84-39	14959-14965	motion	_	
84-40	14965-14966	.	_	

#Text=To control for potential group-differences in global connectivity, mean connectivity strength of all non-homotopic connections (i.e., all intrahemispheric and heterotopic interhemispheric connections) was included as a fixed-effect term (global FC).
85-1	14967-14969	To	_	
85-2	14970-14977	control	_	
85-3	14978-14981	for	_	
85-4	14982-14991	potential	_	
85-5	14992-15009	group-differences	_	
85-6	15010-15012	in	_	
85-7	15013-15019	global	_	
85-8	15020-15032	connectivity	_	
85-9	15032-15033	,	_	
85-10	15034-15038	mean	_	
85-11	15039-15051	connectivity	_	
85-12	15052-15060	strength	_	
85-13	15061-15063	of	_	
85-14	15064-15067	all	_	
85-15	15068-15081	non-homotopic	_	
85-16	15082-15093	connections	_	
85-17	15094-15095	(	_	
85-18	15095-15098	i.e	_	
85-19	15098-15099	.	_	
85-20	15099-15100	,	_	
85-21	15101-15104	all	_	
85-22	15105-15121	intrahemispheric	_	
85-23	15122-15125	and	_	
85-24	15126-15137	heterotopic	_	
85-25	15138-15154	interhemispheric	_	
85-26	15155-15166	connections	_	
85-27	15166-15167	)	_	
85-28	15168-15171	was	_	
85-29	15172-15180	included	_	
85-30	15181-15183	as	_	
85-31	15184-15185	a	_	
85-32	15186-15198	fixed-effect	_	
85-33	15199-15203	term	_	
85-34	15204-15205	(	_	
85-35	15205-15211	global	_	
85-36	15212-15214	FC	_	
85-37	15214-15215	)	_	
85-38	15215-15216	.	_	

#Text=Family ID, encoding the subjects' pedigree information, was included as random-effect term to control for family ties between subjects (Eq. (1)).
86-1	15217-15223	Family	_	
86-2	15224-15226	ID	_	
86-3	15226-15227	,	_	
86-4	15228-15236	encoding	_	
86-5	15237-15240	the	_	
86-6	15241-15249	subjects	_	
86-7	15249-15250	'	_	
86-8	15251-15259	pedigree	_	
86-9	15260-15271	information	_	
86-10	15271-15272	,	_	
86-11	15273-15276	was	_	
86-12	15277-15285	included	_	
86-13	15286-15288	as	_	
86-14	15289-15302	random-effect	_	
86-15	15303-15307	term	_	
86-16	15308-15310	to	_	
86-17	15311-15318	control	_	
86-18	15319-15322	for	_	
86-19	15323-15329	family	_	
86-20	15330-15334	ties	_	
86-21	15335-15342	between	_	
86-22	15343-15351	subjects	_	
86-23	15352-15353	(	_	
86-24	15353-15355	Eq	_	
86-25	15355-15356	.	_	
86-26	15357-15358	(	_	
86-27	15358-15359	1	_	
86-28	15359-15360	)	_	
86-29	15360-15361	)	_	
86-30	15361-15362	.	_	

#Text=The model has 237 observations (number of subjects with complete information), and 10 fixed term predictors (constant, group_sibling, group_patient, age, gender_female, handedness_left, handedness_mixed, scanner_#2, motion, global FC), leaving = 237–10 = 227 residual degrees of freedom.
87-1	15363-15366	The	_	
87-2	15367-15372	model	_	
87-3	15373-15376	has	_	
87-4	15377-15380	237	_	
87-5	15381-15393	observations	_	
87-6	15394-15395	(	_	
87-7	15395-15401	number	_	
87-8	15402-15404	of	_	
87-9	15405-15413	subjects	_	
87-10	15414-15418	with	_	
87-11	15419-15427	complete	_	
87-12	15428-15439	information	_	
87-13	15439-15440	)	_	
87-14	15440-15441	,	_	
87-15	15442-15445	and	_	
87-16	15446-15448	10	_	
87-17	15449-15454	fixed	_	
87-18	15455-15459	term	_	
87-19	15460-15470	predictors	_	
87-20	15471-15472	(	_	
87-21	15472-15480	constant	_	
87-22	15480-15481	,	_	
87-23	15482-15495	group_sibling	_	
87-24	15495-15496	,	_	
87-25	15497-15510	group_patient	_	
87-26	15510-15511	,	_	
87-27	15512-15515	age	_	
87-28	15515-15516	,	_	
87-29	15517-15530	gender_female	_	
87-30	15530-15531	,	_	
87-31	15532-15547	handedness_left	_	
87-32	15547-15548	,	_	
87-33	15549-15565	handedness_mixed	_	
87-34	15565-15566	,	_	
87-35	15567-15574	scanner	_	
87-36	15574-15575	_	_	
87-37	15575-15577	#2	_	
87-38	15577-15578	,	_	
87-39	15579-15585	motion	_	
87-40	15585-15586	,	_	
87-41	15587-15593	global	_	
87-42	15594-15596	FC	_	
87-43	15596-15597	)	_	
87-44	15597-15598	,	_	
87-45	15599-15606	leaving	_	
87-46	15606-15607	 	_	
87-47	15607-15608	=	_	
87-48	15608-15609	 	_	
87-49	15609-15612	237	_	
87-50	15612-15613	–	_	
87-51	15613-15615	10	_	
87-52	15615-15616	 	_	
87-53	15616-15617	=	_	
87-54	15617-15618	 	_	
87-55	15618-15621	227	_	
87-56	15622-15630	residual	_	
87-57	15631-15638	degrees	_	
87-58	15639-15641	of	_	
87-59	15642-15649	freedom	_	
87-60	15649-15650	.	_	

#Text=Equation 1:
#Text=For hemispheric specialization, group status, age, sex, handedness, scanner and head motion were again included as fixed-effect terms.
88-1	15651-15659	Equation	_	
88-2	15660-15661	1	_	
88-3	15661-15662	:	_	
88-4	15663-15666	For	_	
88-5	15667-15678	hemispheric	_	
88-6	15679-15693	specialization	_	
88-7	15693-15694	,	_	
88-8	15695-15700	group	_	
88-9	15701-15707	status	_	
88-10	15707-15708	,	_	
88-11	15709-15712	age	_	
88-12	15712-15713	,	_	
88-13	15714-15717	sex	_	
88-14	15717-15718	,	_	
88-15	15719-15729	handedness	_	
88-16	15729-15730	,	_	
88-17	15731-15738	scanner	_	
88-18	15739-15742	and	_	
88-19	15743-15747	head	_	
88-20	15748-15754	motion	_	
88-21	15755-15759	were	_	
88-22	15760-15765	again	_	
88-23	15766-15774	included	_	
88-24	15775-15777	as	_	
88-25	15778-15790	fixed-effect	_	
88-26	15791-15796	terms	_	
88-27	15796-15797	.	_	

#Text=Additionally, we included hemisphere as a fixed factor to examine potential differences in connectivity patterns between the two hemispheres.
89-1	15798-15810	Additionally	_	
89-2	15810-15811	,	_	
89-3	15812-15814	we	_	
89-4	15815-15823	included	_	
89-5	15824-15834	hemisphere	_	
89-6	15835-15837	as	_	
89-7	15838-15839	a	_	
89-8	15840-15845	fixed	_	
89-9	15846-15852	factor	_	
89-10	15853-15855	to	_	
89-11	15856-15863	examine	_	
89-12	15864-15873	potential	_	
89-13	15874-15885	differences	_	
89-14	15886-15888	in	_	
89-15	15889-15901	connectivity	_	
89-16	15902-15910	patterns	_	
89-17	15911-15918	between	_	
89-18	15919-15922	the	_	
89-19	15923-15926	two	_	
89-20	15927-15938	hemispheres	_	
89-21	15938-15939	.	_	

#Text=Random effect terms include family ID and subject ID nested within family ID.
90-1	15940-15946	Random	_	
90-2	15947-15953	effect	_	
90-3	15954-15959	terms	_	
90-4	15960-15967	include	_	
90-5	15968-15974	family	_	
90-6	15975-15977	ID	_	
90-7	15978-15981	and	_	
90-8	15982-15989	subject	_	
90-9	15990-15992	ID	_	
90-10	15993-15999	nested	_	
90-11	16000-16006	within	_	
90-12	16007-16013	family	_	
90-13	16014-16016	ID	_	
90-14	16016-16017	.	_	

#Text=The number of fixed term predictors is 10 (constant, group_sibling, group_patient, age, gender_female, handedness_left, handedness_mixed, scanner_#2, motion, hemisphere_RH), and residual degrees of freedom is 237 × 2 (hemisphere) – 10 = 464.
91-1	16018-16021	The	_	
91-2	16022-16028	number	_	
91-3	16029-16031	of	_	
91-4	16032-16037	fixed	_	
91-5	16038-16042	term	_	
91-6	16043-16053	predictors	_	
91-7	16054-16056	is	_	
91-8	16057-16059	10	_	
91-9	16060-16061	(	_	
91-10	16061-16069	constant	_	
91-11	16069-16070	,	_	
91-12	16071-16084	group_sibling	_	
91-13	16084-16085	,	_	
91-14	16086-16099	group_patient	_	
91-15	16099-16100	,	_	
91-16	16101-16104	age	_	
91-17	16104-16105	,	_	
91-18	16106-16119	gender_female	_	
91-19	16119-16120	,	_	
91-20	16121-16136	handedness_left	_	
91-21	16136-16137	,	_	
91-22	16138-16154	handedness_mixed	_	
91-23	16154-16155	,	_	
91-24	16156-16163	scanner	_	
91-25	16163-16164	_	_	
91-26	16164-16166	#2	_	
91-27	16166-16167	,	_	
91-28	16168-16174	motion	_	
91-29	16174-16175	,	_	
91-30	16176-16189	hemisphere_RH	_	
91-31	16189-16190	)	_	
91-32	16190-16191	,	_	
91-33	16192-16195	and	_	
91-34	16196-16204	residual	_	
91-35	16205-16212	degrees	_	
91-36	16213-16215	of	_	
91-37	16216-16223	freedom	_	
91-38	16224-16226	is	_	
91-39	16227-16230	237	_	
91-40	16230-16231	 	_	
91-41	16231-16232	×	_	
91-42	16232-16233	 	_	
91-43	16233-16234	2	_	
91-44	16235-16236	(	_	
91-45	16236-16246	hemisphere	_	
91-46	16246-16247	)	_	
91-47	16248-16249	–	_	
91-48	16250-16252	10	_	
91-49	16252-16253	 	_	
91-50	16253-16254	=	_	
91-51	16254-16255	 	_	
91-52	16255-16258	464	_	
91-53	16258-16259	.	_	

#Text=Equation 2:
#Text=Linear-mixed effects analysis was first applied to overall interhemispheric connectivity and hemispheric specialization (p < .05), and then to each of 56 regional measurements, controlling for multiple comparisons (p < .05, Bonferroni corrected).
92-1	16260-16268	Equation	_	
92-2	16269-16270	2	_	
92-3	16270-16271	:	_	
92-4	16272-16284	Linear-mixed	_	
92-5	16285-16292	effects	_	
92-6	16293-16301	analysis	_	
92-7	16302-16305	was	_	
92-8	16306-16311	first	_	
92-9	16312-16319	applied	_	
92-10	16320-16322	to	_	
92-11	16323-16330	overall	_	
92-12	16331-16347	interhemispheric	_	
92-13	16348-16360	connectivity	_	
92-14	16361-16364	and	_	
92-15	16365-16376	hemispheric	_	
92-16	16377-16391	specialization	_	
92-17	16392-16393	(	_	
92-18	16393-16394	p	_	
92-19	16394-16395	 	_	
92-20	16395-16396	<	_	
92-21	16396-16397	 	_	
92-22	16397-16400	.05	_	
92-23	16400-16401	)	_	
92-24	16401-16402	,	_	
92-25	16403-16406	and	_	
92-26	16407-16411	then	_	
92-27	16412-16414	to	_	
92-28	16415-16419	each	_	
92-29	16420-16422	of	_	
92-30	16423-16425	56	_	
92-31	16426-16434	regional	_	
92-32	16435-16447	measurements	_	
92-33	16447-16448	,	_	
92-34	16449-16460	controlling	_	
92-35	16461-16464	for	_	
92-36	16465-16473	multiple	_	
92-37	16474-16485	comparisons	_	
92-38	16486-16487	(	_	
92-39	16487-16488	p	_	
92-40	16488-16489	 	_	
92-41	16489-16490	<	_	
92-42	16490-16491	 	_	
92-43	16491-16494	.05	_	
92-44	16494-16495	,	_	
92-45	16496-16506	Bonferroni	_	
92-46	16507-16516	corrected	_	
92-47	16516-16517	)	_	
92-48	16517-16518	.	_	

#Text=Overall and regional measurements with significant group effects were subjected to post-hoc bivariate comparisons between each pair of subject groups (p < .05).
93-1	16519-16526	Overall	_	
93-2	16527-16530	and	_	
93-3	16531-16539	regional	_	
93-4	16540-16552	measurements	_	
93-5	16553-16557	with	_	
93-6	16558-16569	significant	_	
93-7	16570-16575	group	_	
93-8	16576-16583	effects	_	
93-9	16584-16588	were	_	
93-10	16589-16598	subjected	_	
93-11	16599-16601	to	_	
93-12	16602-16610	post-hoc	_	
93-13	16611-16620	bivariate	_	
93-14	16621-16632	comparisons	_	
93-15	16633-16640	between	_	
93-16	16641-16645	each	_	
93-17	16646-16650	pair	_	
93-18	16651-16653	of	_	
93-19	16654-16661	subject	_	
93-20	16662-16668	groups	_	
93-21	16669-16670	(	_	
93-22	16670-16671	p	_	
93-23	16671-16672	 	_	
93-24	16672-16673	<	_	
93-25	16673-16674	 	_	
93-26	16674-16677	.05	_	
93-27	16677-16678	)	_	
93-28	16678-16679	.	_	

#Text=Relationship between interhemispheric connectivity and hemispheric specialization
#Text=To test whether schizophrenia-related changes in interhemispheric connectivity co-vary with alterations in hemispheric specialization, we calculated the mean difference between controls and patients on both measurements for each brain region.
94-1	16680-16692	Relationship	_	
94-2	16693-16700	between	_	
94-3	16701-16717	interhemispheric	_	
94-4	16718-16730	connectivity	_	
94-5	16731-16734	and	_	
94-6	16735-16746	hemispheric	_	
94-7	16747-16761	specialization	_	
94-8	16762-16764	To	_	
94-9	16765-16769	test	_	
94-10	16770-16777	whether	_	
94-11	16778-16799	schizophrenia-related	_	
94-12	16800-16807	changes	_	
94-13	16808-16810	in	_	
94-14	16811-16827	interhemispheric	_	
94-15	16828-16840	connectivity	_	
94-16	16841-16848	co-vary	_	
94-17	16849-16853	with	_	
94-18	16854-16865	alterations	_	
94-19	16866-16868	in	_	
94-20	16869-16880	hemispheric	_	
94-21	16881-16895	specialization	_	
94-22	16895-16896	,	_	
94-23	16897-16899	we	_	
94-24	16900-16910	calculated	_	
94-25	16911-16914	the	_	
94-26	16915-16919	mean	_	
94-27	16920-16930	difference	_	
94-28	16931-16938	between	_	
94-29	16939-16947	controls	_	
94-30	16948-16951	and	_	
94-31	16952-16960	patients	_	
94-32	16961-16963	on	_	
94-33	16964-16968	both	_	
94-34	16969-16981	measurements	_	
94-35	16982-16985	for	_	
94-36	16986-16990	each	_	
94-37	16991-16996	brain	_	
94-38	16997-17003	region	_	
94-39	17003-17004	.	_	

#Text=Pearson's correlation analysis was performed on group-differences of interhemispheric connectivity and hemispheric specialization across regions (p < .05).
95-1	17005-17014	Pearson's	_	
95-2	17015-17026	correlation	_	
95-3	17027-17035	analysis	_	
95-4	17036-17039	was	_	
95-5	17040-17049	performed	_	
95-6	17050-17052	on	_	
95-7	17053-17070	group-differences	_	
95-8	17071-17073	of	_	
95-9	17074-17090	interhemispheric	_	
95-10	17091-17103	connectivity	_	
95-11	17104-17107	and	_	
95-12	17108-17119	hemispheric	_	
95-13	17120-17134	specialization	_	
95-14	17135-17141	across	_	
95-15	17142-17149	regions	_	
95-16	17150-17151	(	_	
95-17	17151-17152	p	_	
95-18	17152-17153	 	_	
95-19	17153-17154	<	_	
95-20	17154-17155	 	_	
95-21	17155-17158	.05	_	
95-22	17158-17159	)	_	
95-23	17159-17160	.	_	

#Text=The same analysis was performed for siblings as compared to patients, and for controls compared to siblings.
96-1	17161-17164	The	_	
96-2	17165-17169	same	_	
96-3	17170-17178	analysis	_	
96-4	17179-17182	was	_	
96-5	17183-17192	performed	_	
96-6	17193-17196	for	_	
96-7	17197-17205	siblings	_	
96-8	17206-17208	as	_	
96-9	17209-17217	compared	_	
96-10	17218-17220	to	_	
96-11	17221-17229	patients	_	
96-12	17229-17230	,	_	
96-13	17231-17234	and	_	
96-14	17235-17238	for	_	
96-15	17239-17247	controls	_	
96-16	17248-17256	compared	_	
96-17	17257-17259	to	_	
96-18	17260-17268	siblings	_	
96-19	17268-17269	.	_	

#Text=Correlation between connectivity alteration and clinical factors
#Text=To examine the potential clinical relevance of connectivity changes in patients, the level of interhemispheric connectivity and hemispheric specialization were correlated with illness duration and PANSS total scores in patients (p < .05).
97-1	17270-17281	Correlation	_	
97-2	17282-17289	between	_	
97-3	17290-17302	connectivity	_	
97-4	17303-17313	alteration	_	
97-5	17314-17317	and	_	
97-6	17318-17326	clinical	_	
97-7	17327-17334	factors	_	
97-8	17335-17337	To	_	
97-9	17338-17345	examine	_	
97-10	17346-17349	the	_	
97-11	17350-17359	potential	_	
97-12	17360-17368	clinical	_	
97-13	17369-17378	relevance	_	
97-14	17379-17381	of	_	
97-15	17382-17394	connectivity	_	
97-16	17395-17402	changes	_	
97-17	17403-17405	in	_	
97-18	17406-17414	patients	_	
97-19	17414-17415	,	_	
97-20	17416-17419	the	_	
97-21	17420-17425	level	_	
97-22	17426-17428	of	_	
97-23	17429-17445	interhemispheric	_	
97-24	17446-17458	connectivity	_	
97-25	17459-17462	and	_	
97-26	17463-17474	hemispheric	_	
97-27	17475-17489	specialization	_	
97-28	17490-17494	were	_	
97-29	17495-17505	correlated	_	
97-30	17506-17510	with	_	
97-31	17511-17518	illness	_	
97-32	17519-17527	duration	_	
97-33	17528-17531	and	_	
97-34	17532-17537	PANSS	_	
97-35	17538-17543	total	_	
97-36	17544-17550	scores	_	
97-37	17551-17553	in	_	
97-38	17554-17562	patients	_	
97-39	17563-17564	(	_	
97-40	17564-17565	p	_	
97-41	17565-17566	 	_	
97-42	17566-17567	<	_	
97-43	17567-17568	 	_	
97-44	17568-17571	.05	_	
97-45	17571-17572	)	_	
97-46	17572-17573	.	_	

#Text=Moreover, antipsychotic medication was examined as a potential confounder of functional connectivity measurements by correlating daily medication in chlorpromazine equivalent dose with interhemispheric connectivity and hemispheric specialization.
98-1	17574-17582	Moreover	_	
98-2	17582-17583	,	_	
98-3	17584-17597	antipsychotic	_	
98-4	17598-17608	medication	_	
98-5	17609-17612	was	_	
98-6	17613-17621	examined	_	
98-7	17622-17624	as	_	
98-8	17625-17626	a	_	
98-9	17627-17636	potential	_	
98-10	17637-17647	confounder	_	
98-11	17648-17650	of	_	
98-12	17651-17661	functional	_	
98-13	17662-17674	connectivity	_	
98-14	17675-17687	measurements	_	
98-15	17688-17690	by	_	
98-16	17691-17702	correlating	_	
98-17	17703-17708	daily	_	
98-18	17709-17719	medication	_	
98-19	17720-17722	in	_	
98-20	17723-17737	chlorpromazine	_	
98-21	17738-17748	equivalent	_	
98-22	17749-17753	dose	_	
98-23	17754-17758	with	_	
98-24	17759-17775	interhemispheric	_	
98-25	17776-17788	connectivity	_	
98-26	17789-17792	and	_	
98-27	17793-17804	hemispheric	_	
98-28	17805-17819	specialization	_	
98-29	17819-17820	.	_	

#Text=Results
#Text=Interhemispheric connectivity
#Text=Group mean homotopic interhemispheric connectivity strength was plotted on a brain surface for each subject group (Fig. 1).
99-1	17821-17828	Results	_	
99-2	17829-17845	Interhemispheric	_	
99-3	17846-17858	connectivity	_	
99-4	17859-17864	Group	_	
99-5	17865-17869	mean	_	
99-6	17870-17879	homotopic	_	
99-7	17880-17896	interhemispheric	_	
99-8	17897-17909	connectivity	_	
99-9	17910-17918	strength	_	
99-10	17919-17922	was	_	
99-11	17923-17930	plotted	_	
99-12	17931-17933	on	_	
99-13	17934-17935	a	_	
99-14	17936-17941	brain	_	
99-15	17942-17949	surface	_	
99-16	17950-17953	for	_	
99-17	17954-17958	each	_	
99-18	17959-17966	subject	_	
99-19	17967-17972	group	_	
99-20	17973-17974	(	_	
99-21	17974-17977	Fig	_	
99-22	17977-17978	.	_	
99-23	17979-17980	1	_	
99-24	17980-17981	)	_	
99-25	17981-17982	.	_	

#Text=Regional variation in interhemispheric connectivity indicated higher bilateral synchrony in primary sensorimotor, auditory cortex and midline regions as compared to heteromodal association cortex.
100-1	17983-17991	Regional	_	
100-2	17992-18001	variation	_	
100-3	18002-18004	in	_	
100-4	18005-18021	interhemispheric	_	
100-5	18022-18034	connectivity	_	
100-6	18035-18044	indicated	_	
100-7	18045-18051	higher	_	
100-8	18052-18061	bilateral	_	
100-9	18062-18071	synchrony	_	
100-10	18072-18074	in	_	
100-11	18075-18082	primary	_	
100-12	18083-18095	sensorimotor	_	
100-13	18095-18096	,	_	
100-14	18097-18105	auditory	_	
100-15	18106-18112	cortex	_	
100-16	18113-18116	and	_	
100-17	18117-18124	midline	_	
100-18	18125-18132	regions	_	
100-19	18133-18135	as	_	
100-20	18136-18144	compared	_	
100-21	18145-18147	to	_	
100-22	18148-18159	heteromodal	_	
100-23	18160-18171	association	_	
100-24	18172-18178	cortex	_	
100-25	18178-18179	.	_	

#Text=Regional interhemispheric connectivity in healthy controls correlated with values reported in a previous study in healthy subjects (r = 0.41, p = .002, Supplementary Fig. 1).
101-1	18180-18188	Regional	_	
101-2	18189-18205	interhemispheric	_	
101-3	18206-18218	connectivity	_	
101-4	18219-18221	in	_	
101-5	18222-18229	healthy	_	
101-6	18230-18238	controls	_	
101-7	18239-18249	correlated	_	
101-8	18250-18254	with	_	
101-9	18255-18261	values	_	
101-10	18262-18270	reported	_	
101-11	18271-18273	in	_	
101-12	18274-18275	a	_	
101-13	18276-18284	previous	_	
101-14	18285-18290	study	_	
101-15	18291-18293	in	_	
101-16	18294-18301	healthy	_	
101-17	18302-18310	subjects	_	
101-18	18311-18312	(	_	
101-19	18312-18313	r	_	
101-20	18313-18314	 	_	
101-21	18314-18315	=	_	
101-22	18315-18316	 	_	
101-23	18316-18320	0.41	_	
101-24	18320-18321	,	_	
101-25	18322-18323	p	_	
101-26	18323-18324	 	_	
101-27	18324-18325	=	_	
101-28	18325-18326	 	_	
101-29	18326-18330	.002	_	
101-30	18330-18331	,	_	
101-31	18332-18345	Supplementary	_	
101-32	18346-18349	Fig	_	
101-33	18349-18350	.	_	
101-34	18351-18352	1	_	
101-35	18352-18353	)	_	
101-36	18353-18354	.	_	

#Text=Linear mixed-effects analysis showed a significant main effect of group on homotopic interhemispheric connectivity (F(2,227) = 4.31, p = .01, Fig. 1), such that interhemispheric connectivity was lower in patients as compared to both controls (t(227) = 2.03, p = .04) and siblings (t(227) = 2.90, p = .004).
102-1	18355-18361	Linear	_	
102-2	18362-18375	mixed-effects	_	
102-3	18376-18384	analysis	_	
102-4	18385-18391	showed	_	
102-5	18392-18393	a	_	
102-6	18394-18405	significant	_	
102-7	18406-18410	main	_	
102-8	18411-18417	effect	_	
102-9	18418-18420	of	_	
102-10	18421-18426	group	_	
102-11	18427-18429	on	_	
102-12	18430-18439	homotopic	_	
102-13	18440-18456	interhemispheric	_	
102-14	18457-18469	connectivity	_	
102-15	18470-18471	(	_	
102-16	18471-18472	F	_	
102-17	18472-18473	(	_	
102-18	18473-18478	2,227	_	
102-19	18478-18479	)	_	
102-20	18479-18480	 	_	
102-21	18480-18481	=	_	
102-22	18481-18482	 	_	
102-23	18482-18486	4.31	_	
102-24	18486-18487	,	_	
102-25	18488-18489	p	_	
102-26	18489-18490	 	_	
102-27	18490-18491	=	_	
102-28	18491-18492	 	_	
102-29	18492-18495	.01	_	
102-30	18495-18496	,	_	
102-31	18497-18500	Fig	_	
102-32	18500-18501	.	_	
102-33	18502-18503	1	_	
102-34	18503-18504	)	_	
102-35	18504-18505	,	_	
102-36	18506-18510	such	_	
102-37	18511-18515	that	_	
102-38	18516-18532	interhemispheric	_	
102-39	18533-18545	connectivity	_	
102-40	18546-18549	was	_	
102-41	18550-18555	lower	_	
102-42	18556-18558	in	_	
102-43	18559-18567	patients	_	
102-44	18568-18570	as	_	
102-45	18571-18579	compared	_	
102-46	18580-18582	to	_	
102-47	18583-18587	both	_	
102-48	18588-18596	controls	_	
102-49	18597-18598	(	_	
102-50	18598-18599	t	_	
102-51	18599-18600	(	_	
102-52	18600-18603	227	_	
102-53	18603-18604	)	_	
102-54	18604-18605	 	_	
102-55	18605-18606	=	_	
102-56	18606-18607	 	_	
102-57	18607-18611	2.03	_	
102-58	18611-18612	,	_	
102-59	18613-18614	p	_	
102-60	18614-18615	 	_	
102-61	18615-18616	=	_	
102-62	18616-18617	 	_	
102-63	18617-18620	.04	_	
102-64	18620-18621	)	_	
102-65	18622-18625	and	_	
102-66	18626-18634	siblings	_	
102-67	18635-18636	(	_	
102-68	18636-18637	t	_	
102-69	18637-18638	(	_	
102-70	18638-18641	227	_	
102-71	18641-18642	)	_	
102-72	18642-18643	 	_	
102-73	18643-18644	=	_	
102-74	18644-18645	 	_	
102-75	18645-18649	2.90	_	
102-76	18649-18650	,	_	
102-77	18651-18652	p	_	
102-78	18652-18653	 	_	
102-79	18653-18654	=	_	
102-80	18654-18655	 	_	
102-81	18655-18659	.004	_	
102-82	18659-18660	)	_	
102-83	18660-18661	.	_	

#Text=Group-differences for heterotopic interhemispheric connectivity or left and right intra-hemispheric functional connectivity was not significant after controlling for global connectivity differences (F(2,227) = 0.61, 0.11, 0.14, p = .54, 0.89, 0.87 respectively, Supplementary Fig. 2).
103-1	18662-18679	Group-differences	_	
103-2	18680-18683	for	_	
103-3	18684-18695	heterotopic	_	
103-4	18696-18712	interhemispheric	_	
103-5	18713-18725	connectivity	_	
103-6	18726-18728	or	_	
103-7	18729-18733	left	_	
103-8	18734-18737	and	_	
103-9	18738-18743	right	_	
103-10	18744-18761	intra-hemispheric	_	
103-11	18762-18772	functional	_	
103-12	18773-18785	connectivity	_	
103-13	18786-18789	was	_	
103-14	18790-18793	not	_	
103-15	18794-18805	significant	_	
103-16	18806-18811	after	_	
103-17	18812-18823	controlling	_	
103-18	18824-18827	for	_	
103-19	18828-18834	global	_	
103-20	18835-18847	connectivity	_	
103-21	18848-18859	differences	_	
103-22	18860-18861	(	_	
103-23	18861-18862	F	_	
103-24	18862-18863	(	_	
103-25	18863-18868	2,227	_	
103-26	18868-18869	)	_	
103-27	18869-18870	 	_	
103-28	18870-18871	=	_	
103-29	18871-18872	 	_	
103-30	18872-18876	0.61	_	
103-31	18876-18877	,	_	
103-32	18878-18882	0.11	_	
103-33	18882-18883	,	_	
103-34	18884-18888	0.14	_	
103-35	18888-18889	,	_	
103-36	18890-18891	p	_	
103-37	18891-18892	 	_	
103-38	18892-18893	=	_	
103-39	18893-18894	 	_	
103-40	18894-18897	.54	_	
103-41	18897-18898	,	_	
103-42	18899-18903	0.89	_	
103-43	18903-18904	,	_	
103-44	18905-18909	0.87	_	
103-45	18910-18922	respectively	_	
103-46	18922-18923	,	_	
103-47	18924-18937	Supplementary	_	
103-48	18938-18941	Fig	_	
103-49	18941-18942	.	_	
103-50	18943-18944	2	_	
103-51	18944-18945	)	_	
103-52	18945-18946	.	_	

#Text=Regional homotopic interhemispheric connectivity strength (z score) were plotted on brain volume for the three subject groups.
104-1	18947-18955	Regional	_	
104-2	18956-18965	homotopic	_	
104-3	18966-18982	interhemispheric	_	
104-4	18983-18995	connectivity	_	
104-5	18996-19004	strength	_	
104-6	19005-19006	(	_	
104-7	19006-19007	z	_	
104-8	19008-19013	score	_	
104-9	19013-19014	)	_	
104-10	19015-19019	were	_	
104-11	19020-19027	plotted	_	
104-12	19028-19030	on	_	
104-13	19031-19036	brain	_	
104-14	19037-19043	volume	_	
104-15	19044-19047	for	_	
104-16	19048-19051	the	_	
104-17	19052-19057	three	_	
104-18	19058-19065	subject	_	
104-19	19066-19072	groups	_	
104-20	19072-19073	.	_	

#Text=The lower right boxplot depicts global interhemispheric connectivity for every subject.
105-1	19074-19077	The	_	
105-2	19078-19083	lower	_	
105-3	19084-19089	right	_	
105-4	19090-19097	boxplot	_	
105-5	19098-19105	depicts	_	
105-6	19106-19112	global	_	
105-7	19113-19129	interhemispheric	_	
105-8	19130-19142	connectivity	_	
105-9	19143-19146	for	_	
105-10	19147-19152	every	_	
105-11	19153-19160	subject	_	
105-12	19160-19161	.	_	

#Text=Patients had lower interhemispheric connectivity strength than controls (p = .04) and siblings (p = .004).
106-1	19162-19170	Patients	_	
106-2	19171-19174	had	_	
106-3	19175-19180	lower	_	
106-4	19181-19197	interhemispheric	_	
106-5	19198-19210	connectivity	_	
106-6	19211-19219	strength	_	
106-7	19220-19224	than	_	
106-8	19225-19233	controls	_	
106-9	19234-19235	(	_	
106-10	19235-19236	p	_	
106-11	19236-19237	 	_	
106-12	19237-19238	=	_	
106-13	19238-19239	 	_	
106-14	19239-19242	.04	_	
106-15	19242-19243	)	_	
106-16	19244-19247	and	_	
106-17	19248-19256	siblings	_	
106-18	19257-19258	(	_	
106-19	19258-19259	p	_	
106-20	19259-19260	 	_	
106-21	19260-19261	=	_	
106-22	19261-19262	 	_	
106-23	19262-19266	.004	_	
106-24	19266-19267	)	_	
106-25	19267-19268	.	_	

#Text=Fig. 1
#Text=Regions showing a significant group effect on interhemispheric connectivity (p < .05, Bonferroni corrected).
107-1	19269-19272	Fig	_	
107-2	19272-19273	.	_	
107-3	19274-19275	1	_	
107-4	19276-19283	Regions	_	
107-5	19284-19291	showing	_	
107-6	19292-19293	a	_	
107-7	19294-19305	significant	_	
107-8	19306-19311	group	_	
107-9	19312-19318	effect	_	
107-10	19319-19321	on	_	
107-11	19322-19338	interhemispheric	_	
107-12	19339-19351	connectivity	_	
107-13	19352-19353	(	_	
107-14	19353-19354	p	_	
107-15	19354-19355	 	_	
107-16	19355-19356	<	_	
107-17	19356-19357	 	_	
107-18	19357-19360	.05	_	
107-19	19360-19361	,	_	
107-20	19362-19372	Bonferroni	_	
107-21	19373-19382	corrected	_	
107-22	19382-19383	)	_	
107-23	19383-19384	.	_	

#Text=Post-hoc analyses revealed significant reductions in interhemispheric connectivity in patients relative to both controls and siblings for all these regions (p < .05, detailed statistics were provided in the Supplementary Table 3).
108-1	19385-19393	Post-hoc	_	
108-2	19394-19402	analyses	_	
108-3	19403-19411	revealed	_	
108-4	19412-19423	significant	_	
108-5	19424-19434	reductions	_	
108-6	19435-19437	in	_	
108-7	19438-19454	interhemispheric	_	
108-8	19455-19467	connectivity	_	
108-9	19468-19470	in	_	
108-10	19471-19479	patients	_	
108-11	19480-19488	relative	_	
108-12	19489-19491	to	_	
108-13	19492-19496	both	_	
108-14	19497-19505	controls	_	
108-15	19506-19509	and	_	
108-16	19510-19518	siblings	_	
108-17	19519-19522	for	_	
108-18	19523-19526	all	_	
108-19	19527-19532	these	_	
108-20	19533-19540	regions	_	
108-21	19541-19542	(	_	
108-22	19542-19543	p	_	
108-23	19543-19544	 	_	
108-24	19544-19545	<	_	
108-25	19545-19546	 	_	
108-26	19546-19549	.05	_	
108-27	19549-19550	,	_	
108-28	19551-19559	detailed	_	
108-29	19560-19570	statistics	_	
108-30	19571-19575	were	_	
108-31	19576-19584	provided	_	
108-32	19585-19587	in	_	
108-33	19588-19591	the	_	
108-34	19592-19605	Supplementary	_	
108-35	19606-19611	Table	_	
108-36	19612-19613	3	_	
108-37	19613-19614	)	_	
108-38	19614-19615	.	_	

#Text=Abbreviation: CON, healthy controls; SIB, unaffected siblings; PAT, schizophrenia patients.
109-1	19616-19628	Abbreviation	_	
109-2	19628-19629	:	_	
109-3	19630-19633	CON	_	
109-4	19633-19634	,	_	
109-5	19635-19642	healthy	_	
109-6	19643-19651	controls	_	
109-7	19651-19652	;	_	
109-8	19653-19656	SIB	_	
109-9	19656-19657	,	_	
109-10	19658-19668	unaffected	_	
109-11	19669-19677	siblings	_	
109-12	19677-19678	;	_	
109-13	19679-19682	PAT	_	
109-14	19682-19683	,	_	
109-15	19684-19697	schizophrenia	_	
109-16	19698-19706	patients	_	
109-17	19706-19707	.	_	

#Text=Fig. 2
#Text=Regional homotopic interhemispheric connectivity showed a significant group-effect in pre- and postcentral gyrus, subcallosal cortex and anterior supramarginal gyrus (p < .05, Bonferroni corrected, Fig. 2).
110-1	19708-19711	Fig	_	
110-2	19711-19712	.	_	
110-3	19713-19714	2	_	
110-4	19715-19723	Regional	_	
110-5	19724-19733	homotopic	_	
110-6	19734-19750	interhemispheric	_	
110-7	19751-19763	connectivity	_	
110-8	19764-19770	showed	_	
110-9	19771-19772	a	_	
110-10	19773-19784	significant	_	
110-11	19785-19797	group-effect	_	
110-12	19798-19800	in	_	
110-13	19801-19804	pre	_	
110-14	19804-19805	-	_	
110-15	19806-19809	and	_	
110-16	19810-19821	postcentral	_	
110-17	19822-19827	gyrus	_	
110-18	19827-19828	,	_	
110-19	19829-19840	subcallosal	_	
110-20	19841-19847	cortex	_	
110-21	19848-19851	and	_	
110-22	19852-19860	anterior	_	
110-23	19861-19874	supramarginal	_	
110-24	19875-19880	gyrus	_	
110-25	19881-19882	(	_	
110-26	19882-19883	p	_	
110-27	19883-19884	 	_	
110-28	19884-19885	<	_	
110-29	19885-19886	 	_	
110-30	19886-19889	.05	_	
110-31	19889-19890	,	_	
110-32	19891-19901	Bonferroni	_	
110-33	19902-19911	corrected	_	
110-34	19911-19912	,	_	
110-35	19913-19916	Fig	_	
110-36	19916-19917	.	_	
110-37	19918-19919	2	_	
110-38	19919-19920	)	_	
110-39	19920-19921	.	_	

#Text=Post-hoc analyses revealed significant reductions in interhemispheric connectivity in patients relative to both controls and siblings for all these regions (p < .05, detailed statistics are provided in the Supplementary Table 3).
111-1	19922-19930	Post-hoc	_	
111-2	19931-19939	analyses	_	
111-3	19940-19948	revealed	_	
111-4	19949-19960	significant	_	
111-5	19961-19971	reductions	_	
111-6	19972-19974	in	_	
111-7	19975-19991	interhemispheric	_	
111-8	19992-20004	connectivity	_	
111-9	20005-20007	in	_	
111-10	20008-20016	patients	_	
111-11	20017-20025	relative	_	
111-12	20026-20028	to	_	
111-13	20029-20033	both	_	
111-14	20034-20042	controls	_	
111-15	20043-20046	and	_	
111-16	20047-20055	siblings	_	
111-17	20056-20059	for	_	
111-18	20060-20063	all	_	
111-19	20064-20069	these	_	
111-20	20070-20077	regions	_	
111-21	20078-20079	(	_	
111-22	20079-20080	p	_	
111-23	20080-20081	 	_	
111-24	20081-20082	<	_	
111-25	20082-20083	 	_	
111-26	20083-20086	.05	_	
111-27	20086-20087	,	_	
111-28	20088-20096	detailed	_	
111-29	20097-20107	statistics	_	
111-30	20108-20111	are	_	
111-31	20112-20120	provided	_	
111-32	20121-20123	in	_	
111-33	20124-20127	the	_	
111-34	20128-20141	Supplementary	_	
111-35	20142-20147	Table	_	
111-36	20148-20149	3	_	
111-37	20149-20150	)	_	
111-38	20150-20151	.	_	

#Text=There were no significant group-differences in regional interhemispheric connectivity between controls and siblings.
112-1	20152-20157	There	_	
112-2	20158-20162	were	_	
112-3	20163-20165	no	_	
112-4	20166-20177	significant	_	
112-5	20178-20195	group-differences	_	
112-6	20196-20198	in	_	
112-7	20199-20207	regional	_	
112-8	20208-20224	interhemispheric	_	
112-9	20225-20237	connectivity	_	
112-10	20238-20245	between	_	
112-11	20246-20254	controls	_	
112-12	20255-20258	and	_	
112-13	20259-20267	siblings	_	
112-14	20267-20268	.	_	

#Text=Hemispheric specialization: group effects
#Text=The color of brain volume represents regional hemispheric specialization (z score) in the three subject groups.
113-1	20269-20280	Hemispheric	_	
113-2	20281-20295	specialization	_	
113-3	20295-20296	:	_	
113-4	20297-20302	group	_	
113-5	20303-20310	effects	_	
113-6	20311-20314	The	_	
113-7	20315-20320	color	_	
113-8	20321-20323	of	_	
113-9	20324-20329	brain	_	
113-10	20330-20336	volume	_	
113-11	20337-20347	represents	_	
113-12	20348-20356	regional	_	
113-13	20357-20368	hemispheric	_	
113-14	20369-20383	specialization	_	
113-15	20384-20385	(	_	
113-16	20385-20386	z	_	
113-17	20387-20392	score	_	
113-18	20392-20393	)	_	
113-19	20394-20396	in	_	
113-20	20397-20400	the	_	
113-21	20401-20406	three	_	
113-22	20407-20414	subject	_	
113-23	20415-20421	groups	_	
113-24	20421-20422	.	_	

#Text=The boxplot shows individual global hemispheric specialization.
114-1	20423-20426	The	_	
114-2	20427-20434	boxplot	_	
114-3	20435-20440	shows	_	
114-4	20441-20451	individual	_	
114-5	20452-20458	global	_	
114-6	20459-20470	hemispheric	_	
114-7	20471-20485	specialization	_	
114-8	20485-20486	.	_	

#Text=Patients with schizophrenia had higher global hemispheric specialization than siblings (p = .01).
115-1	20487-20495	Patients	_	
115-2	20496-20500	with	_	
115-3	20501-20514	schizophrenia	_	
115-4	20515-20518	had	_	
115-5	20519-20525	higher	_	
115-6	20526-20532	global	_	
115-7	20533-20544	hemispheric	_	
115-8	20545-20559	specialization	_	
115-9	20560-20564	than	_	
115-10	20565-20573	siblings	_	
115-11	20574-20575	(	_	
115-12	20575-20576	p	_	
115-13	20576-20577	 	_	
115-14	20577-20578	=	_	
115-15	20578-20579	 	_	
115-16	20579-20582	.01	_	
115-17	20582-20583	)	_	
115-18	20583-20584	.	_	

#Text=Fig. 3
#Text=Regional variation of hemispheric specialization showed a distinct pattern from interhemispheric connectivity (Fig. 3).
116-1	20585-20588	Fig	_	
116-2	20588-20589	.	_	
116-3	20590-20591	3	_	
116-4	20592-20600	Regional	_	
116-5	20601-20610	variation	_	
116-6	20611-20613	of	_	
116-7	20614-20625	hemispheric	_	
116-8	20626-20640	specialization	_	
116-9	20641-20647	showed	_	
116-10	20648-20649	a	_	
116-11	20650-20658	distinct	_	
116-12	20659-20666	pattern	_	
116-13	20667-20671	from	_	
116-14	20672-20688	interhemispheric	_	
116-15	20689-20701	connectivity	_	
116-16	20702-20703	(	_	
116-17	20703-20706	Fig	_	
116-18	20706-20707	.	_	
116-19	20708-20709	3	_	
116-20	20709-20710	)	_	
116-21	20710-20711	.	_	

#Text=Heteromodal regions showed higher levels of hemispheric specialization than primary sensorimotor areas, indicating a tendency of heteromodal regions to interact preferentially with ipsilateral brain areas.
117-1	20712-20723	Heteromodal	_	
117-2	20724-20731	regions	_	
117-3	20732-20738	showed	_	
117-4	20739-20745	higher	_	
117-5	20746-20752	levels	_	
117-6	20753-20755	of	_	
117-7	20756-20767	hemispheric	_	
117-8	20768-20782	specialization	_	
117-9	20783-20787	than	_	
117-10	20788-20795	primary	_	
117-11	20796-20808	sensorimotor	_	
117-12	20809-20814	areas	_	
117-13	20814-20815	,	_	
117-14	20816-20826	indicating	_	
117-15	20827-20828	a	_	
117-16	20829-20837	tendency	_	
117-17	20838-20840	of	_	
117-18	20841-20852	heteromodal	_	
117-19	20853-20860	regions	_	
117-20	20861-20863	to	_	
117-21	20864-20872	interact	_	
117-22	20873-20887	preferentially	_	
117-23	20888-20892	with	_	
117-24	20893-20904	ipsilateral	_	
117-25	20905-20910	brain	_	
117-26	20911-20916	areas	_	
117-27	20916-20917	.	_	

#Text=There was a significant main effect of group on global hemispheric specialization (F(2,464) = 3.73, p = .02).
118-1	20918-20923	There	_	
118-2	20924-20927	was	_	
118-3	20928-20929	a	_	
118-4	20930-20941	significant	_	
118-5	20942-20946	main	_	
118-6	20947-20953	effect	_	
118-7	20954-20956	of	_	
118-8	20957-20962	group	_	
118-9	20963-20965	on	_	
118-10	20966-20972	global	_	
118-11	20973-20984	hemispheric	_	
118-12	20985-20999	specialization	_	
118-13	21000-21001	(	_	
118-14	21001-21002	F	_	
118-15	21002-21003	(	_	
118-16	21003-21008	2,464	_	
118-17	21008-21009	)	_	
118-18	21009-21010	 	_	
118-19	21010-21011	=	_	
118-20	21011-21012	 	_	
118-21	21012-21016	3.73	_	
118-22	21016-21017	,	_	
118-23	21018-21019	p	_	
118-24	21019-21020	 	_	
118-25	21020-21021	=	_	
118-26	21021-21022	 	_	
118-27	21022-21025	.02	_	
118-28	21025-21026	)	_	
118-29	21026-21027	.	_	

#Text=Post-hoc comparisons showed that hemispheric specialization is higher in patients as compared to siblings (t(464) = 2.73, p = .01), indicating that functional connectivity in schizophrenia patients is more confined within their own hemispheres.
119-1	21028-21036	Post-hoc	_	
119-2	21037-21048	comparisons	_	
119-3	21049-21055	showed	_	
119-4	21056-21060	that	_	
119-5	21061-21072	hemispheric	_	
119-6	21073-21087	specialization	_	
119-7	21088-21090	is	_	
119-8	21091-21097	higher	_	
119-9	21098-21100	in	_	
119-10	21101-21109	patients	_	
119-11	21110-21112	as	_	
119-12	21113-21121	compared	_	
119-13	21122-21124	to	_	
119-14	21125-21133	siblings	_	
119-15	21134-21135	(	_	
119-16	21135-21136	t	_	
119-17	21136-21137	(	_	
119-18	21137-21140	464	_	
119-19	21140-21141	)	_	
119-20	21141-21142	 	_	
119-21	21142-21143	=	_	
119-22	21143-21144	 	_	
119-23	21144-21148	2.73	_	
119-24	21148-21149	,	_	
119-25	21150-21151	p	_	
119-26	21151-21152	 	_	
119-27	21152-21153	=	_	
119-28	21153-21154	 	_	
119-29	21154-21157	.01	_	
119-30	21157-21158	)	_	
119-31	21158-21159	,	_	
119-32	21160-21170	indicating	_	
119-33	21171-21175	that	_	
119-34	21176-21186	functional	_	
119-35	21187-21199	connectivity	_	
119-36	21200-21202	in	_	
119-37	21203-21216	schizophrenia	_	
119-38	21217-21225	patients	_	
119-39	21226-21228	is	_	
119-40	21229-21233	more	_	
119-41	21234-21242	confined	_	
119-42	21243-21249	within	_	
119-43	21250-21255	their	_	
119-44	21256-21259	own	_	
119-45	21260-21271	hemispheres	_	
119-46	21271-21272	.	_	

#Text=Regional hemispheric specialization showing significant (A) group differences; (B) hemispheric effects (p < .05, Bonferroni corrected, Supplementary Tables 4, 5).
120-1	21273-21281	Regional	_	
120-2	21282-21293	hemispheric	_	
120-3	21294-21308	specialization	_	
120-4	21309-21316	showing	_	
120-5	21317-21328	significant	_	
120-6	21329-21330	(	_	
120-7	21330-21331	A	_	
120-8	21331-21332	)	_	
120-9	21333-21338	group	_	
120-10	21339-21350	differences	_	
120-11	21350-21351	;	_	
120-12	21352-21353	(	_	
120-13	21353-21354	B	_	
120-14	21354-21355	)	_	
120-15	21356-21367	hemispheric	_	
120-16	21368-21375	effects	_	
120-17	21376-21377	(	_	
120-18	21377-21378	p	_	
120-19	21378-21379	 	_	
120-20	21379-21380	<	_	
120-21	21380-21381	 	_	
120-22	21381-21384	.05	_	
120-23	21384-21385	,	_	
120-24	21386-21396	Bonferroni	_	
120-25	21397-21406	corrected	_	
120-26	21406-21407	,	_	
120-27	21408-21421	Supplementary	_	
120-28	21422-21428	Tables	_	
120-29	21429-21430	4	_	
120-30	21430-21431	,	_	
120-31	21432-21433	5	_	
120-32	21433-21434	)	_	
120-33	21434-21435	.	_	

#Text=For group effects (A), patients exhibited increased hemispheric specialization in unimodal and heteromodal association cortices, sensorimotor cortices and limbic areas.
121-1	21436-21439	For	_	
121-2	21440-21445	group	_	
121-3	21446-21453	effects	_	
121-4	21454-21455	(	_	
121-5	21455-21456	A	_	
121-6	21456-21457	)	_	
121-7	21457-21458	,	_	
121-8	21459-21467	patients	_	
121-9	21468-21477	exhibited	_	
121-10	21478-21487	increased	_	
121-11	21488-21499	hemispheric	_	
121-12	21500-21514	specialization	_	
121-13	21515-21517	in	_	
121-14	21518-21526	unimodal	_	
121-15	21527-21530	and	_	
121-16	21531-21542	heteromodal	_	
121-17	21543-21554	association	_	
121-18	21555-21563	cortices	_	
121-19	21563-21564	,	_	
121-20	21565-21577	sensorimotor	_	
121-21	21578-21586	cortices	_	
121-22	21587-21590	and	_	
121-23	21591-21597	limbic	_	
121-24	21598-21603	areas	_	
121-25	21603-21604	.	_	

#Text=The hemispheric effects (B) indicate higher specialization in frontal and temporal regions and subcortical structures in the left hemisphere, whereas higher specialization was observed in the right hemisphere for parietal, occipital, auditory, subcortical and anterior cingulate cortex.
122-1	21605-21608	The	_	
122-2	21609-21620	hemispheric	_	
122-3	21621-21628	effects	_	
122-4	21629-21630	(	_	
122-5	21630-21631	B	_	
122-6	21631-21632	)	_	
122-7	21633-21641	indicate	_	
122-8	21642-21648	higher	_	
122-9	21649-21663	specialization	_	
122-10	21664-21666	in	_	
122-11	21667-21674	frontal	_	
122-12	21675-21678	and	_	
122-13	21679-21687	temporal	_	
122-14	21688-21695	regions	_	
122-15	21696-21699	and	_	
122-16	21700-21711	subcortical	_	
122-17	21712-21722	structures	_	
122-18	21723-21725	in	_	
122-19	21726-21729	the	_	
122-20	21730-21734	left	_	
122-21	21735-21745	hemisphere	_	
122-22	21745-21746	,	_	
122-23	21747-21754	whereas	_	
122-24	21755-21761	higher	_	
122-25	21762-21776	specialization	_	
122-26	21777-21780	was	_	
122-27	21781-21789	observed	_	
122-28	21790-21792	in	_	
122-29	21793-21796	the	_	
122-30	21797-21802	right	_	
122-31	21803-21813	hemisphere	_	
122-32	21814-21817	for	_	
122-33	21818-21826	parietal	_	
122-34	21826-21827	,	_	
122-35	21828-21837	occipital	_	
122-36	21837-21838	,	_	
122-37	21839-21847	auditory	_	
122-38	21847-21848	,	_	
122-39	21849-21860	subcortical	_	
122-40	21861-21864	and	_	
122-41	21865-21873	anterior	_	
122-42	21874-21883	cingulate	_	
122-43	21884-21890	cortex	_	
122-44	21890-21891	.	_	

#Text=For illustration purpose, regional hemispheric specialization values were averaged over the two hemispheres (A) and over the three groups (B).
123-1	21892-21895	For	_	
123-2	21896-21908	illustration	_	
123-3	21909-21916	purpose	_	
123-4	21916-21917	,	_	
123-5	21918-21926	regional	_	
123-6	21927-21938	hemispheric	_	
123-7	21939-21953	specialization	_	
123-8	21954-21960	values	_	
123-9	21961-21965	were	_	
123-10	21966-21974	averaged	_	
123-11	21975-21979	over	_	
123-12	21980-21983	the	_	
123-13	21984-21987	two	_	
123-14	21988-21999	hemispheres	_	
123-15	22000-22001	(	_	
123-16	22001-22002	A	_	
123-17	22002-22003	)	_	
123-18	22004-22007	and	_	
123-19	22008-22012	over	_	
123-20	22013-22016	the	_	
123-21	22017-22022	three	_	
123-22	22023-22029	groups	_	
123-23	22030-22031	(	_	
123-24	22031-22032	B	_	
123-25	22032-22033	)	_	
123-26	22033-22034	.	_	

#Text=Abbreviation: LH, left hemisphere; RH, right hemisphere; brain regional abbreviation and classification please refer to Supplementary Table 2.
124-1	22035-22047	Abbreviation	_	
124-2	22047-22048	:	_	
124-3	22049-22051	LH	_	
124-4	22051-22052	,	_	
124-5	22053-22057	left	_	
124-6	22058-22068	hemisphere	_	
124-7	22068-22069	;	_	
124-8	22070-22072	RH	_	
124-9	22072-22073	,	_	
124-10	22074-22079	right	_	
124-11	22080-22090	hemisphere	_	
124-12	22090-22091	;	_	
124-13	22092-22097	brain	_	
124-14	22098-22106	regional	_	
124-15	22107-22119	abbreviation	_	
124-16	22120-22123	and	_	
124-17	22124-22138	classification	_	
124-18	22139-22145	please	_	
124-19	22146-22151	refer	_	
124-20	22152-22154	to	_	
124-21	22155-22168	Supplementary	_	
124-22	22169-22174	Table	_	
124-23	22175-22176	2	_	
124-24	22176-22177	.	_	

#Text=Fig. 4
#Text=Ten out of 56 whole-brain areas showed significant group effects of regional hemispheric specialization (p < .05, Bonferroni corrected), including parietal, temporal and occipital association cortices, sensorimotor regions and limbic areas, mainly belonging to unimodal and heteromodal association cortices (Fig. 4A).
125-1	22178-22181	Fig	_	
125-2	22181-22182	.	_	
125-3	22183-22184	4	_	
125-4	22185-22188	Ten	_	
125-5	22189-22192	out	_	
125-6	22193-22195	of	_	
125-7	22196-22198	56	_	
125-8	22199-22210	whole-brain	_	
125-9	22211-22216	areas	_	
125-10	22217-22223	showed	_	
125-11	22224-22235	significant	_	
125-12	22236-22241	group	_	
125-13	22242-22249	effects	_	
125-14	22250-22252	of	_	
125-15	22253-22261	regional	_	
125-16	22262-22273	hemispheric	_	
125-17	22274-22288	specialization	_	
125-18	22289-22290	(	_	
125-19	22290-22291	p	_	
125-20	22291-22292	 	_	
125-21	22292-22293	<	_	
125-22	22293-22294	 	_	
125-23	22294-22297	.05	_	
125-24	22297-22298	,	_	
125-25	22299-22309	Bonferroni	_	
125-26	22310-22319	corrected	_	
125-27	22319-22320	)	_	
125-28	22320-22321	,	_	
125-29	22322-22331	including	_	
125-30	22332-22340	parietal	_	
125-31	22340-22341	,	_	
125-32	22342-22350	temporal	_	
125-33	22351-22354	and	_	
125-34	22355-22364	occipital	_	
125-35	22365-22376	association	_	
125-36	22377-22385	cortices	_	
125-37	22385-22386	,	_	
125-38	22387-22399	sensorimotor	_	
125-39	22400-22407	regions	_	
125-40	22408-22411	and	_	
125-41	22412-22418	limbic	_	
125-42	22419-22424	areas	_	
125-43	22424-22425	,	_	
125-44	22426-22432	mainly	_	
125-45	22433-22442	belonging	_	
125-46	22443-22445	to	_	
125-47	22446-22454	unimodal	_	
125-48	22455-22458	and	_	
125-49	22459-22470	heteromodal	_	
125-50	22471-22482	association	_	
125-51	22483-22491	cortices	_	
125-52	22492-22493	(	_	
125-53	22493-22496	Fig	_	
125-54	22496-22497	.	_	
125-55	22498-22500	4A	_	
125-56	22500-22501	)	_	
125-57	22501-22502	.	_	

#Text=In these regions, hemispheric specialization was increased in patients as compared to both controls and siblings (p < .05, Supplementary Table 4).
126-1	22503-22505	In	_	
126-2	22506-22511	these	_	
126-3	22512-22519	regions	_	
126-4	22519-22520	,	_	
126-5	22521-22532	hemispheric	_	
126-6	22533-22547	specialization	_	
126-7	22548-22551	was	_	
126-8	22552-22561	increased	_	
126-9	22562-22564	in	_	
126-10	22565-22573	patients	_	
126-11	22574-22576	as	_	
126-12	22577-22585	compared	_	
126-13	22586-22588	to	_	
126-14	22589-22593	both	_	
126-15	22594-22602	controls	_	
126-16	22603-22606	and	_	
126-17	22607-22615	siblings	_	
126-18	22616-22617	(	_	
126-19	22617-22618	p	_	
126-20	22618-22619	 	_	
126-21	22619-22620	<	_	
126-22	22620-22621	 	_	
126-23	22621-22624	.05	_	
126-24	22624-22625	,	_	
126-25	22626-22639	Supplementary	_	
126-26	22640-22645	Table	_	
126-27	22646-22647	4	_	
126-28	22647-22648	)	_	
126-29	22648-22649	.	_	

#Text=The only exception was the posterior supramarginal gyrus which showed marginally higher hemispheric specialization in patients relative to controls (t(464) = 1.90, p = .058), but lower hemispheric specialization in siblings relative to controls (t(464) = −1.73, p = .084).
127-1	22650-22653	The	_	
127-2	22654-22658	only	_	
127-3	22659-22668	exception	_	
127-4	22669-22672	was	_	
127-5	22673-22676	the	_	
127-6	22677-22686	posterior	_	
127-7	22687-22700	supramarginal	_	
127-8	22701-22706	gyrus	_	
127-9	22707-22712	which	_	
127-10	22713-22719	showed	_	
127-11	22720-22730	marginally	_	
127-12	22731-22737	higher	_	
127-13	22738-22749	hemispheric	_	
127-14	22750-22764	specialization	_	
127-15	22765-22767	in	_	
127-16	22768-22776	patients	_	
127-17	22777-22785	relative	_	
127-18	22786-22788	to	_	
127-19	22789-22797	controls	_	
127-20	22798-22799	(	_	
127-21	22799-22800	t	_	
127-22	22800-22801	(	_	
127-23	22801-22804	464	_	
127-24	22804-22805	)	_	
127-25	22805-22806	 	_	
127-26	22806-22807	=	_	
127-27	22807-22808	 	_	
127-28	22808-22812	1.90	_	
127-29	22812-22813	,	_	
127-30	22814-22815	p	_	
127-31	22815-22816	 	_	
127-32	22816-22817	=	_	
127-33	22817-22818	 	_	
127-34	22818-22822	.058	_	
127-35	22822-22823	)	_	
127-36	22823-22824	,	_	
127-37	22825-22828	but	_	
127-38	22829-22834	lower	_	
127-39	22835-22846	hemispheric	_	
127-40	22847-22861	specialization	_	
127-41	22862-22864	in	_	
127-42	22865-22873	siblings	_	
127-43	22874-22882	relative	_	
127-44	22883-22885	to	_	
127-45	22886-22894	controls	_	
127-46	22895-22896	(	_	
127-47	22896-22897	t	_	
127-48	22897-22898	(	_	
127-49	22898-22901	464	_	
127-50	22901-22902	)	_	
127-51	22902-22903	 	_	
127-52	22903-22904	=	_	
127-53	22904-22905	 	_	
127-54	22905-22906	−	_	
127-55	22906-22910	1.73	_	
127-56	22910-22911	,	_	
127-57	22912-22913	p	_	
127-58	22913-22914	 	_	
127-59	22914-22915	=	_	
127-60	22915-22916	 	_	
127-61	22916-22920	.084	_	
127-62	22920-22921	)	_	
127-63	22921-22922	.	_	

#Text=There were no significant group-differences between siblings and controls in hemispheric specialization.
128-1	22923-22928	There	_	
128-2	22929-22933	were	_	
128-3	22934-22936	no	_	
128-4	22937-22948	significant	_	
128-5	22949-22966	group-differences	_	
128-6	22967-22974	between	_	
128-7	22975-22983	siblings	_	
128-8	22984-22987	and	_	
128-9	22988-22996	controls	_	
128-10	22997-22999	in	_	
128-11	23000-23011	hemispheric	_	
128-12	23012-23026	specialization	_	
128-13	23026-23027	.	_	

#Text=Hemispheric specialization: hemispheric effects
#Text=There were no significant hemispheric effects of global hemispheric specialization (F(1,464) = 0.02, p = .89).
129-1	23028-23039	Hemispheric	_	
129-2	23040-23054	specialization	_	
129-3	23054-23055	:	_	
129-4	23056-23067	hemispheric	_	
129-5	23068-23075	effects	_	
129-6	23076-23081	There	_	
129-7	23082-23086	were	_	
129-8	23087-23089	no	_	
129-9	23090-23101	significant	_	
129-10	23102-23113	hemispheric	_	
129-11	23114-23121	effects	_	
129-12	23122-23124	of	_	
129-13	23125-23131	global	_	
129-14	23132-23143	hemispheric	_	
129-15	23144-23158	specialization	_	
129-16	23159-23160	(	_	
129-17	23160-23161	F	_	
129-18	23161-23162	(	_	
129-19	23162-23167	1,464	_	
129-20	23167-23168	)	_	
129-21	23168-23169	 	_	
129-22	23169-23170	=	_	
129-23	23170-23171	 	_	
129-24	23171-23175	0.02	_	
129-25	23175-23176	,	_	
129-26	23177-23178	p	_	
129-27	23178-23179	 	_	
129-28	23179-23180	=	_	
129-29	23180-23181	 	_	
129-30	23181-23184	.89	_	
129-31	23184-23185	)	_	
129-32	23185-23186	.	_	

#Text=On the regional level, significant main effects of hemisphere were observed for a range of cortical and subcortical brain (p < .05, Bonferroni corrected, Fig. 4B).
130-1	23187-23189	On	_	
130-2	23190-23193	the	_	
130-3	23194-23202	regional	_	
130-4	23203-23208	level	_	
130-5	23208-23209	,	_	
130-6	23210-23221	significant	_	
130-7	23222-23226	main	_	
130-8	23227-23234	effects	_	
130-9	23235-23237	of	_	
130-10	23238-23248	hemisphere	_	
130-11	23249-23253	were	_	
130-12	23254-23262	observed	_	
130-13	23263-23266	for	_	
130-14	23267-23268	a	_	
130-15	23269-23274	range	_	
130-16	23275-23277	of	_	
130-17	23278-23286	cortical	_	
130-18	23287-23290	and	_	
130-19	23291-23302	subcortical	_	
130-20	23303-23308	brain	_	
130-21	23309-23310	(	_	
130-22	23310-23311	p	_	
130-23	23311-23312	 	_	
130-24	23312-23313	<	_	
130-25	23313-23314	 	_	
130-26	23314-23317	.05	_	
130-27	23317-23318	,	_	
130-28	23319-23329	Bonferroni	_	
130-29	23330-23339	corrected	_	
130-30	23339-23340	,	_	
130-31	23341-23344	Fig	_	
130-32	23344-23345	.	_	
130-33	23346-23348	4B	_	
130-34	23348-23349	)	_	
130-35	23349-23350	.	_	

#Text=Higher left-hemispheric specialization was found predominantly in superior/inferior frontal and inferior/middle temporal gyrus, as well as subcortical regions and posterior cingulate cortex.
131-1	23351-23357	Higher	_	
131-2	23358-23374	left-hemispheric	_	
131-3	23375-23389	specialization	_	
131-4	23390-23393	was	_	
131-5	23394-23399	found	_	
131-6	23400-23413	predominantly	_	
131-7	23414-23416	in	_	
131-8	23417-23425	superior	_	
131-9	23425-23426	/	_	
131-10	23426-23434	inferior	_	
131-11	23435-23442	frontal	_	
131-12	23443-23446	and	_	
131-13	23447-23455	inferior	_	
131-14	23455-23456	/	_	
131-15	23456-23462	middle	_	
131-16	23463-23471	temporal	_	
131-17	23472-23477	gyrus	_	
131-18	23477-23478	,	_	
131-19	23479-23481	as	_	
131-20	23482-23486	well	_	
131-21	23487-23489	as	_	
131-22	23490-23501	subcortical	_	
131-23	23502-23509	regions	_	
131-24	23510-23513	and	_	
131-25	23514-23523	posterior	_	
131-26	23524-23533	cingulate	_	
131-27	23534-23540	cortex	_	
131-28	23540-23541	.	_	

#Text=Regions with higher right-hemispheric specialization included parietal and occipital areas, central opercular cortex, heschls gyrus, planum temporale, caudate nucleus and accumbens, anterior and paracingulate gyrus (Supplementary Table 5).
132-1	23542-23549	Regions	_	
132-2	23550-23554	with	_	
132-3	23555-23561	higher	_	
132-4	23562-23579	right-hemispheric	_	
132-5	23580-23594	specialization	_	
132-6	23595-23603	included	_	
132-7	23604-23612	parietal	_	
132-8	23613-23616	and	_	
132-9	23617-23626	occipital	_	
132-10	23627-23632	areas	_	
132-11	23632-23633	,	_	
132-12	23634-23641	central	_	
132-13	23642-23651	opercular	_	
132-14	23652-23658	cortex	_	
132-15	23658-23659	,	_	
132-16	23660-23667	heschls	_	
132-17	23668-23673	gyrus	_	
132-18	23673-23674	,	_	
132-19	23675-23681	planum	_	
132-20	23682-23691	temporale	_	
132-21	23691-23692	,	_	
132-22	23693-23700	caudate	_	
132-23	23701-23708	nucleus	_	
132-24	23709-23712	and	_	
132-25	23713-23722	accumbens	_	
132-26	23722-23723	,	_	
132-27	23724-23732	anterior	_	
132-28	23733-23736	and	_	
132-29	23737-23750	paracingulate	_	
132-30	23751-23756	gyrus	_	
132-31	23757-23758	(	_	
132-32	23758-23771	Supplementary	_	
132-33	23772-23777	Table	_	
132-34	23778-23779	5	_	
132-35	23779-23780	)	_	
132-36	23780-23781	.	_	

#Text=Relationship between interhemispheric connectivity and hemispheric specialization
#Text=Correlation between group-differences in homotopic interhemispheric connectivity and differences in hemispheric specialization.
133-1	23782-23794	Relationship	_	
133-2	23795-23802	between	_	
133-3	23803-23819	interhemispheric	_	
133-4	23820-23832	connectivity	_	
133-5	23833-23836	and	_	
133-6	23837-23848	hemispheric	_	
133-7	23849-23863	specialization	_	
133-8	23864-23875	Correlation	_	
133-9	23876-23883	between	_	
133-10	23884-23901	group-differences	_	
133-11	23902-23904	in	_	
133-12	23905-23914	homotopic	_	
133-13	23915-23931	interhemispheric	_	
133-14	23932-23944	connectivity	_	
133-15	23945-23948	and	_	
133-16	23949-23960	differences	_	
133-17	23961-23963	in	_	
133-18	23964-23975	hemispheric	_	
133-19	23976-23990	specialization	_	
133-20	23990-23991	.	_	

#Text=Decreased regional interhemispheric connectivity is negatively correlated with increased hemispheric specialization in patients as compared to controls (r = −0.54, p < .001) and siblings (r = −0.54, p < .001).
134-1	23992-24001	Decreased	_	
134-2	24002-24010	regional	_	
134-3	24011-24027	interhemispheric	_	
134-4	24028-24040	connectivity	_	
134-5	24041-24043	is	_	
134-6	24044-24054	negatively	_	
134-7	24055-24065	correlated	_	
134-8	24066-24070	with	_	
134-9	24071-24080	increased	_	
134-10	24081-24092	hemispheric	_	
134-11	24093-24107	specialization	_	
134-12	24108-24110	in	_	
134-13	24111-24119	patients	_	
134-14	24120-24122	as	_	
134-15	24123-24131	compared	_	
134-16	24132-24134	to	_	
134-17	24135-24143	controls	_	
134-18	24144-24145	(	_	
134-19	24145-24146	r	_	
134-20	24146-24147	 	_	
134-21	24147-24148	=	_	
134-22	24148-24149	 	_	
134-23	24149-24150	−	_	
134-24	24150-24154	0.54	_	
134-25	24154-24155	,	_	
134-26	24156-24157	p	_	
134-27	24157-24158	 	_	
134-28	24158-24159	<	_	
134-29	24159-24160	 	_	
134-30	24160-24164	.001	_	
134-31	24164-24165	)	_	
134-32	24166-24169	and	_	
134-33	24170-24178	siblings	_	
134-34	24179-24180	(	_	
134-35	24180-24181	r	_	
134-36	24181-24182	 	_	
134-37	24182-24183	=	_	
134-38	24183-24184	 	_	
134-39	24184-24185	−	_	
134-40	24185-24189	0.54	_	
134-41	24189-24190	,	_	
134-42	24191-24192	p	_	
134-43	24192-24193	 	_	
134-44	24193-24194	<	_	
134-45	24194-24195	 	_	
134-46	24195-24199	.001	_	
134-47	24199-24200	)	_	
134-48	24200-24201	.	_	

#Text=For the control-sibling comparison, co-variation of group-differences in the two connectivity measurements is marginally significant (r = −0.26, p = .053).
135-1	24202-24205	For	_	
135-2	24206-24209	the	_	
135-3	24210-24225	control-sibling	_	
135-4	24226-24236	comparison	_	
135-5	24236-24237	,	_	
135-6	24238-24250	co-variation	_	
135-7	24251-24253	of	_	
135-8	24254-24271	group-differences	_	
135-9	24272-24274	in	_	
135-10	24275-24278	the	_	
135-11	24279-24282	two	_	
135-12	24283-24295	connectivity	_	
135-13	24296-24308	measurements	_	
135-14	24309-24311	is	_	
135-15	24312-24322	marginally	_	
135-16	24323-24334	significant	_	
135-17	24335-24336	(	_	
135-18	24336-24337	r	_	
135-19	24337-24338	 	_	
135-20	24338-24339	=	_	
135-21	24339-24340	 	_	
135-22	24340-24341	−	_	
135-23	24341-24345	0.26	_	
135-24	24345-24346	,	_	
135-25	24347-24348	p	_	
135-26	24348-24349	 	_	
135-27	24349-24350	=	_	
135-28	24350-24351	 	_	
135-29	24351-24355	.053	_	
135-30	24355-24356	)	_	
135-31	24356-24357	.	_	

#Text=Fig. 5
#Text=Comparing patients to controls, group-differences in regional interhemispheric connectivity correlated with changes of regional hemispheric specialization averaged for the left and right hemisphere (r = −0.54, p < .001, Fig. 5).
136-1	24358-24361	Fig	_	
136-2	24361-24362	.	_	
136-3	24363-24364	5	_	
136-4	24365-24374	Comparing	_	
136-5	24375-24383	patients	_	
136-6	24384-24386	to	_	
136-7	24387-24395	controls	_	
136-8	24395-24396	,	_	
136-9	24397-24414	group-differences	_	
136-10	24415-24417	in	_	
136-11	24418-24426	regional	_	
136-12	24427-24443	interhemispheric	_	
136-13	24444-24456	connectivity	_	
136-14	24457-24467	correlated	_	
136-15	24468-24472	with	_	
136-16	24473-24480	changes	_	
136-17	24481-24483	of	_	
136-18	24484-24492	regional	_	
136-19	24493-24504	hemispheric	_	
136-20	24505-24519	specialization	_	
136-21	24520-24528	averaged	_	
136-22	24529-24532	for	_	
136-23	24533-24536	the	_	
136-24	24537-24541	left	_	
136-25	24542-24545	and	_	
136-26	24546-24551	right	_	
136-27	24552-24562	hemisphere	_	
136-28	24563-24564	(	_	
136-29	24564-24565	r	_	
136-30	24565-24566	 	_	
136-31	24566-24567	=	_	
136-32	24567-24568	 	_	
136-33	24568-24569	−	_	
136-34	24569-24573	0.54	_	
136-35	24573-24574	,	_	
136-36	24575-24576	p	_	
136-37	24576-24577	 	_	
136-38	24577-24578	<	_	
136-39	24578-24579	 	_	
136-40	24579-24583	.001	_	
136-41	24583-24584	,	_	
136-42	24585-24588	Fig	_	
136-43	24588-24589	.	_	
136-44	24590-24591	5	_	
136-45	24591-24592	)	_	
136-46	24592-24593	.	_	

#Text=Co-variation of group-differences in the two measurements was also significant for the sibling-patient comparison (r = −0.54, p < .001), and marginally significant for the control-sibling comparison (r = −0.26, p = .053).
137-1	24594-24606	Co-variation	_	
137-2	24607-24609	of	_	
137-3	24610-24627	group-differences	_	
137-4	24628-24630	in	_	
137-5	24631-24634	the	_	
137-6	24635-24638	two	_	
137-7	24639-24651	measurements	_	
137-8	24652-24655	was	_	
137-9	24656-24660	also	_	
137-10	24661-24672	significant	_	
137-11	24673-24676	for	_	
137-12	24677-24680	the	_	
137-13	24681-24696	sibling-patient	_	
137-14	24697-24707	comparison	_	
137-15	24708-24709	(	_	
137-16	24709-24710	r	_	
137-17	24710-24711	 	_	
137-18	24711-24712	=	_	
137-19	24712-24713	 	_	
137-20	24713-24714	−	_	
137-21	24714-24718	0.54	_	
137-22	24718-24719	,	_	
137-23	24720-24721	p	_	
137-24	24721-24722	 	_	
137-25	24722-24723	<	_	
137-26	24723-24724	 	_	
137-27	24724-24728	.001	_	
137-28	24728-24729	)	_	
137-29	24729-24730	,	_	
137-30	24731-24734	and	_	
137-31	24735-24745	marginally	_	
137-32	24746-24757	significant	_	
137-33	24758-24761	for	_	
137-34	24762-24765	the	_	
137-35	24766-24781	control-sibling	_	
137-36	24782-24792	comparison	_	
137-37	24793-24794	(	_	
137-38	24794-24795	r	_	
137-39	24795-24796	 	_	
137-40	24796-24797	=	_	
137-41	24797-24798	 	_	
137-42	24798-24799	−	_	
137-43	24799-24803	0.26	_	
137-44	24803-24804	,	_	
137-45	24805-24806	p	_	
137-46	24806-24807	 	_	
137-47	24807-24808	=	_	
137-48	24808-24809	 	_	
137-49	24809-24813	.053	_	
137-50	24813-24814	)	_	
137-51	24814-24815	.	_	

#Text=These correlations indicate that regions showing a larger decrease in interhemispheric connectivity in patients as compared to controls or siblings show higher level of hemispheric specialization, indicating that they are preferentially collaborating with regions within the same hemisphere.
138-1	24816-24821	These	_	
138-2	24822-24834	correlations	_	
138-3	24835-24843	indicate	_	
138-4	24844-24848	that	_	
138-5	24849-24856	regions	_	
138-6	24857-24864	showing	_	
138-7	24865-24866	a	_	
138-8	24867-24873	larger	_	
138-9	24874-24882	decrease	_	
138-10	24883-24885	in	_	
138-11	24886-24902	interhemispheric	_	
138-12	24903-24915	connectivity	_	
138-13	24916-24918	in	_	
138-14	24919-24927	patients	_	
138-15	24928-24930	as	_	
138-16	24931-24939	compared	_	
138-17	24940-24942	to	_	
138-18	24943-24951	controls	_	
138-19	24952-24954	or	_	
138-20	24955-24963	siblings	_	
138-21	24964-24968	show	_	
138-22	24969-24975	higher	_	
138-23	24976-24981	level	_	
138-24	24982-24984	of	_	
138-25	24985-24996	hemispheric	_	
138-26	24997-25011	specialization	_	
138-27	25011-25012	,	_	
138-28	25013-25023	indicating	_	
138-29	25024-25028	that	_	
138-30	25029-25033	they	_	
138-31	25034-25037	are	_	
138-32	25038-25052	preferentially	_	
138-33	25053-25066	collaborating	_	
138-34	25067-25071	with	_	
138-35	25072-25079	regions	_	
138-36	25080-25086	within	_	
138-37	25087-25090	the	_	
138-38	25091-25095	same	_	
138-39	25096-25106	hemisphere	_	
138-40	25106-25107	.	_	

#Text=Correlation between connectivity alterations and clinical factors
#Text=Duration of illness is negatively correlated with global homotopic connectivity (r = −0.26, p = .03) and marginally associated with hemispheric specialization (r = 0.24, p = .049) in the patient group.
139-1	25108-25119	Correlation	_	
139-2	25120-25127	between	_	
139-3	25128-25140	connectivity	_	
139-4	25141-25152	alterations	_	
139-5	25153-25156	and	_	
139-6	25157-25165	clinical	_	
139-7	25166-25173	factors	_	
139-8	25174-25182	Duration	_	
139-9	25183-25185	of	_	
139-10	25186-25193	illness	_	
139-11	25194-25196	is	_	
139-12	25197-25207	negatively	_	
139-13	25208-25218	correlated	_	
139-14	25219-25223	with	_	
139-15	25224-25230	global	_	
139-16	25231-25240	homotopic	_	
139-17	25241-25253	connectivity	_	
139-18	25254-25255	(	_	
139-19	25255-25256	r	_	
139-20	25256-25257	 	_	
139-21	25257-25258	=	_	
139-22	25258-25259	 	_	
139-23	25259-25260	−	_	
139-24	25260-25264	0.26	_	
139-25	25264-25265	,	_	
139-26	25266-25267	p	_	
139-27	25267-25268	 	_	
139-28	25268-25269	=	_	
139-29	25269-25270	 	_	
139-30	25270-25273	.03	_	
139-31	25273-25274	)	_	
139-32	25275-25278	and	_	
139-33	25279-25289	marginally	_	
139-34	25290-25300	associated	_	
139-35	25301-25305	with	_	
139-36	25306-25317	hemispheric	_	
139-37	25318-25332	specialization	_	
139-38	25333-25334	(	_	
139-39	25334-25335	r	_	
139-40	25335-25336	 	_	
139-41	25336-25337	=	_	
139-42	25337-25338	 	_	
139-43	25338-25342	0.24	_	
139-44	25342-25343	,	_	
139-45	25344-25345	p	_	
139-46	25345-25346	 	_	
139-47	25346-25347	=	_	
139-48	25347-25348	 	_	
139-49	25348-25352	.049	_	
139-50	25352-25353	)	_	
139-51	25354-25356	in	_	
139-52	25357-25360	the	_	
139-53	25361-25368	patient	_	
139-54	25369-25374	group	_	
139-55	25374-25375	.	_	

#Text=Fig. 6
#Text=Duration of illness was negatively correlated with interhemispheric connectivity (r = −0.26, p = .03), and marginally associated with hemispheric specialization (r = 0.24, p = .049) in patients (Fig. 6).
140-1	25376-25379	Fig	_	
140-2	25379-25380	.	_	
140-3	25381-25382	6	_	
140-4	25383-25391	Duration	_	
140-5	25392-25394	of	_	
140-6	25395-25402	illness	_	
140-7	25403-25406	was	_	
140-8	25407-25417	negatively	_	
140-9	25418-25428	correlated	_	
140-10	25429-25433	with	_	
140-11	25434-25450	interhemispheric	_	
140-12	25451-25463	connectivity	_	
140-13	25464-25465	(	_	
140-14	25465-25466	r	_	
140-15	25466-25467	 	_	
140-16	25467-25468	=	_	
140-17	25468-25469	 	_	
140-18	25469-25470	−	_	
140-19	25470-25474	0.26	_	
140-20	25474-25475	,	_	
140-21	25476-25477	p	_	
140-22	25477-25478	 	_	
140-23	25478-25479	=	_	
140-24	25479-25480	 	_	
140-25	25480-25483	.03	_	
140-26	25483-25484	)	_	
140-27	25484-25485	,	_	
140-28	25486-25489	and	_	
140-29	25490-25500	marginally	_	
140-30	25501-25511	associated	_	
140-31	25512-25516	with	_	
140-32	25517-25528	hemispheric	_	
140-33	25529-25543	specialization	_	
140-34	25544-25545	(	_	
140-35	25545-25546	r	_	
140-36	25546-25547	 	_	
140-37	25547-25548	=	_	
140-38	25548-25549	 	_	
140-39	25549-25553	0.24	_	
140-40	25553-25554	,	_	
140-41	25555-25556	p	_	
140-42	25556-25557	 	_	
140-43	25557-25558	=	_	
140-44	25558-25559	 	_	
140-45	25559-25563	.049	_	
140-46	25563-25564	)	_	
140-47	25565-25567	in	_	
140-48	25568-25576	patients	_	
140-49	25577-25578	(	_	
140-50	25578-25581	Fig	_	
140-51	25581-25582	.	_	
140-52	25583-25584	6	_	
140-53	25584-25585	)	_	
140-54	25585-25586	.	_	

#Text=With longer course of illness, patients have more reduced interhemispheric connectivity and a higher level of segregation between the hemispheres.
141-1	25587-25591	With	_	
141-2	25592-25598	longer	_	
141-3	25599-25605	course	_	
141-4	25606-25608	of	_	
141-5	25609-25616	illness	_	
141-6	25616-25617	,	_	
141-7	25618-25626	patients	_	
141-8	25627-25631	have	_	
141-9	25632-25636	more	_	
141-10	25637-25644	reduced	_	
141-11	25645-25661	interhemispheric	_	
141-12	25662-25674	connectivity	_	
141-13	25675-25678	and	_	
141-14	25679-25680	a	_	
141-15	25681-25687	higher	_	
141-16	25688-25693	level	_	
141-17	25694-25696	of	_	
141-18	25697-25708	segregation	_	
141-19	25709-25716	between	_	
141-20	25717-25720	the	_	
141-21	25721-25732	hemispheres	_	
141-22	25732-25733	.	_	

#Text=These connectivity alterations are not likely to be attributable to age, as for controls and siblings, we found no correlations between age and interhemispheric connectivity (controls: r = −0.05, p = .69, siblings: r = −0.07, p = .50) or between age and hemispheric specialization (controls: r = −0.03, p = .84, siblings: r = 0.04, p = .70).
142-1	25734-25739	These	_	
142-2	25740-25752	connectivity	_	
142-3	25753-25764	alterations	_	
142-4	25765-25768	are	_	
142-5	25769-25772	not	_	
142-6	25773-25779	likely	_	
142-7	25780-25782	to	_	
142-8	25783-25785	be	_	
142-9	25786-25798	attributable	_	
142-10	25799-25801	to	_	
142-11	25802-25805	age	_	
142-12	25805-25806	,	_	
142-13	25807-25809	as	_	
142-14	25810-25813	for	_	
142-15	25814-25822	controls	_	
142-16	25823-25826	and	_	
142-17	25827-25835	siblings	_	
142-18	25835-25836	,	_	
142-19	25837-25839	we	_	
142-20	25840-25845	found	_	
142-21	25846-25848	no	_	
142-22	25849-25861	correlations	_	
142-23	25862-25869	between	_	
142-24	25870-25873	age	_	
142-25	25874-25877	and	_	
142-26	25878-25894	interhemispheric	_	
142-27	25895-25907	connectivity	_	
142-28	25908-25909	(	_	
142-29	25909-25917	controls	_	
142-30	25917-25918	:	_	
142-31	25919-25920	r	_	
142-32	25920-25921	 	_	
142-33	25921-25922	=	_	
142-34	25922-25923	 	_	
142-35	25923-25924	−	_	
142-36	25924-25928	0.05	_	
142-37	25928-25929	,	_	
142-38	25930-25931	p	_	
142-39	25931-25932	 	_	
142-40	25932-25933	=	_	
142-41	25933-25934	 	_	
142-42	25934-25937	.69	_	
142-43	25937-25938	,	_	
142-44	25939-25947	siblings	_	
142-45	25947-25948	:	_	
142-46	25949-25950	r	_	
142-47	25950-25951	 	_	
142-48	25951-25952	=	_	
142-49	25952-25953	 	_	
142-50	25953-25954	−	_	
142-51	25954-25958	0.07	_	
142-52	25958-25959	,	_	
142-53	25960-25961	p	_	
142-54	25961-25962	 	_	
142-55	25962-25963	=	_	
142-56	25963-25964	 	_	
142-57	25964-25967	.50	_	
142-58	25967-25968	)	_	
142-59	25969-25971	or	_	
142-60	25972-25979	between	_	
142-61	25980-25983	age	_	
142-62	25984-25987	and	_	
142-63	25988-25999	hemispheric	_	
142-64	26000-26014	specialization	_	
142-65	26015-26016	(	_	
142-66	26016-26024	controls	_	
142-67	26024-26025	:	_	
142-68	26026-26027	r	_	
142-69	26027-26028	 	_	
142-70	26028-26029	=	_	
142-71	26029-26030	 	_	
142-72	26030-26031	−	_	
142-73	26031-26035	0.03	_	
142-74	26035-26036	,	_	
142-75	26037-26038	p	_	
142-76	26038-26039	 	_	
142-77	26039-26040	=	_	
142-78	26040-26041	 	_	
142-79	26041-26044	.84	_	
142-80	26044-26045	,	_	
142-81	26046-26054	siblings	_	
142-82	26054-26055	:	_	
142-83	26056-26057	r	_	
142-84	26057-26058	 	_	
142-85	26058-26059	=	_	
142-86	26059-26060	 	_	
142-87	26060-26064	0.04	_	
142-88	26064-26065	,	_	
142-89	26066-26067	p	_	
142-90	26067-26068	 	_	
142-91	26068-26069	=	_	
142-92	26069-26070	 	_	
142-93	26070-26073	.70	_	
142-94	26073-26074	)	_	
142-95	26074-26075	.	_	

#Text=We found no correlations between PANSS total scores and connectivity measurements in patients (interhemispheric connectivity: r = 0.12, p = .34, hemispheric specialization r = −0.07, p = .60).
143-1	26076-26078	We	_	
143-2	26079-26084	found	_	
143-3	26085-26087	no	_	
143-4	26088-26100	correlations	_	
143-5	26101-26108	between	_	
143-6	26109-26114	PANSS	_	
143-7	26115-26120	total	_	
143-8	26121-26127	scores	_	
143-9	26128-26131	and	_	
143-10	26132-26144	connectivity	_	
143-11	26145-26157	measurements	_	
143-12	26158-26160	in	_	
143-13	26161-26169	patients	_	
143-14	26170-26171	(	_	
143-15	26171-26187	interhemispheric	_	
143-16	26188-26200	connectivity	_	
143-17	26200-26201	:	_	
143-18	26202-26203	r	_	
143-19	26203-26204	 	_	
143-20	26204-26205	=	_	
143-21	26205-26206	 	_	
143-22	26206-26210	0.12	_	
143-23	26210-26211	,	_	
143-24	26212-26213	p	_	
143-25	26213-26214	 	_	
143-26	26214-26215	=	_	
143-27	26215-26216	 	_	
143-28	26216-26219	.34	_	
143-29	26219-26220	,	_	
143-30	26221-26232	hemispheric	_	
143-31	26233-26247	specialization	_	
143-32	26248-26249	r	_	
143-33	26249-26250	 	_	
143-34	26250-26251	=	_	
143-35	26251-26252	 	_	
143-36	26252-26253	−	_	
143-37	26253-26257	0.07	_	
143-38	26257-26258	,	_	
143-39	26259-26260	p	_	
143-40	26260-26261	 	_	
143-41	26261-26262	=	_	
143-42	26262-26263	 	_	
143-43	26263-26266	.60	_	
143-44	26266-26267	)	_	
143-45	26267-26268	.	_	

#Text=Dosage of antipsychotic medication did not show significant associations with interhemispheric connectivity (r = −0.05, p = .70) or hemispheric specialization (r = 0.09, p = .49).
144-1	26269-26275	Dosage	_	
144-2	26276-26278	of	_	
144-3	26279-26292	antipsychotic	_	
144-4	26293-26303	medication	_	
144-5	26304-26307	did	_	
144-6	26308-26311	not	_	
144-7	26312-26316	show	_	
144-8	26317-26328	significant	_	
144-9	26329-26341	associations	_	
144-10	26342-26346	with	_	
144-11	26347-26363	interhemispheric	_	
144-12	26364-26376	connectivity	_	
144-13	26377-26378	(	_	
144-14	26378-26379	r	_	
144-15	26379-26380	 	_	
144-16	26380-26381	=	_	
144-17	26381-26382	 	_	
144-18	26382-26383	−	_	
144-19	26383-26387	0.05	_	
144-20	26387-26388	,	_	
144-21	26389-26390	p	_	
144-22	26390-26391	 	_	
144-23	26391-26392	=	_	
144-24	26392-26393	 	_	
144-25	26393-26396	.70	_	
144-26	26396-26397	)	_	
144-27	26398-26400	or	_	
144-28	26401-26412	hemispheric	_	
144-29	26413-26427	specialization	_	
144-30	26428-26429	(	_	
144-31	26429-26430	r	_	
144-32	26430-26431	 	_	
144-33	26431-26432	=	_	
144-34	26432-26433	 	_	
144-35	26433-26437	0.09	_	
144-36	26437-26438	,	_	
144-37	26439-26440	p	_	
144-38	26440-26441	 	_	
144-39	26441-26442	=	_	
144-40	26442-26443	 	_	
144-41	26443-26446	.49	_	
144-42	26446-26447	)	_	
144-43	26447-26448	.	_	

#Text=Discussion
#Text=The current study examined interhemispheric connectivity and hemispheric specialization in a large cohort of schizophrenia patients, their unaffected siblings, and healthy controls.
145-1	26449-26459	Discussion	_	
145-2	26460-26463	The	_	
145-3	26464-26471	current	_	
145-4	26472-26477	study	_	
145-5	26478-26486	examined	_	
145-6	26487-26503	interhemispheric	_	
145-7	26504-26516	connectivity	_	
145-8	26517-26520	and	_	
145-9	26521-26532	hemispheric	_	
145-10	26533-26547	specialization	_	
145-11	26548-26550	in	_	
145-12	26551-26552	a	_	
145-13	26553-26558	large	_	
145-14	26559-26565	cohort	_	
145-15	26566-26568	of	_	
145-16	26569-26582	schizophrenia	_	
145-17	26583-26591	patients	_	
145-18	26591-26592	,	_	
145-19	26593-26598	their	_	
145-20	26599-26609	unaffected	_	
145-21	26610-26618	siblings	_	
145-22	26618-26619	,	_	
145-23	26620-26623	and	_	
145-24	26624-26631	healthy	_	
145-25	26632-26640	controls	_	
145-26	26640-26641	.	_	

#Text=Compared to controls and siblings, patients showed marked decreases in interhemispheric connectivity, as well as increased hemispheric specialization on a global and regional level.
146-1	26642-26650	Compared	_	
146-2	26651-26653	to	_	
146-3	26654-26662	controls	_	
146-4	26663-26666	and	_	
146-5	26667-26675	siblings	_	
146-6	26675-26676	,	_	
146-7	26677-26685	patients	_	
146-8	26686-26692	showed	_	
146-9	26693-26699	marked	_	
146-10	26700-26709	decreases	_	
146-11	26710-26712	in	_	
146-12	26713-26729	interhemispheric	_	
146-13	26730-26742	connectivity	_	
146-14	26742-26743	,	_	
146-15	26744-26746	as	_	
146-16	26747-26751	well	_	
146-17	26752-26754	as	_	
146-18	26755-26764	increased	_	
146-19	26765-26776	hemispheric	_	
146-20	26777-26791	specialization	_	
146-21	26792-26794	on	_	
146-22	26795-26796	a	_	
146-23	26797-26803	global	_	
146-24	26804-26807	and	_	
146-25	26808-26816	regional	_	
146-26	26817-26822	level	_	
146-27	26822-26823	.	_	

#Text=No major deficits in interhemispheric connectivity or hemispheric specialization were found in unaffected siblings of patients.
147-1	26824-26826	No	_	
147-2	26827-26832	major	_	
147-3	26833-26841	deficits	_	
147-4	26842-26844	in	_	
147-5	26845-26861	interhemispheric	_	
147-6	26862-26874	connectivity	_	
147-7	26875-26877	or	_	
147-8	26878-26889	hemispheric	_	
147-9	26890-26904	specialization	_	
147-10	26905-26909	were	_	
147-11	26910-26915	found	_	
147-12	26916-26918	in	_	
147-13	26919-26929	unaffected	_	
147-14	26930-26938	siblings	_	
147-15	26939-26941	of	_	
147-16	26942-26950	patients	_	
147-17	26950-26951	.	_	

#Text=Moreover, interhemispheric connectivity and hemispheric specialization were found to correlate with duration of illness in patients.
148-1	26952-26960	Moreover	_	
148-2	26960-26961	,	_	
148-3	26962-26978	interhemispheric	_	
148-4	26979-26991	connectivity	_	
148-5	26992-26995	and	_	
148-6	26996-27007	hemispheric	_	
148-7	27008-27022	specialization	_	
148-8	27023-27027	were	_	
148-9	27028-27033	found	_	
148-10	27034-27036	to	_	
148-11	27037-27046	correlate	_	
148-12	27047-27051	with	_	
148-13	27052-27060	duration	_	
148-14	27061-27063	of	_	
148-15	27064-27071	illness	_	
148-16	27072-27074	in	_	
148-17	27075-27083	patients	_	
148-18	27083-27084	.	_	

#Text=Taken together, our study shows impaired interhemispheric connectivity and a more segregated hemispheric connectivity profile in schizophrenia patients and suggests that these abnormalities are likely to be characteristics of established disease, rather than an expression of preexistent risk for the disorder.
149-1	27085-27090	Taken	_	
149-2	27091-27099	together	_	
149-3	27099-27100	,	_	
149-4	27101-27104	our	_	
149-5	27105-27110	study	_	
149-6	27111-27116	shows	_	
149-7	27117-27125	impaired	_	
149-8	27126-27142	interhemispheric	_	
149-9	27143-27155	connectivity	_	
149-10	27156-27159	and	_	
149-11	27160-27161	a	_	
149-12	27162-27166	more	_	
149-13	27167-27177	segregated	_	
149-14	27178-27189	hemispheric	_	
149-15	27190-27202	connectivity	_	
149-16	27203-27210	profile	_	
149-17	27211-27213	in	_	
149-18	27214-27227	schizophrenia	_	
149-19	27228-27236	patients	_	
149-20	27237-27240	and	_	
149-21	27241-27249	suggests	_	
149-22	27250-27254	that	_	
149-23	27255-27260	these	_	
149-24	27261-27274	abnormalities	_	
149-25	27275-27278	are	_	
149-26	27279-27285	likely	_	
149-27	27286-27288	to	_	
149-28	27289-27291	be	_	
149-29	27292-27307	characteristics	_	
149-30	27308-27310	of	_	
149-31	27311-27322	established	_	
149-32	27323-27330	disease	_	
149-33	27330-27331	,	_	
149-34	27332-27338	rather	_	
149-35	27339-27343	than	_	
149-36	27344-27346	an	_	
149-37	27347-27357	expression	_	
149-38	27358-27360	of	_	
149-39	27361-27372	preexistent	_	
149-40	27373-27377	risk	_	
149-41	27378-27381	for	_	
149-42	27382-27385	the	_	
149-43	27386-27394	disorder	_	
149-44	27394-27395	.	_	

#Text=The first question we set out to answer is whether impairments in interhemispheric connectivity are present in patients with schizophrenia and, if so, whether these impairments relate to preexistent familial risk for the illness.
150-1	27396-27399	The	_	
150-2	27400-27405	first	_	
150-3	27406-27414	question	_	
150-4	27415-27417	we	_	
150-5	27418-27421	set	_	
150-6	27422-27425	out	_	
150-7	27426-27428	to	_	
150-8	27429-27435	answer	_	
150-9	27436-27438	is	_	
150-10	27439-27446	whether	_	
150-11	27447-27458	impairments	_	
150-12	27459-27461	in	_	
150-13	27462-27478	interhemispheric	_	
150-14	27479-27491	connectivity	_	
150-15	27492-27495	are	_	
150-16	27496-27503	present	_	
150-17	27504-27506	in	_	
150-18	27507-27515	patients	_	
150-19	27516-27520	with	_	
150-20	27521-27534	schizophrenia	_	
150-21	27535-27538	and	_	
150-22	27538-27539	,	_	
150-23	27540-27542	if	_	
150-24	27543-27545	so	_	
150-25	27545-27546	,	_	
150-26	27547-27554	whether	_	
150-27	27555-27560	these	_	
150-28	27561-27572	impairments	_	
150-29	27573-27579	relate	_	
150-30	27580-27582	to	_	
150-31	27583-27594	preexistent	_	
150-32	27595-27603	familial	_	
150-33	27604-27608	risk	_	
150-34	27609-27612	for	_	
150-35	27613-27616	the	_	
150-36	27617-27624	illness	_	
150-37	27624-27625	.	_	

#Text=To answer this question, we examined a group of unaffected siblings of schizophrenia patients, who share 50% of their genetic information with affected probands on average.
151-1	27626-27628	To	_	
151-2	27629-27635	answer	_	
151-3	27636-27640	this	_	
151-4	27641-27649	question	_	
151-5	27649-27650	,	_	
151-6	27651-27653	we	_	
151-7	27654-27662	examined	_	
151-8	27663-27664	a	_	
151-9	27665-27670	group	_	
151-10	27671-27673	of	_	
151-11	27674-27684	unaffected	_	
151-12	27685-27693	siblings	_	
151-13	27694-27696	of	_	
151-14	27697-27710	schizophrenia	_	
151-15	27711-27719	patients	_	
151-16	27719-27720	,	_	
151-17	27721-27724	who	_	
151-18	27725-27730	share	_	
151-19	27731-27734	50%	_	
151-20	27735-27737	of	_	
151-21	27738-27743	their	_	
151-22	27744-27751	genetic	_	
151-23	27752-27763	information	_	
151-24	27764-27768	with	_	
151-25	27769-27777	affected	_	
151-26	27778-27786	probands	_	
151-27	27787-27789	on	_	
151-28	27790-27797	average	_	
151-29	27797-27798	.	_	

#Text=In contrast to a previous study reporting a subtle decline of regional interhemispheric connectivity strength in siblings as compared to controls, our current study does not find significant reductions in interhemispheric connectivity in unaffected siblings, suggesting that interhemispheric connectivity impairments may be an overt clinical phenotype of schizophrenia.
152-1	27799-27801	In	_	
152-2	27802-27810	contrast	_	
152-3	27811-27813	to	_	
152-4	27814-27815	a	_	
152-5	27816-27824	previous	_	
152-6	27825-27830	study	_	
152-7	27831-27840	reporting	_	
152-8	27841-27842	a	_	
152-9	27843-27849	subtle	_	
152-10	27850-27857	decline	_	
152-11	27858-27860	of	_	
152-12	27861-27869	regional	_	
152-13	27870-27886	interhemispheric	_	
152-14	27887-27899	connectivity	_	
152-15	27900-27908	strength	_	
152-16	27909-27911	in	_	
152-17	27912-27920	siblings	_	
152-18	27921-27923	as	_	
152-19	27924-27932	compared	_	
152-20	27933-27935	to	_	
152-21	27936-27944	controls	_	
152-22	27944-27945	,	_	
152-23	27946-27949	our	_	
152-24	27950-27957	current	_	
152-25	27958-27963	study	_	
152-26	27964-27968	does	_	
152-27	27969-27972	not	_	
152-28	27973-27977	find	_	
152-29	27978-27989	significant	_	
152-30	27990-28000	reductions	_	
152-31	28001-28003	in	_	
152-32	28004-28020	interhemispheric	_	
152-33	28021-28033	connectivity	_	
152-34	28034-28036	in	_	
152-35	28037-28047	unaffected	_	
152-36	28048-28056	siblings	_	
152-37	28056-28057	,	_	
152-38	28058-28068	suggesting	_	
152-39	28069-28073	that	_	
152-40	28074-28090	interhemispheric	_	
152-41	28091-28103	connectivity	_	
152-42	28104-28115	impairments	_	
152-43	28116-28119	may	_	
152-44	28120-28122	be	_	
152-45	28123-28125	an	_	
152-46	28126-28131	overt	_	
152-47	28132-28140	clinical	_	
152-48	28141-28150	phenotype	_	
152-49	28151-28153	of	_	
152-50	28154-28167	schizophrenia	_	
152-51	28167-28168	.	_	

#Text=Alternatively, interhemispheric connectivity impairments may be present from a young age in patients and siblings, but normalize with development in unaffected siblings due to a compensatory mechanism, as has been shown for siblings of childhood-onset schizophrenia patients.
153-1	28169-28182	Alternatively	_	
153-2	28182-28183	,	_	
153-3	28184-28200	interhemispheric	_	
153-4	28201-28213	connectivity	_	
153-5	28214-28225	impairments	_	
153-6	28226-28229	may	_	
153-7	28230-28232	be	_	
153-8	28233-28240	present	_	
153-9	28241-28245	from	_	
153-10	28246-28247	a	_	
153-11	28248-28253	young	_	
153-12	28254-28257	age	_	
153-13	28258-28260	in	_	
153-14	28261-28269	patients	_	
153-15	28270-28273	and	_	
153-16	28274-28282	siblings	_	
153-17	28282-28283	,	_	
153-18	28284-28287	but	_	
153-19	28288-28297	normalize	_	
153-20	28298-28302	with	_	
153-21	28303-28314	development	_	
153-22	28315-28317	in	_	
153-23	28318-28328	unaffected	_	
153-24	28329-28337	siblings	_	
153-25	28338-28341	due	_	
153-26	28342-28344	to	_	
153-27	28345-28346	a	_	
153-28	28347-28359	compensatory	_	
153-29	28360-28369	mechanism	_	
153-30	28369-28370	,	_	
153-31	28371-28373	as	_	
153-32	28374-28377	has	_	
153-33	28378-28382	been	_	
153-34	28383-28388	shown	_	
153-35	28389-28392	for	_	
153-36	28393-28401	siblings	_	
153-37	28402-28404	of	_	
153-38	28405-28420	childhood-onset	_	
153-39	28421-28434	schizophrenia	_	
153-40	28435-28443	patients	_	
153-41	28443-28444	.	_	

#Text=Another interest of the current study was to examine disturbances of interhemispheric connectivity in relation to putative abnormalities in hemispheric specialization.
154-1	28445-28452	Another	_	
154-2	28453-28461	interest	_	
154-3	28462-28464	of	_	
154-4	28465-28468	the	_	
154-5	28469-28476	current	_	
154-6	28477-28482	study	_	
154-7	28483-28486	was	_	
154-8	28487-28489	to	_	
154-9	28490-28497	examine	_	
154-10	28498-28510	disturbances	_	
154-11	28511-28513	of	_	
154-12	28514-28530	interhemispheric	_	
154-13	28531-28543	connectivity	_	
154-14	28544-28546	in	_	
154-15	28547-28555	relation	_	
154-16	28556-28558	to	_	
154-17	28559-28567	putative	_	
154-18	28568-28581	abnormalities	_	
154-19	28582-28584	in	_	
154-20	28585-28596	hemispheric	_	
154-21	28597-28611	specialization	_	
154-22	28611-28612	.	_	

#Text=We find that schizophrenia patients exhibit increased hemispheric specialization in several unimodal and heteromodal association regions, as well as sensorimotor cortex and limbic areas (Fig. 4A), indicating an excessive reduction in cross-hemisphere connectivity relative to within-hemisphere connectivity in these brain regions.
155-1	28613-28615	We	_	
155-2	28616-28620	find	_	
155-3	28621-28625	that	_	
155-4	28626-28639	schizophrenia	_	
155-5	28640-28648	patients	_	
155-6	28649-28656	exhibit	_	
155-7	28657-28666	increased	_	
155-8	28667-28678	hemispheric	_	
155-9	28679-28693	specialization	_	
155-10	28694-28696	in	_	
155-11	28697-28704	several	_	
155-12	28705-28713	unimodal	_	
155-13	28714-28717	and	_	
155-14	28718-28729	heteromodal	_	
155-15	28730-28741	association	_	
155-16	28742-28749	regions	_	
155-17	28749-28750	,	_	
155-18	28751-28753	as	_	
155-19	28754-28758	well	_	
155-20	28759-28761	as	_	
155-21	28762-28774	sensorimotor	_	
155-22	28775-28781	cortex	_	
155-23	28782-28785	and	_	
155-24	28786-28792	limbic	_	
155-25	28793-28798	areas	_	
155-26	28799-28800	(	_	
155-27	28800-28803	Fig	_	
155-28	28803-28804	.	_	
155-29	28805-28807	4A	_	
155-30	28807-28808	)	_	
155-31	28808-28809	,	_	
155-32	28810-28820	indicating	_	
155-33	28821-28823	an	_	
155-34	28824-28833	excessive	_	
155-35	28834-28843	reduction	_	
155-36	28844-28846	in	_	
155-37	28847-28863	cross-hemisphere	_	
155-38	28864-28876	connectivity	_	
155-39	28877-28885	relative	_	
155-40	28886-28888	to	_	
155-41	28889-28906	within-hemisphere	_	
155-42	28907-28919	connectivity	_	
155-43	28920-28922	in	_	
155-44	28923-28928	these	_	
155-45	28929-28934	brain	_	
155-46	28935-28942	regions	_	
155-47	28942-28943	.	_	

#Text=The unimodal and heteromodal association cortices have reciprocal connectivity with lower level brain regions, and are involved in the integration of sensory information from multiple modalities.
156-1	28944-28947	The	_	
156-2	28948-28956	unimodal	_	
156-3	28957-28960	and	_	
156-4	28961-28972	heteromodal	_	
156-5	28973-28984	association	_	
156-6	28985-28993	cortices	_	
156-7	28994-28998	have	_	
156-8	28999-29009	reciprocal	_	
156-9	29010-29022	connectivity	_	
156-10	29023-29027	with	_	
156-11	29028-29033	lower	_	
156-12	29034-29039	level	_	
156-13	29040-29045	brain	_	
156-14	29046-29053	regions	_	
156-15	29053-29054	,	_	
156-16	29055-29058	and	_	
156-17	29059-29062	are	_	
156-18	29063-29071	involved	_	
156-19	29072-29074	in	_	
156-20	29075-29078	the	_	
156-21	29079-29090	integration	_	
156-22	29091-29093	of	_	
156-23	29094-29101	sensory	_	
156-24	29102-29113	information	_	
156-25	29114-29118	from	_	
156-26	29119-29127	multiple	_	
156-27	29128-29138	modalities	_	
156-28	29138-29139	.	_	

#Text=Previous studies have shown that the cortical network of multimodal brain regions is disproportionately affected in schizophrenia and abnormalities in association cortices such as reduced cortical thickness and fiber integrity have been found in schizophrenia patients.
157-1	29140-29148	Previous	_	
157-2	29149-29156	studies	_	
157-3	29157-29161	have	_	
157-4	29162-29167	shown	_	
157-5	29168-29172	that	_	
157-6	29173-29176	the	_	
157-7	29177-29185	cortical	_	
157-8	29186-29193	network	_	
157-9	29194-29196	of	_	
157-10	29197-29207	multimodal	_	
157-11	29208-29213	brain	_	
157-12	29214-29221	regions	_	
157-13	29222-29224	is	_	
157-14	29225-29243	disproportionately	_	
157-15	29244-29252	affected	_	
157-16	29253-29255	in	_	
157-17	29256-29269	schizophrenia	_	
157-18	29270-29273	and	_	
157-19	29274-29287	abnormalities	_	
157-20	29288-29290	in	_	
157-21	29291-29302	association	_	
157-22	29303-29311	cortices	_	
157-23	29312-29316	such	_	
157-24	29317-29319	as	_	
157-25	29320-29327	reduced	_	
157-26	29328-29336	cortical	_	
157-27	29337-29346	thickness	_	
157-28	29347-29350	and	_	
157-29	29351-29356	fiber	_	
157-30	29357-29366	integrity	_	
157-31	29367-29371	have	_	
157-32	29372-29376	been	_	
157-33	29377-29382	found	_	
157-34	29383-29385	in	_	
157-35	29386-29399	schizophrenia	_	
157-36	29400-29408	patients	_	
157-37	29408-29409	.	_	

#Text=Extending previous findings, we suggest that unimodal and heteromodal areas more preferentially connected to ipsilateral brain areas in schizophrenia, at the expense of facilitating cross-hemisphere interactions with a broader range of brain regions.
158-1	29410-29419	Extending	_	
158-2	29420-29428	previous	_	
158-3	29429-29437	findings	_	
158-4	29437-29438	,	_	
158-5	29439-29441	we	_	
158-6	29442-29449	suggest	_	
158-7	29450-29454	that	_	
158-8	29455-29463	unimodal	_	
158-9	29464-29467	and	_	
158-10	29468-29479	heteromodal	_	
158-11	29480-29485	areas	_	
158-12	29486-29490	more	_	
158-13	29491-29505	preferentially	_	
158-14	29506-29515	connected	_	
158-15	29516-29518	to	_	
158-16	29519-29530	ipsilateral	_	
158-17	29531-29536	brain	_	
158-18	29537-29542	areas	_	
158-19	29543-29545	in	_	
158-20	29546-29559	schizophrenia	_	
158-21	29559-29560	,	_	
158-22	29561-29563	at	_	
158-23	29564-29567	the	_	
158-24	29568-29575	expense	_	
158-25	29576-29578	of	_	
158-26	29579-29591	facilitating	_	
158-27	29592-29608	cross-hemisphere	_	
158-28	29609-29621	interactions	_	
158-29	29622-29626	with	_	
158-30	29627-29628	a	_	
158-31	29629-29636	broader	_	
158-32	29637-29642	range	_	
158-33	29643-29645	of	_	
158-34	29646-29651	brain	_	
158-35	29652-29659	regions	_	
158-36	29659-29660	.	_	

#Text=In terms of the relationship between interhemispheric connectivity and hemispheric specialization, we find a significant correlation between lower interhemispheric connectivity and higher hemispheric specialization index in patients as compared to both controls and siblings (Fig. 5).
159-1	29661-29663	In	_	
159-2	29664-29669	terms	_	
159-3	29670-29672	of	_	
159-4	29673-29676	the	_	
159-5	29677-29689	relationship	_	
159-6	29690-29697	between	_	
159-7	29698-29714	interhemispheric	_	
159-8	29715-29727	connectivity	_	
159-9	29728-29731	and	_	
159-10	29732-29743	hemispheric	_	
159-11	29744-29758	specialization	_	
159-12	29758-29759	,	_	
159-13	29760-29762	we	_	
159-14	29763-29767	find	_	
159-15	29768-29769	a	_	
159-16	29770-29781	significant	_	
159-17	29782-29793	correlation	_	
159-18	29794-29801	between	_	
159-19	29802-29807	lower	_	
159-20	29808-29824	interhemispheric	_	
159-21	29825-29837	connectivity	_	
159-22	29838-29841	and	_	
159-23	29842-29848	higher	_	
159-24	29849-29860	hemispheric	_	
159-25	29861-29875	specialization	_	
159-26	29876-29881	index	_	
159-27	29882-29884	in	_	
159-28	29885-29893	patients	_	
159-29	29894-29896	as	_	
159-30	29897-29905	compared	_	
159-31	29906-29908	to	_	
159-32	29909-29913	both	_	
159-33	29914-29922	controls	_	
159-34	29923-29926	and	_	
159-35	29927-29935	siblings	_	
159-36	29936-29937	(	_	
159-37	29937-29940	Fig	_	
159-38	29940-29941	.	_	
159-39	29942-29943	5	_	
159-40	29943-29944	)	_	
159-41	29944-29945	.	_	

#Text=These connectivity abnormalities may relate to reduced lateralization in schizophrenia.
160-1	29946-29951	These	_	
160-2	29952-29964	connectivity	_	
160-3	29965-29978	abnormalities	_	
160-4	29979-29982	may	_	
160-5	29983-29989	relate	_	
160-6	29990-29992	to	_	
160-7	29993-30000	reduced	_	
160-8	30001-30015	lateralization	_	
160-9	30016-30018	in	_	
160-10	30019-30032	schizophrenia	_	
160-11	30032-30033	.	_	

#Text=Previous studies have found that schizophrenia patients exhibit a loss of asymmetry in the auditory cortex in task-induced activation, and its functional connectivity with other regions.
161-1	30034-30042	Previous	_	
161-2	30043-30050	studies	_	
161-3	30051-30055	have	_	
161-4	30056-30061	found	_	
161-5	30062-30066	that	_	
161-6	30067-30080	schizophrenia	_	
161-7	30081-30089	patients	_	
161-8	30090-30097	exhibit	_	
161-9	30098-30099	a	_	
161-10	30100-30104	loss	_	
161-11	30105-30107	of	_	
161-12	30108-30117	asymmetry	_	
161-13	30118-30120	in	_	
161-14	30121-30124	the	_	
161-15	30125-30133	auditory	_	
161-16	30134-30140	cortex	_	
161-17	30141-30143	in	_	
161-18	30144-30156	task-induced	_	
161-19	30157-30167	activation	_	
161-20	30167-30168	,	_	
161-21	30169-30172	and	_	
161-22	30173-30176	its	_	
161-23	30177-30187	functional	_	
161-24	30188-30200	connectivity	_	
161-25	30201-30205	with	_	
161-26	30206-30211	other	_	
161-27	30212-30219	regions	_	
161-28	30219-30220	.	_	

#Text=In addition, reduced asymmetry in brain morphology and white matter connectivity have also been reported (for review and meta-analysis please refer to).
162-1	30221-30223	In	_	
162-2	30224-30232	addition	_	
162-3	30232-30233	,	_	
162-4	30234-30241	reduced	_	
162-5	30242-30251	asymmetry	_	
162-6	30252-30254	in	_	
162-7	30255-30260	brain	_	
162-8	30261-30271	morphology	_	
162-9	30272-30275	and	_	
162-10	30276-30281	white	_	
162-11	30282-30288	matter	_	
162-12	30289-30301	connectivity	_	
162-13	30302-30306	have	_	
162-14	30307-30311	also	_	
162-15	30312-30316	been	_	
162-16	30317-30325	reported	_	
162-17	30326-30327	(	_	
162-18	30327-30330	for	_	
162-19	30331-30337	review	_	
162-20	30338-30341	and	_	
162-21	30342-30355	meta-analysis	_	
162-22	30356-30362	please	_	
162-23	30363-30368	refer	_	
162-24	30369-30371	to	_	
162-25	30371-30372	)	_	
162-26	30372-30373	.	_	

#Text=The identified abnormalities of intrinsic interhemispheric connectivity and hemispheric specialization suggest impairments of synchronization between the two hemispheres, and a preference of intra- versus inter-hemispheric connectivity in patients, which is consistent with a lack of efficient lateralized processing in the dominant hemisphere during tasks.
163-1	30374-30377	The	_	
163-2	30378-30388	identified	_	
163-3	30389-30402	abnormalities	_	
163-4	30403-30405	of	_	
163-5	30406-30415	intrinsic	_	
163-6	30416-30432	interhemispheric	_	
163-7	30433-30445	connectivity	_	
163-8	30446-30449	and	_	
163-9	30450-30461	hemispheric	_	
163-10	30462-30476	specialization	_	
163-11	30477-30484	suggest	_	
163-12	30485-30496	impairments	_	
163-13	30497-30499	of	_	
163-14	30500-30515	synchronization	_	
163-15	30516-30523	between	_	
163-16	30524-30527	the	_	
163-17	30528-30531	two	_	
163-18	30532-30543	hemispheres	_	
163-19	30543-30544	,	_	
163-20	30545-30548	and	_	
163-21	30549-30550	a	_	
163-22	30551-30561	preference	_	
163-23	30562-30564	of	_	
163-24	30565-30570	intra	_	
163-25	30570-30571	-	_	
163-26	30572-30578	versus	_	
163-27	30579-30596	inter-hemispheric	_	
163-28	30597-30609	connectivity	_	
163-29	30610-30612	in	_	
163-30	30613-30621	patients	_	
163-31	30621-30622	,	_	
163-32	30623-30628	which	_	
163-33	30629-30631	is	_	
163-34	30632-30642	consistent	_	
163-35	30643-30647	with	_	
163-36	30648-30649	a	_	
163-37	30650-30654	lack	_	
163-38	30655-30657	of	_	
163-39	30658-30667	efficient	_	
163-40	30668-30679	lateralized	_	
163-41	30680-30690	processing	_	
163-42	30691-30693	in	_	
163-43	30694-30697	the	_	
163-44	30698-30706	dominant	_	
163-45	30707-30717	hemisphere	_	
163-46	30718-30724	during	_	
163-47	30725-30730	tasks	_	
163-48	30730-30731	.	_	

#Text=A strong main effect of hemisphere was found for hemispheric autonomy of many cortical and subcortical regions (Fig. 4B).
164-1	30732-30733	A	_	
164-2	30734-30740	strong	_	
164-3	30741-30745	main	_	
164-4	30746-30752	effect	_	
164-5	30753-30755	of	_	
164-6	30756-30766	hemisphere	_	
164-7	30767-30770	was	_	
164-8	30771-30776	found	_	
164-9	30777-30780	for	_	
164-10	30781-30792	hemispheric	_	
164-11	30793-30801	autonomy	_	
164-12	30802-30804	of	_	
164-13	30805-30809	many	_	
164-14	30810-30818	cortical	_	
164-15	30819-30822	and	_	
164-16	30823-30834	subcortical	_	
164-17	30835-30842	regions	_	
164-18	30843-30844	(	_	
164-19	30844-30847	Fig	_	
164-20	30847-30848	.	_	
164-21	30849-30851	4B	_	
164-22	30851-30852	)	_	
164-23	30852-30853	.	_	

#Text=Higher hemispheric specialization in the left hemisphere was found predominately in language-related regions, as well as subcortical regions and posterior cingulate cortex.
165-1	30854-30860	Higher	_	
165-2	30861-30872	hemispheric	_	
165-3	30873-30887	specialization	_	
165-4	30888-30890	in	_	
165-5	30891-30894	the	_	
165-6	30895-30899	left	_	
165-7	30900-30910	hemisphere	_	
165-8	30911-30914	was	_	
165-9	30915-30920	found	_	
165-10	30921-30934	predominately	_	
165-11	30935-30937	in	_	
165-12	30938-30954	language-related	_	
165-13	30955-30962	regions	_	
165-14	30962-30963	,	_	
165-15	30964-30966	as	_	
165-16	30967-30971	well	_	
165-17	30972-30974	as	_	
165-18	30975-30986	subcortical	_	
165-19	30987-30994	regions	_	
165-20	30995-30998	and	_	
165-21	30999-31008	posterior	_	
165-22	31009-31018	cingulate	_	
165-23	31019-31025	cortex	_	
165-24	31025-31026	.	_	

#Text=Regions with higher autonomy in the right hemisphere mainly included parietal and occipital areas, as well as a few frontal, temporal, cingulate, and subcortical regions.
166-1	31027-31034	Regions	_	
166-2	31035-31039	with	_	
166-3	31040-31046	higher	_	
166-4	31047-31055	autonomy	_	
166-5	31056-31058	in	_	
166-6	31059-31062	the	_	
166-7	31063-31068	right	_	
166-8	31069-31079	hemisphere	_	
166-9	31080-31086	mainly	_	
166-10	31087-31095	included	_	
166-11	31096-31104	parietal	_	
166-12	31105-31108	and	_	
166-13	31109-31118	occipital	_	
166-14	31119-31124	areas	_	
166-15	31124-31125	,	_	
166-16	31126-31128	as	_	
166-17	31129-31133	well	_	
166-18	31134-31136	as	_	
166-19	31137-31138	a	_	
166-20	31139-31142	few	_	
166-21	31143-31150	frontal	_	
166-22	31150-31151	,	_	
166-23	31152-31160	temporal	_	
166-24	31160-31161	,	_	
166-25	31162-31171	cingulate	_	
166-26	31171-31172	,	_	
166-27	31173-31176	and	_	
166-28	31177-31188	subcortical	_	
166-29	31189-31196	regions	_	
166-30	31196-31197	.	_	

#Text=This lateralization pattern is consistent with previous findings of a dissociation between left hemisphere specialization in language areas and a right hemisphere dominance in visuospatial and attentional areas.
167-1	31198-31202	This	_	
167-2	31203-31217	lateralization	_	
167-3	31218-31225	pattern	_	
167-4	31226-31228	is	_	
167-5	31229-31239	consistent	_	
167-6	31240-31244	with	_	
167-7	31245-31253	previous	_	
167-8	31254-31262	findings	_	
167-9	31263-31265	of	_	
167-10	31266-31267	a	_	
167-11	31268-31280	dissociation	_	
167-12	31281-31288	between	_	
167-13	31289-31293	left	_	
167-14	31294-31304	hemisphere	_	
167-15	31305-31319	specialization	_	
167-16	31320-31322	in	_	
167-17	31323-31331	language	_	
167-18	31332-31337	areas	_	
167-19	31338-31341	and	_	
167-20	31342-31343	a	_	
167-21	31344-31349	right	_	
167-22	31350-31360	hemisphere	_	
167-23	31361-31370	dominance	_	
167-24	31371-31373	in	_	
167-25	31374-31386	visuospatial	_	
167-26	31387-31390	and	_	
167-27	31391-31402	attentional	_	
167-28	31403-31408	areas	_	
167-29	31408-31409	.	_	

#Text=Interestingly, we found that the hemispheric specialization of Heschl's gyrus and the temporal plane is lower in the left than the right hemispheric regions, indicating that in these primary auditory cortices, left hemispheric regions are more bilaterally connected (low hemispheric specialization), whereas right-sided regions are more ipsilaterally connected (high hemispheric specialization).
168-1	31410-31423	Interestingly	_	
168-2	31423-31424	,	_	
168-3	31425-31427	we	_	
168-4	31428-31433	found	_	
168-5	31434-31438	that	_	
168-6	31439-31442	the	_	
168-7	31443-31454	hemispheric	_	
168-8	31455-31469	specialization	_	
168-9	31470-31472	of	_	
168-10	31473-31481	Heschl's	_	
168-11	31482-31487	gyrus	_	
168-12	31488-31491	and	_	
168-13	31492-31495	the	_	
168-14	31496-31504	temporal	_	
168-15	31505-31510	plane	_	
168-16	31511-31513	is	_	
168-17	31514-31519	lower	_	
168-18	31520-31522	in	_	
168-19	31523-31526	the	_	
168-20	31527-31531	left	_	
168-21	31532-31536	than	_	
168-22	31537-31540	the	_	
168-23	31541-31546	right	_	
168-24	31547-31558	hemispheric	_	
168-25	31559-31566	regions	_	
168-26	31566-31567	,	_	
168-27	31568-31578	indicating	_	
168-28	31579-31583	that	_	
168-29	31584-31586	in	_	
168-30	31587-31592	these	_	
168-31	31593-31600	primary	_	
168-32	31601-31609	auditory	_	
168-33	31610-31618	cortices	_	
168-34	31618-31619	,	_	
168-35	31620-31624	left	_	
168-36	31625-31636	hemispheric	_	
168-37	31637-31644	regions	_	
168-38	31645-31648	are	_	
168-39	31649-31653	more	_	
168-40	31654-31665	bilaterally	_	
168-41	31666-31675	connected	_	
168-42	31676-31677	(	_	
168-43	31677-31680	low	_	
168-44	31681-31692	hemispheric	_	
168-45	31693-31707	specialization	_	
168-46	31707-31708	)	_	
168-47	31708-31709	,	_	
168-48	31710-31717	whereas	_	
168-49	31718-31729	right-sided	_	
168-50	31730-31737	regions	_	
168-51	31738-31741	are	_	
168-52	31742-31746	more	_	
168-53	31747-31760	ipsilaterally	_	
168-54	31761-31770	connected	_	
168-55	31771-31772	(	_	
168-56	31772-31776	high	_	
168-57	31777-31788	hemispheric	_	
168-58	31789-31803	specialization	_	
168-59	31803-31804	)	_	
168-60	31804-31805	.	_	

#Text=This connectivity profile may indicate a more important role of the left primary auditory cortex in integration and processing of auditory information.
169-1	31806-31810	This	_	
169-2	31811-31823	connectivity	_	
169-3	31824-31831	profile	_	
169-4	31832-31835	may	_	
169-5	31836-31844	indicate	_	
169-6	31845-31846	a	_	
169-7	31847-31851	more	_	
169-8	31852-31861	important	_	
169-9	31862-31866	role	_	
169-10	31867-31869	of	_	
169-11	31870-31873	the	_	
169-12	31874-31878	left	_	
169-13	31879-31886	primary	_	
169-14	31887-31895	auditory	_	
169-15	31896-31902	cortex	_	
169-16	31903-31905	in	_	
169-17	31906-31917	integration	_	
169-18	31918-31921	and	_	
169-19	31922-31932	processing	_	
169-20	31933-31935	of	_	
169-21	31936-31944	auditory	_	
169-22	31945-31956	information	_	
169-23	31956-31957	.	_	

#Text=Connectivity of the caudate nucleus tends to be more ipsilateral in the right hemisphere as compared to the left hemisphere, which is different from the results of a previous study, but is consistent with a right-over-left dopamine receptor availability in this region in healthy subjects.
170-1	31958-31970	Connectivity	_	
170-2	31971-31973	of	_	
170-3	31974-31977	the	_	
170-4	31978-31985	caudate	_	
170-5	31986-31993	nucleus	_	
170-6	31994-31999	tends	_	
170-7	32000-32002	to	_	
170-8	32003-32005	be	_	
170-9	32006-32010	more	_	
170-10	32011-32022	ipsilateral	_	
170-11	32023-32025	in	_	
170-12	32026-32029	the	_	
170-13	32030-32035	right	_	
170-14	32036-32046	hemisphere	_	
170-15	32047-32049	as	_	
170-16	32050-32058	compared	_	
170-17	32059-32061	to	_	
170-18	32062-32065	the	_	
170-19	32066-32070	left	_	
170-20	32071-32081	hemisphere	_	
170-21	32081-32082	,	_	
170-22	32083-32088	which	_	
170-23	32089-32091	is	_	
170-24	32092-32101	different	_	
170-25	32102-32106	from	_	
170-26	32107-32110	the	_	
170-27	32111-32118	results	_	
170-28	32119-32121	of	_	
170-29	32122-32123	a	_	
170-30	32124-32132	previous	_	
170-31	32133-32138	study	_	
170-32	32138-32139	,	_	
170-33	32140-32143	but	_	
170-34	32144-32146	is	_	
170-35	32147-32157	consistent	_	
170-36	32158-32162	with	_	
170-37	32163-32164	a	_	
170-38	32165-32180	right-over-left	_	
170-39	32181-32189	dopamine	_	
170-40	32190-32198	receptor	_	
170-41	32199-32211	availability	_	
170-42	32212-32214	in	_	
170-43	32215-32219	this	_	
170-44	32220-32226	region	_	
170-45	32227-32229	in	_	
170-46	32230-32237	healthy	_	
170-47	32238-32246	subjects	_	
170-48	32246-32247	.	_	

#Text=Other subcortical regions such as thalamus, putamen, pallidum, and amygdala were all found to exhibit higher hemispheric autonomy for the right hemisphere, in line with previous findings of a more bilaterally connected pattern in the right hemisphere.
171-1	32248-32253	Other	_	
171-2	32254-32265	subcortical	_	
171-3	32266-32273	regions	_	
171-4	32274-32278	such	_	
171-5	32279-32281	as	_	
171-6	32282-32290	thalamus	_	
171-7	32290-32291	,	_	
171-8	32292-32299	putamen	_	
171-9	32299-32300	,	_	
171-10	32301-32309	pallidum	_	
171-11	32309-32310	,	_	
171-12	32311-32314	and	_	
171-13	32315-32323	amygdala	_	
171-14	32324-32328	were	_	
171-15	32329-32332	all	_	
171-16	32333-32338	found	_	
171-17	32339-32341	to	_	
171-18	32342-32349	exhibit	_	
171-19	32350-32356	higher	_	
171-20	32357-32368	hemispheric	_	
171-21	32369-32377	autonomy	_	
171-22	32378-32381	for	_	
171-23	32382-32385	the	_	
171-24	32386-32391	right	_	
171-25	32392-32402	hemisphere	_	
171-26	32402-32403	,	_	
171-27	32404-32406	in	_	
171-28	32407-32411	line	_	
171-29	32412-32416	with	_	
171-30	32417-32425	previous	_	
171-31	32426-32434	findings	_	
171-32	32435-32437	of	_	
171-33	32438-32439	a	_	
171-34	32440-32444	more	_	
171-35	32445-32456	bilaterally	_	
171-36	32457-32466	connected	_	
171-37	32467-32474	pattern	_	
171-38	32475-32477	in	_	
171-39	32478-32481	the	_	
171-40	32482-32487	right	_	
171-41	32488-32498	hemisphere	_	
171-42	32498-32499	.	_	

#Text=Several points need to be taken into consideration when interpreting our results.
172-1	32500-32507	Several	_	
172-2	32508-32514	points	_	
172-3	32515-32519	need	_	
172-4	32520-32522	to	_	
172-5	32523-32525	be	_	
172-6	32526-32531	taken	_	
172-7	32532-32536	into	_	
172-8	32537-32550	consideration	_	
172-9	32551-32555	when	_	
172-10	32556-32568	interpreting	_	
172-11	32569-32572	our	_	
172-12	32573-32580	results	_	
172-13	32580-32581	.	_	

#Text=First, we preformed region-based rather than voxel-based analyses of interhemispheric connectivity and hemispheric specialization.
173-1	32582-32587	First	_	
173-2	32587-32588	,	_	
173-3	32589-32591	we	_	
173-4	32592-32601	preformed	_	
173-5	32602-32614	region-based	_	
173-6	32615-32621	rather	_	
173-7	32622-32626	than	_	
173-8	32627-32638	voxel-based	_	
173-9	32639-32647	analyses	_	
173-10	32648-32650	of	_	
173-11	32651-32667	interhemispheric	_	
173-12	32668-32680	connectivity	_	
173-13	32681-32684	and	_	
173-14	32685-32696	hemispheric	_	
173-15	32697-32711	specialization	_	
173-16	32711-32712	.	_	

#Text=Hence, our definition of hemispheric specialization is different from a previous study based on voxel-wise measurements.
174-1	32713-32718	Hence	_	
174-2	32718-32719	,	_	
174-3	32720-32723	our	_	
174-4	32724-32734	definition	_	
174-5	32735-32737	of	_	
174-6	32738-32749	hemispheric	_	
174-7	32750-32764	specialization	_	
174-8	32765-32767	is	_	
174-9	32768-32777	different	_	
174-10	32778-32782	from	_	
174-11	32783-32784	a	_	
174-12	32785-32793	previous	_	
174-13	32794-32799	study	_	
174-14	32800-32805	based	_	
174-15	32806-32808	on	_	
174-16	32809-32819	voxel-wise	_	
174-17	32820-32832	measurements	_	
174-18	32832-32833	.	_	

#Text=Region-based and voxel-based approaches each have their benefits and limitations.
175-1	32834-32846	Region-based	_	
175-2	32847-32850	and	_	
175-3	32851-32862	voxel-based	_	
175-4	32863-32873	approaches	_	
175-5	32874-32878	each	_	
175-6	32879-32883	have	_	
175-7	32884-32889	their	_	
175-8	32890-32898	benefits	_	
175-9	32899-32902	and	_	
175-10	32903-32914	limitations	_	
175-11	32914-32915	.	_	

#Text=We adopted a region-based approach for better sensitivity and interpretability of the results, and to allow us to correlate measurements of interhemispheric connectivity and hemispheric specialization across brain regions.
176-1	32916-32918	We	_	
176-2	32919-32926	adopted	_	
176-3	32927-32928	a	_	
176-4	32929-32941	region-based	_	
176-5	32942-32950	approach	_	
176-6	32951-32954	for	_	
176-7	32955-32961	better	_	
176-8	32962-32973	sensitivity	_	
176-9	32974-32977	and	_	
176-10	32978-32994	interpretability	_	
176-11	32995-32997	of	_	
176-12	32998-33001	the	_	
176-13	33002-33009	results	_	
176-14	33009-33010	,	_	
176-15	33011-33014	and	_	
176-16	33015-33017	to	_	
176-17	33018-33023	allow	_	
176-18	33024-33026	us	_	
176-19	33027-33029	to	_	
176-20	33030-33039	correlate	_	
176-21	33040-33052	measurements	_	
176-22	33053-33055	of	_	
176-23	33056-33072	interhemispheric	_	
176-24	33073-33085	connectivity	_	
176-25	33086-33089	and	_	
176-26	33090-33101	hemispheric	_	
176-27	33102-33116	specialization	_	
176-28	33117-33123	across	_	
176-29	33124-33129	brain	_	
176-30	33130-33137	regions	_	
176-31	33137-33138	.	_	

#Text=Second, the proportion of male and female subjects are not balanced across groups.
177-1	33139-33145	Second	_	
177-2	33145-33146	,	_	
177-3	33147-33150	the	_	
177-4	33151-33161	proportion	_	
177-5	33162-33164	of	_	
177-6	33165-33169	male	_	
177-7	33170-33173	and	_	
177-8	33174-33180	female	_	
177-9	33181-33189	subjects	_	
177-10	33190-33193	are	_	
177-11	33194-33197	not	_	
177-12	33198-33206	balanced	_	
177-13	33207-33213	across	_	
177-14	33214-33220	groups	_	
177-15	33220-33221	.	_	

#Text=To address this issue, we included sex as a covariate when performing group-comparisons.
178-1	33222-33224	To	_	
178-2	33225-33232	address	_	
178-3	33233-33237	this	_	
178-4	33238-33243	issue	_	
178-5	33243-33244	,	_	
178-6	33245-33247	we	_	
178-7	33248-33256	included	_	
178-8	33257-33260	sex	_	
178-9	33261-33263	as	_	
178-10	33264-33265	a	_	
178-11	33266-33275	covariate	_	
178-12	33276-33280	when	_	
178-13	33281-33291	performing	_	
178-14	33292-33309	group-comparisons	_	
178-15	33309-33310	.	_	

#Text=Previous studies have produced mixed results in terms of the effects of sex on interhemispheric connectivity strength.
179-1	33311-33319	Previous	_	
179-2	33320-33327	studies	_	
179-3	33328-33332	have	_	
179-4	33333-33341	produced	_	
179-5	33342-33347	mixed	_	
179-6	33348-33355	results	_	
179-7	33356-33358	in	_	
179-8	33359-33364	terms	_	
179-9	33365-33367	of	_	
179-10	33368-33371	the	_	
179-11	33372-33379	effects	_	
179-12	33380-33382	of	_	
179-13	33383-33386	sex	_	
179-14	33387-33389	on	_	
179-15	33390-33406	interhemispheric	_	
179-16	33407-33419	connectivity	_	
179-17	33420-33428	strength	_	
179-18	33428-33429	.	_	

#Text=Future studies with a balanced sex distribution would be better suited to examine potential sex differences on interhemispheric connectivity and hemispheric specialization in schizophrenia.
180-1	33430-33436	Future	_	
180-2	33437-33444	studies	_	
180-3	33445-33449	with	_	
180-4	33450-33451	a	_	
180-5	33452-33460	balanced	_	
180-6	33461-33464	sex	_	
180-7	33465-33477	distribution	_	
180-8	33478-33483	would	_	
180-9	33484-33486	be	_	
180-10	33487-33493	better	_	
180-11	33494-33500	suited	_	
180-12	33501-33503	to	_	
180-13	33504-33511	examine	_	
180-14	33512-33521	potential	_	
180-15	33522-33525	sex	_	
180-16	33526-33537	differences	_	
180-17	33538-33540	on	_	
180-18	33541-33557	interhemispheric	_	
180-19	33558-33570	connectivity	_	
180-20	33571-33574	and	_	
180-21	33575-33586	hemispheric	_	
180-22	33587-33601	specialization	_	
180-23	33602-33604	in	_	
180-24	33605-33618	schizophrenia	_	
180-25	33618-33619	.	_	

#Text=Third, we did not find a significant correlation between regional interhemispheric disconnectivity and symptom severity in patients as some previous studies have reported.
181-1	33620-33625	Third	_	
181-2	33625-33626	,	_	
181-3	33627-33629	we	_	
181-4	33630-33633	did	_	
181-5	33634-33637	not	_	
181-6	33638-33642	find	_	
181-7	33643-33644	a	_	
181-8	33645-33656	significant	_	
181-9	33657-33668	correlation	_	
181-10	33669-33676	between	_	
181-11	33677-33685	regional	_	
181-12	33686-33702	interhemispheric	_	
181-13	33703-33718	disconnectivity	_	
181-14	33719-33722	and	_	
181-15	33723-33730	symptom	_	
181-16	33731-33739	severity	_	
181-17	33740-33742	in	_	
181-18	33743-33751	patients	_	
181-19	33752-33754	as	_	
181-20	33755-33759	some	_	
181-21	33760-33768	previous	_	
181-22	33769-33776	studies	_	
181-23	33777-33781	have	_	
181-24	33782-33790	reported	_	
181-25	33790-33791	.	_	

#Text=A possible reason for the lack of association may be that the patients recruited in this study were relatively stable at the time of participation (PANSS total scores 48.38 ± 14.89, see Table 1).
182-1	33792-33793	A	_	
182-2	33794-33802	possible	_	
182-3	33803-33809	reason	_	
182-4	33810-33813	for	_	
182-5	33814-33817	the	_	
182-6	33818-33822	lack	_	
182-7	33823-33825	of	_	
182-8	33826-33837	association	_	
182-9	33838-33841	may	_	
182-10	33842-33844	be	_	
182-11	33845-33849	that	_	
182-12	33850-33853	the	_	
182-13	33854-33862	patients	_	
182-14	33863-33872	recruited	_	
182-15	33873-33875	in	_	
182-16	33876-33880	this	_	
182-17	33881-33886	study	_	
182-18	33887-33891	were	_	
182-19	33892-33902	relatively	_	
182-20	33903-33909	stable	_	
182-21	33910-33912	at	_	
182-22	33913-33916	the	_	
182-23	33917-33921	time	_	
182-24	33922-33924	of	_	
182-25	33925-33938	participation	_	
182-26	33939-33940	(	_	
182-27	33940-33945	PANSS	_	
182-28	33946-33951	total	_	
182-29	33952-33958	scores	_	
182-30	33959-33964	48.38	_	
182-31	33964-33965	 	_	
182-32	33965-33966	±	_	
182-33	33966-33967	 	_	
182-34	33967-33972	14.89	_	
182-35	33972-33973	,	_	
182-36	33974-33977	see	_	
182-37	33978-33983	Table	_	
182-38	33984-33985	1	_	
182-39	33985-33986	)	_	
182-40	33986-33987	.	_	

#Text=Therefore, we cannot rule out the possibility that an association exists between disconnectivity and symptoms in patients with more pronounced clinical symptoms.
183-1	33988-33997	Therefore	_	
183-2	33997-33998	,	_	
183-3	33999-34001	we	_	
183-4	34002-34008	cannot	_	
183-5	34009-34013	rule	_	
183-6	34014-34017	out	_	
183-7	34018-34021	the	_	
183-8	34022-34033	possibility	_	
183-9	34034-34038	that	_	
183-10	34039-34041	an	_	
183-11	34042-34053	association	_	
183-12	34054-34060	exists	_	
183-13	34061-34068	between	_	
183-14	34069-34084	disconnectivity	_	
183-15	34085-34088	and	_	
183-16	34089-34097	symptoms	_	
183-17	34098-34100	in	_	
183-18	34101-34109	patients	_	
183-19	34110-34114	with	_	
183-20	34115-34119	more	_	
183-21	34120-34130	pronounced	_	
183-22	34131-34139	clinical	_	
183-23	34140-34148	symptoms	_	
183-24	34148-34149	.	_	

#Text=Conclusion
#Text=This study explored interhemispheric connectivity and hemispheric specialization in a large cohort of schizophrenia patients, their unaffected siblings and healthy controls.
184-1	34150-34160	Conclusion	_	
184-2	34161-34165	This	_	
184-3	34166-34171	study	_	
184-4	34172-34180	explored	_	
184-5	34181-34197	interhemispheric	_	
184-6	34198-34210	connectivity	_	
184-7	34211-34214	and	_	
184-8	34215-34226	hemispheric	_	
184-9	34227-34241	specialization	_	
184-10	34242-34244	in	_	
184-11	34245-34246	a	_	
184-12	34247-34252	large	_	
184-13	34253-34259	cohort	_	
184-14	34260-34262	of	_	
184-15	34263-34276	schizophrenia	_	
184-16	34277-34285	patients	_	
184-17	34285-34286	,	_	
184-18	34287-34292	their	_	
184-19	34293-34303	unaffected	_	
184-20	34304-34312	siblings	_	
184-21	34313-34316	and	_	
184-22	34317-34324	healthy	_	
184-23	34325-34333	controls	_	
184-24	34333-34334	.	_	

#Text=Our results indicate that patients exhibit decreased interhemispheric connectivity as compared to both healthy controls and unaffected siblings, and these impairments were found to correlate with increases in the level of hemispheric specialization.
185-1	34335-34338	Our	_	
185-2	34339-34346	results	_	
185-3	34347-34355	indicate	_	
185-4	34356-34360	that	_	
185-5	34361-34369	patients	_	
185-6	34370-34377	exhibit	_	
185-7	34378-34387	decreased	_	
185-8	34388-34404	interhemispheric	_	
185-9	34405-34417	connectivity	_	
185-10	34418-34420	as	_	
185-11	34421-34429	compared	_	
185-12	34430-34432	to	_	
185-13	34433-34437	both	_	
185-14	34438-34445	healthy	_	
185-15	34446-34454	controls	_	
185-16	34455-34458	and	_	
185-17	34459-34469	unaffected	_	
185-18	34470-34478	siblings	_	
185-19	34478-34479	,	_	
185-20	34480-34483	and	_	
185-21	34484-34489	these	_	
185-22	34490-34501	impairments	_	
185-23	34502-34506	were	_	
185-24	34507-34512	found	_	
185-25	34513-34515	to	_	
185-26	34516-34525	correlate	_	
185-27	34526-34530	with	_	
185-28	34531-34540	increases	_	
185-29	34541-34543	in	_	
185-30	34544-34547	the	_	
185-31	34548-34553	level	_	
185-32	34554-34556	of	_	
185-33	34557-34568	hemispheric	_	
185-34	34569-34583	specialization	_	
185-35	34583-34584	.	_	

#Text=These connectivity alterations appear to be primarily related to illness manifestation, as siblings did not show significant changes compared to controls, and connectivity changes in patients correlated with duration of illness.
186-1	34585-34590	These	_	
186-2	34591-34603	connectivity	_	
186-3	34604-34615	alterations	_	
186-4	34616-34622	appear	_	
186-5	34623-34625	to	_	
186-6	34626-34628	be	_	
186-7	34629-34638	primarily	_	
186-8	34639-34646	related	_	
186-9	34647-34649	to	_	
186-10	34650-34657	illness	_	
186-11	34658-34671	manifestation	_	
186-12	34671-34672	,	_	
186-13	34673-34675	as	_	
186-14	34676-34684	siblings	_	
186-15	34685-34688	did	_	
186-16	34689-34692	not	_	
186-17	34693-34697	show	_	
186-18	34698-34709	significant	_	
186-19	34710-34717	changes	_	
186-20	34718-34726	compared	_	
186-21	34727-34729	to	_	
186-22	34730-34738	controls	_	
186-23	34738-34739	,	_	
186-24	34740-34743	and	_	
186-25	34744-34756	connectivity	_	
186-26	34757-34764	changes	_	
186-27	34765-34767	in	_	
186-28	34768-34776	patients	_	
186-29	34777-34787	correlated	_	
186-30	34788-34792	with	_	
186-31	34793-34801	duration	_	
186-32	34802-34804	of	_	
186-33	34805-34812	illness	_	
186-34	34812-34813	.	_	

#Text=In summary, the current study suggests that decreased interhemispheric connectivity and associated abnormalities in hemispheric specialization are features of established schizophrenia rather than an expression of preexistent risk for the disorder.
187-1	34814-34816	In	_	
187-2	34817-34824	summary	_	
187-3	34824-34825	,	_	
187-4	34826-34829	the	_	
187-5	34830-34837	current	_	
187-6	34838-34843	study	_	
187-7	34844-34852	suggests	_	
187-8	34853-34857	that	_	
187-9	34858-34867	decreased	_	
187-10	34868-34884	interhemispheric	_	
187-11	34885-34897	connectivity	_	
187-12	34898-34901	and	_	
187-13	34902-34912	associated	_	
187-14	34913-34926	abnormalities	_	
187-15	34927-34929	in	_	
187-16	34930-34941	hemispheric	_	
187-17	34942-34956	specialization	_	
187-18	34957-34960	are	_	
187-19	34961-34969	features	_	
187-20	34970-34972	of	_	
187-21	34973-34984	established	_	
187-22	34985-34998	schizophrenia	_	
187-23	34999-35005	rather	_	
187-24	35006-35010	than	_	
187-25	35011-35013	an	_	
187-26	35014-35024	expression	_	
187-27	35025-35027	of	_	
187-28	35028-35039	preexistent	_	
187-29	35040-35044	risk	_	
187-30	35045-35048	for	_	
187-31	35049-35052	the	_	
187-32	35053-35061	disorder	_	
187-33	35061-35062	.	_	

#Text=The following are the supplementary data related to this article.
188-1	35063-35066	The	_	
188-2	35067-35076	following	_	
188-3	35077-35080	are	_	
188-4	35081-35084	the	_	
188-5	35085-35098	supplementary	_	
188-6	35099-35103	data	_	
188-7	35104-35111	related	_	
188-8	35112-35114	to	_	
188-9	35115-35119	this	_	
188-10	35120-35127	article	_	
188-11	35127-35128	.	_	

#Text=Funding statement
#Text=The infrastructure for the GROUP study is funded through the Geestkracht programme of the  (Zon-Mw, grant number 10-000-1001), and matching funds from participating pharmaceutical companies (, , , ) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the  and the mental health institutions: , , , , , .
189-1	35129-35136	Funding	_	
189-2	35137-35146	statement	_	
189-3	35147-35150	The	_	
189-4	35151-35165	infrastructure	_	
189-5	35166-35169	for	_	
189-6	35170-35173	the	_	
189-7	35174-35179	GROUP	_	
189-8	35180-35185	study	_	
189-9	35186-35188	is	_	
189-10	35189-35195	funded	_	
189-11	35196-35203	through	_	
189-12	35204-35207	the	_	
189-13	35208-35219	Geestkracht	_	
189-14	35220-35229	programme	_	
189-15	35230-35232	of	_	
189-16	35233-35236	the	_	
189-17	35238-35239	(	_	
189-18	35239-35245	Zon-Mw	_	
189-19	35245-35246	,	_	
189-20	35247-35252	grant	_	
189-21	35253-35259	number	_	
189-22	35260-35262	10	_	
189-23	35262-35263	-	_	
189-24	35263-35266	000	_	
189-25	35266-35267	-	_	
189-26	35267-35271	1001	_	
189-27	35271-35272	)	_	
189-28	35272-35273	,	_	
189-29	35274-35277	and	_	
189-30	35278-35286	matching	_	
189-31	35287-35292	funds	_	
189-32	35293-35297	from	_	
189-33	35298-35311	participating	_	
189-34	35312-35326	pharmaceutical	_	
189-35	35327-35336	companies	_	
189-36	35337-35338	(	_	
189-37	35338-35339	,	_	
189-38	35340-35341	,	_	
189-39	35342-35343	,	_	
189-40	35344-35345	)	_	
189-41	35346-35349	and	_	
189-42	35350-35362	universities	_	
189-43	35363-35366	and	_	
189-44	35367-35373	mental	_	
189-45	35374-35380	health	_	
189-46	35381-35385	care	_	
189-47	35386-35399	organizations	_	
189-48	35400-35401	(	_	
189-49	35401-35410	Amsterdam	_	
189-50	35410-35411	:	_	
189-51	35412-35420	Academic	_	
189-52	35421-35432	Psychiatric	_	
189-53	35433-35439	Centre	_	
189-54	35440-35442	of	_	
189-55	35443-35446	the	_	
189-56	35448-35451	and	_	
189-57	35452-35455	the	_	
189-58	35456-35462	mental	_	
189-59	35463-35469	health	_	
189-60	35470-35482	institutions	_	
189-61	35482-35483	:	_	
189-62	35484-35485	,	_	
189-63	35486-35487	,	_	
189-64	35488-35489	,	_	
189-65	35490-35491	,	_	
189-66	35492-35493	,	_	
189-67	35494-35495	.	_	

#Text=Groningen:  Groningen and the mental health institutions: , , , , , ,  and  The Hague.
190-1	35496-35505	Groningen	_	
190-2	35505-35506	:	_	
190-3	35508-35517	Groningen	_	
190-4	35518-35521	and	_	
190-5	35522-35525	the	_	
190-6	35526-35532	mental	_	
190-7	35533-35539	health	_	
190-8	35540-35552	institutions	_	
190-9	35552-35553	:	_	
190-10	35554-35555	,	_	
190-11	35556-35557	,	_	
190-12	35558-35559	,	_	
190-13	35560-35561	,	_	
190-14	35562-35563	,	_	
190-15	35564-35565	,	_	
190-16	35567-35570	and	_	
190-17	35572-35575	The	_	
190-18	35576-35581	Hague	_	
190-19	35581-35582	.	_	

#Text=Maastricht:  and the mental health institutions: , , , , , , , , , , , , .
191-1	35583-35593	Maastricht	_	
191-2	35593-35594	:	_	
191-3	35596-35599	and	_	
191-4	35600-35603	the	_	
191-5	35604-35610	mental	_	
191-6	35611-35617	health	_	
191-7	35618-35630	institutions	_	
191-8	35630-35631	:	_	
191-9	35632-35633	,	_	
191-10	35634-35635	,	_	
191-11	35636-35637	,	_	
191-12	35638-35639	,	_	
191-13	35640-35641	,	_	
191-14	35642-35643	,	_	
191-15	35644-35645	,	_	
191-16	35646-35647	,	_	
191-17	35648-35649	,	_	
191-18	35650-35651	,	_	
191-19	35652-35653	,	_	
191-20	35654-35655	,	_	
191-21	35656-35657	.	_	

#Text=Utrecht:  and the mental health institutions , ).
192-1	35658-35665	Utrecht	_	
192-2	35665-35666	:	_	
192-3	35668-35671	and	_	
192-4	35672-35675	the	_	
192-5	35676-35682	mental	_	
192-6	35683-35689	health	_	
192-7	35690-35702	institutions	_	
192-8	35703-35704	,	_	
192-9	35705-35706	)	_	
192-10	35706-35707	.	_	

#Text=Conflict of interest
#Text=All authors declare no conflict of interest.
193-1	35708-35716	Conflict	_	
193-2	35717-35719	of	_	
193-3	35720-35728	interest	_	
193-4	35729-35732	All	_	
193-5	35733-35740	authors	_	
193-6	35741-35748	declare	_	
193-7	35749-35751	no	_	
193-8	35752-35760	conflict	_	
193-9	35761-35763	of	_	
193-10	35764-35772	interest	_	
193-11	35772-35773	.	_	

#Text=References
#Text=Decreased interhemispheric functional connectivity in autism
#Text=The comprehensive assessment of symptoms and history (CASH).
194-1	35774-35784	References	_	
194-2	35785-35794	Decreased	_	
194-3	35795-35811	interhemispheric	_	
194-4	35812-35822	functional	_	
194-5	35823-35835	connectivity	_	
194-6	35836-35838	in	_	
194-7	35839-35845	autism	_	
194-8	35846-35849	The	_	
194-9	35850-35863	comprehensive	_	
194-10	35864-35874	assessment	_	
194-11	35875-35877	of	_	
194-12	35878-35886	symptoms	_	
194-13	35887-35890	and	_	
194-14	35891-35898	history	_	
194-15	35899-35900	(	_	
194-16	35900-35904	CASH	_	
194-17	35904-35905	)	_	
194-18	35905-35906	.	_	

#Text=An instrument for assessing diagnosis and psychopathology
#Text=Lack of asymmetrical transfer for linguistic stimuli in schizophrenia: an ERP study
#Text=Planum temporale asymmetry reversal in schizophrenia: replication and relationship to gray matter abnormalities
#Text=Hierarchical organization of human cortical networks in health and schizophrenia
#Text=Absence of regional hemispheric volume asymmetries in first-episode schizophrenia
#Text=Reduced language lateralization in first-episode schizophrenia: an fMRI index of functional asymmetry
#Text=Diminished language lateralization in schizophrenia corresponds to impaired inter-hemispheric functional connectivity
#Text=Focal and global brain measurements in siblings of patients with schizophrenia
#Text=Complementary hemispheric specialization for language production and visuospatial attention
#Text=Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia
#Text=Distinct inter-hemispheric dysconnectivity in schizophrenia patients with and without auditory verbal hallucinations
#Text=Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings
#Text=Schizophrenia as a transcallosal misconnection syndrome
#Text=Reduced interhemispheric transmission in schizophrenia patients: evidence from event-related potentials
#Text=Principles of human brain organization derived from split-brain studies
#Text=Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability
#Text=Two distinct forms of functional lateralization in the human brain
#Text=Hemispheric asymmetry and homotopy of resting state functional connectivity correlate with visuospatial abilities in school-age children
#Text=Brain-wide functional inter-hemispheric disconnection is a potential biomarker for schizophrenia and distinguishes it from depression
#Text=Decreased resting-state interhemispheric functional connectivity in unaffected siblings of schizophrenia patients
#Text=Comparison of characteristics between region-and voxel-based network analyses in resting-state fMRI data
#Text=Revisiting human hemispheric specialization with neuroimaging
#Text=Decreased interhemispheric coordination in schizophrenia: a resting state fMRI study
#Text=Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity
#Text=Schizophrenia, neurodevelopment and corpus callosum
#Text=Brain hemispheric structural efficiency and interconnectivity rightward asymmetry in human and nonhuman primates
#Text=AICHA: an atlas of intrinsic connectivity of homotopic areas
#Text=The positive and negative Syndrome Scale (PANSS) for Schizophrenia
#Text=Bilateral functional asymmetry disparity in positive and negative schizophrenia revealed by resting-state fMRI
#Text=Interhemispheric hypoconnectivity in schizophrenia: fiber integrity and volume differences of the corpus callosum in patients and unaffected relatives
#Text=Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: Objectives, sample characteristics, recruitment and assessment methods
#Text=Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study
#Text=Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study
#Text=Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum
#Text=Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography
#Text=Homotopic connectivity in drug-naïve, first-episode, early-onset schizophrenia
#Text=A.
195-1	35907-35909	An	_	
195-2	35910-35920	instrument	_	
195-3	35921-35924	for	_	
195-4	35925-35934	assessing	_	
195-5	35935-35944	diagnosis	_	
195-6	35945-35948	and	_	
195-7	35949-35964	psychopathology	_	
195-8	35965-35969	Lack	_	
195-9	35970-35972	of	_	
195-10	35973-35985	asymmetrical	_	
195-11	35986-35994	transfer	_	
195-12	35995-35998	for	_	
195-13	35999-36009	linguistic	_	
195-14	36010-36017	stimuli	_	
195-15	36018-36020	in	_	
195-16	36021-36034	schizophrenia	_	
195-17	36034-36035	:	_	
195-18	36036-36038	an	_	
195-19	36039-36042	ERP	_	
195-20	36043-36048	study	_	
195-21	36049-36055	Planum	_	
195-22	36056-36065	temporale	_	
195-23	36066-36075	asymmetry	_	
195-24	36076-36084	reversal	_	
195-25	36085-36087	in	_	
195-26	36088-36101	schizophrenia	_	
195-27	36101-36102	:	_	
195-28	36103-36114	replication	_	
195-29	36115-36118	and	_	
195-30	36119-36131	relationship	_	
195-31	36132-36134	to	_	
195-32	36135-36139	gray	_	
195-33	36140-36146	matter	_	
195-34	36147-36160	abnormalities	_	
195-35	36161-36173	Hierarchical	_	
195-36	36174-36186	organization	_	
195-37	36187-36189	of	_	
195-38	36190-36195	human	_	
195-39	36196-36204	cortical	_	
195-40	36205-36213	networks	_	
195-41	36214-36216	in	_	
195-42	36217-36223	health	_	
195-43	36224-36227	and	_	
195-44	36228-36241	schizophrenia	_	
195-45	36242-36249	Absence	_	
195-46	36250-36252	of	_	
195-47	36253-36261	regional	_	
195-48	36262-36273	hemispheric	_	
195-49	36274-36280	volume	_	
195-50	36281-36292	asymmetries	_	
195-51	36293-36295	in	_	
195-52	36296-36309	first-episode	_	
195-53	36310-36323	schizophrenia	_	
195-54	36324-36331	Reduced	_	
195-55	36332-36340	language	_	
195-56	36341-36355	lateralization	_	
195-57	36356-36358	in	_	
195-58	36359-36372	first-episode	_	
195-59	36373-36386	schizophrenia	_	
195-60	36386-36387	:	_	
195-61	36388-36390	an	_	
195-62	36391-36395	fMRI	_	
195-63	36396-36401	index	_	
195-64	36402-36404	of	_	
195-65	36405-36415	functional	_	
195-66	36416-36425	asymmetry	_	
195-67	36426-36436	Diminished	_	
195-68	36437-36445	language	_	
195-69	36446-36460	lateralization	_	
195-70	36461-36463	in	_	
195-71	36464-36477	schizophrenia	_	
195-72	36478-36489	corresponds	_	
195-73	36490-36492	to	_	
195-74	36493-36501	impaired	_	
195-75	36502-36519	inter-hemispheric	_	
195-76	36520-36530	functional	_	
195-77	36531-36543	connectivity	_	
195-78	36544-36549	Focal	_	
195-79	36550-36553	and	_	
195-80	36554-36560	global	_	
195-81	36561-36566	brain	_	
195-82	36567-36579	measurements	_	
195-83	36580-36582	in	_	
195-84	36583-36591	siblings	_	
195-85	36592-36594	of	_	
195-86	36595-36603	patients	_	
195-87	36604-36608	with	_	
195-88	36609-36622	schizophrenia	_	
195-89	36623-36636	Complementary	_	
195-90	36637-36648	hemispheric	_	
195-91	36649-36663	specialization	_	
195-92	36664-36667	for	_	
195-93	36668-36676	language	_	
195-94	36677-36687	production	_	
195-95	36688-36691	and	_	
195-96	36692-36704	visuospatial	_	
195-97	36705-36714	attention	_	
195-98	36715-36721	Cortex	_	
195-99	36722-36729	mapping	_	
195-100	36730-36737	reveals	_	
195-101	36738-36748	regionally	_	
195-102	36749-36757	specific	_	
195-103	36758-36766	patterns	_	
195-104	36767-36769	of	_	
195-105	36770-36777	genetic	_	
195-106	36778-36781	and	_	
195-107	36782-36798	disease-specific	_	
195-108	36799-36810	gray-matter	_	
195-109	36811-36819	deficits	_	
195-110	36820-36822	in	_	
195-111	36823-36828	twins	_	
195-112	36829-36839	discordant	_	
195-113	36840-36843	for	_	
195-114	36844-36857	schizophrenia	_	
195-115	36858-36866	Distinct	_	
195-116	36867-36884	inter-hemispheric	_	
195-117	36885-36900	dysconnectivity	_	
195-118	36901-36903	in	_	
195-119	36904-36917	schizophrenia	_	
195-120	36918-36926	patients	_	
195-121	36927-36931	with	_	
195-122	36932-36935	and	_	
195-123	36936-36943	without	_	
195-124	36944-36952	auditory	_	
195-125	36953-36959	verbal	_	
195-126	36960-36974	hallucinations	_	
195-127	36975-36983	Impaired	_	
195-128	36984-36994	cerebellar	_	
195-129	36995-37005	functional	_	
195-130	37006-37018	connectivity	_	
195-131	37019-37021	in	_	
195-132	37022-37035	schizophrenia	_	
195-133	37036-37044	patients	_	
195-134	37045-37048	and	_	
195-135	37049-37054	their	_	
195-136	37055-37062	healthy	_	
195-137	37063-37071	siblings	_	
195-138	37072-37085	Schizophrenia	_	
195-139	37086-37088	as	_	
195-140	37089-37090	a	_	
195-141	37091-37104	transcallosal	_	
195-142	37105-37118	misconnection	_	
195-143	37119-37127	syndrome	_	
195-144	37128-37135	Reduced	_	
195-145	37136-37152	interhemispheric	_	
195-146	37153-37165	transmission	_	
195-147	37166-37168	in	_	
195-148	37169-37182	schizophrenia	_	
195-149	37183-37191	patients	_	
195-150	37191-37192	:	_	
195-151	37193-37201	evidence	_	
195-152	37202-37206	from	_	
195-153	37207-37220	event-related	_	
195-154	37221-37231	potentials	_	
195-155	37232-37242	Principles	_	
195-156	37243-37245	of	_	
195-157	37246-37251	human	_	
195-158	37252-37257	brain	_	
195-159	37258-37270	organization	_	
195-160	37271-37278	derived	_	
195-161	37279-37283	from	_	
195-162	37284-37295	split-brain	_	
195-163	37296-37303	studies	_	
195-164	37304-37316	Hypothalamic	_	
195-165	37317-37330	abnormalities	_	
195-166	37331-37333	in	_	
195-167	37334-37347	schizophrenia	_	
195-168	37347-37348	:	_	
195-169	37349-37352	sex	_	
195-170	37353-37360	effects	_	
195-171	37361-37364	and	_	
195-172	37365-37372	genetic	_	
195-173	37373-37386	vulnerability	_	
195-174	37387-37390	Two	_	
195-175	37391-37399	distinct	_	
195-176	37400-37405	forms	_	
195-177	37406-37408	of	_	
195-178	37409-37419	functional	_	
195-179	37420-37434	lateralization	_	
195-180	37435-37437	in	_	
195-181	37438-37441	the	_	
195-182	37442-37447	human	_	
195-183	37448-37453	brain	_	
195-184	37454-37465	Hemispheric	_	
195-185	37466-37475	asymmetry	_	
195-186	37476-37479	and	_	
195-187	37480-37488	homotopy	_	
195-188	37489-37491	of	_	
195-189	37492-37499	resting	_	
195-190	37500-37505	state	_	
195-191	37506-37516	functional	_	
195-192	37517-37529	connectivity	_	
195-193	37530-37539	correlate	_	
195-194	37540-37544	with	_	
195-195	37545-37557	visuospatial	_	
195-196	37558-37567	abilities	_	
195-197	37568-37570	in	_	
195-198	37571-37581	school-age	_	
195-199	37582-37590	children	_	
195-200	37591-37601	Brain-wide	_	
195-201	37602-37612	functional	_	
195-202	37613-37630	inter-hemispheric	_	
195-203	37631-37644	disconnection	_	
195-204	37645-37647	is	_	
195-205	37648-37649	a	_	
195-206	37650-37659	potential	_	
195-207	37660-37669	biomarker	_	
195-208	37670-37673	for	_	
195-209	37674-37687	schizophrenia	_	
195-210	37688-37691	and	_	
195-211	37692-37705	distinguishes	_	
195-212	37706-37708	it	_	
195-213	37709-37713	from	_	
195-214	37714-37724	depression	_	
195-215	37725-37734	Decreased	_	
195-216	37735-37748	resting-state	_	
195-217	37749-37765	interhemispheric	_	
195-218	37766-37776	functional	_	
195-219	37777-37789	connectivity	_	
195-220	37790-37792	in	_	
195-221	37793-37803	unaffected	_	
195-222	37804-37812	siblings	_	
195-223	37813-37815	of	_	
195-224	37816-37829	schizophrenia	_	
195-225	37830-37838	patients	_	
195-226	37839-37849	Comparison	_	
195-227	37850-37852	of	_	
195-228	37853-37868	characteristics	_	
195-229	37869-37876	between	_	
195-230	37877-37887	region-and	_	
195-231	37888-37899	voxel-based	_	
195-232	37900-37907	network	_	
195-233	37908-37916	analyses	_	
195-234	37917-37919	in	_	
195-235	37920-37933	resting-state	_	
195-236	37934-37938	fMRI	_	
195-237	37939-37943	data	_	
195-238	37944-37954	Revisiting	_	
195-239	37955-37960	human	_	
195-240	37961-37972	hemispheric	_	
195-241	37973-37987	specialization	_	
195-242	37988-37992	with	_	
195-243	37993-38005	neuroimaging	_	
195-244	38006-38015	Decreased	_	
195-245	38016-38032	interhemispheric	_	
195-246	38033-38045	coordination	_	
195-247	38046-38048	in	_	
195-248	38049-38062	schizophrenia	_	
195-249	38062-38063	:	_	
195-250	38064-38065	a	_	
195-251	38066-38073	resting	_	
195-252	38074-38079	state	_	
195-253	38080-38084	fMRI	_	
195-254	38085-38090	study	_	
195-255	38091-38096	Focal	_	
195-256	38097-38102	white	_	
195-257	38103-38109	matter	_	
195-258	38110-38117	density	_	
195-259	38118-38125	changes	_	
195-260	38126-38128	in	_	
195-261	38129-38142	schizophrenia	_	
195-262	38142-38143	:	_	
195-263	38144-38151	reduced	_	
195-264	38152-38169	inter-hemispheric	_	
195-265	38170-38182	connectivity	_	
195-266	38183-38196	Schizophrenia	_	
195-267	38196-38197	,	_	
195-268	38198-38214	neurodevelopment	_	
195-269	38215-38218	and	_	
195-270	38219-38225	corpus	_	
195-271	38226-38234	callosum	_	
195-272	38235-38240	Brain	_	
195-273	38241-38252	hemispheric	_	
195-274	38253-38263	structural	_	
195-275	38264-38274	efficiency	_	
195-276	38275-38278	and	_	
195-277	38279-38296	interconnectivity	_	
195-278	38297-38306	rightward	_	
195-279	38307-38316	asymmetry	_	
195-280	38317-38319	in	_	
195-281	38320-38325	human	_	
195-282	38326-38329	and	_	
195-283	38330-38338	nonhuman	_	
195-284	38339-38347	primates	_	
195-285	38348-38353	AICHA	_	
195-286	38353-38354	:	_	
195-287	38355-38357	an	_	
195-288	38358-38363	atlas	_	
195-289	38364-38366	of	_	
195-290	38367-38376	intrinsic	_	
195-291	38377-38389	connectivity	_	
195-292	38390-38392	of	_	
195-293	38393-38402	homotopic	_	
195-294	38403-38408	areas	_	
195-295	38409-38412	The	_	
195-296	38413-38421	positive	_	
195-297	38422-38425	and	_	
195-298	38426-38434	negative	_	
195-299	38435-38443	Syndrome	_	
195-300	38444-38449	Scale	_	
195-301	38450-38451	(	_	
195-302	38451-38456	PANSS	_	
195-303	38456-38457	)	_	
195-304	38458-38461	for	_	
195-305	38462-38475	Schizophrenia	_	
195-306	38476-38485	Bilateral	_	
195-307	38486-38496	functional	_	
195-308	38497-38506	asymmetry	_	
195-309	38507-38516	disparity	_	
195-310	38517-38519	in	_	
195-311	38520-38528	positive	_	
195-312	38529-38532	and	_	
195-313	38533-38541	negative	_	
195-314	38542-38555	schizophrenia	_	
195-315	38556-38564	revealed	_	
195-316	38565-38567	by	_	
195-317	38568-38581	resting-state	_	
195-318	38582-38586	fMRI	_	
195-319	38587-38603	Interhemispheric	_	
195-320	38604-38620	hypoconnectivity	_	
195-321	38621-38623	in	_	
195-322	38624-38637	schizophrenia	_	
195-323	38637-38638	:	_	
195-324	38639-38644	fiber	_	
195-325	38645-38654	integrity	_	
195-326	38655-38658	and	_	
195-327	38659-38665	volume	_	
195-328	38666-38677	differences	_	
195-329	38678-38680	of	_	
195-330	38681-38684	the	_	
195-331	38685-38691	corpus	_	
195-332	38692-38700	callosum	_	
195-333	38701-38703	in	_	
195-334	38704-38712	patients	_	
195-335	38713-38716	and	_	
195-336	38717-38727	unaffected	_	
195-337	38728-38737	relatives	_	
195-338	38738-38745	Genetic	_	
195-339	38746-38750	Risk	_	
195-340	38751-38754	and	_	
195-341	38755-38762	Outcome	_	
195-342	38763-38765	of	_	
195-343	38766-38775	Psychosis	_	
195-344	38776-38777	(	_	
195-345	38777-38782	GROUP	_	
195-346	38782-38783	)	_	
195-347	38783-38784	,	_	
195-348	38785-38786	a	_	
195-349	38787-38792	multi	_	
195-350	38793-38797	site	_	
195-351	38798-38810	longitudinal	_	
195-352	38811-38817	cohort	_	
195-353	38818-38823	study	_	
195-354	38824-38831	focused	_	
195-355	38832-38834	on	_	
195-356	38835-38851	gene-environment	_	
195-357	38852-38863	interaction	_	
195-358	38863-38864	:	_	
195-359	38865-38875	Objectives	_	
195-360	38875-38876	,	_	
195-361	38877-38883	sample	_	
195-362	38884-38899	characteristics	_	
195-363	38899-38900	,	_	
195-364	38901-38912	recruitment	_	
195-365	38913-38916	and	_	
195-366	38917-38927	assessment	_	
195-367	38928-38935	methods	_	
195-368	38936-38945	Treatment	_	
195-369	38946-38948	of	_	
195-370	38949-38962	schizophrenia	_	
195-371	38963-38967	with	_	
195-372	38968-38982	antipsychotics	_	
195-373	38983-38985	in	_	
195-374	38986-38995	Norwegian	_	
195-375	38996-39005	emergency	_	
195-376	39006-39011	wards	_	
195-377	39011-39012	,	_	
195-378	39013-39014	a	_	
195-379	39015-39030	cross-sectional	_	
195-380	39031-39039	national	_	
195-381	39040-39045	study	_	
195-382	39046-39054	Uncinate	_	
195-383	39055-39065	fasciculus	_	
195-384	39066-39074	findings	_	
195-385	39075-39077	in	_	
195-386	39078-39091	schizophrenia	_	
195-387	39091-39092	:	_	
195-388	39093-39094	a	_	
195-389	39095-39103	magnetic	_	
195-390	39104-39113	resonance	_	
195-391	39114-39123	diffusion	_	
195-392	39124-39130	tensor	_	
195-393	39131-39138	imaging	_	
195-394	39139-39144	study	_	
195-395	39145-39152	Reduced	_	
195-396	39153-39169	interhemispheric	_	
195-397	39170-39182	connectivity	_	
195-398	39183-39185	in	_	
195-399	39186-39212	schizophrenia-tractography	_	
195-400	39213-39218	based	_	
195-401	39219-39231	segmentation	_	
195-402	39232-39234	of	_	
195-403	39235-39238	the	_	
195-404	39239-39245	corpus	_	
195-405	39246-39254	callosum	_	
195-406	39255-39263	Striatal	_	
195-407	39264-39272	dopamine	_	
195-408	39273-39284	transporter	_	
195-409	39285-39292	binding	_	
195-410	39293-39295	in	_	
195-411	39296-39313	neuroleptic-naive	_	
195-412	39314-39322	patients	_	
195-413	39323-39327	with	_	
195-414	39328-39341	schizophrenia	_	
195-415	39342-39349	studied	_	
195-416	39350-39354	with	_	
195-417	39355-39363	positron	_	
195-418	39364-39372	emission	_	
195-419	39373-39383	tomography	_	
195-420	39384-39393	Homotopic	_	
195-421	39394-39406	connectivity	_	
195-422	39407-39409	in	_	
195-423	39410-39420	drug-naïve	_	
195-424	39420-39421	,	_	
195-425	39422-39435	first-episode	_	
195-426	39435-39436	,	_	
195-427	39437-39448	early-onset	_	
195-428	39449-39462	schizophrenia	_	
195-429	39463-39464	A	_	
195-430	39464-39465	.	_	

#Text=Functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO)
#Text=Evidence from intrinsic activity that asymmetry of the human brain is controlled by multiple factors
#Text=Decreased resting-state interhemispheric functional connectivity correlated with neurocognitive deficits in drug-naive first-episode adolescent-onset schizophrenia
#Text=Impaired hemispheric communication in schizophrenia: a study using the consonant–vowel–consonant task
#Text=Imaging genetic liability to schizophrenia: systematic review of fMRI studies of patients' nonpsychotic relatives
#Text=Decreased volume of left and total anterior insular lobule in schizophrenia
#Text=
#Text=From sensation to cognition
#Text=Abnormal asymmetry of white matter integrity in schizophrenia revealed by voxelwise diffusion tensor imaging
#Text=Interhemispheric cooperation during word processing: evidence for callosal transfer dysfunction in schizophrenic patients
#Text=Hemispheric cooperation-a crucial factor in schizophrenia?
196-1	39466-39476	Functional	_	
196-2	39477-39480	MRI	_	
196-3	39481-39490	technique	_	
196-4	39491-39500	combining	_	
196-5	39501-39511	principles	_	
196-6	39512-39514	of	_	
196-7	39515-39528	echo-shifting	_	
196-8	39529-39533	with	_	
196-9	39534-39535	a	_	
196-10	39536-39541	train	_	
196-11	39542-39544	of	_	
196-12	39545-39557	observations	_	
196-13	39558-39559	(	_	
196-14	39559-39565	PRESTO	_	
196-15	39565-39566	)	_	
196-16	39567-39575	Evidence	_	
196-17	39576-39580	from	_	
196-18	39581-39590	intrinsic	_	
196-19	39591-39599	activity	_	
196-20	39600-39604	that	_	
196-21	39605-39614	asymmetry	_	
196-22	39615-39617	of	_	
196-23	39618-39621	the	_	
196-24	39622-39627	human	_	
196-25	39628-39633	brain	_	
196-26	39634-39636	is	_	
196-27	39637-39647	controlled	_	
196-28	39648-39650	by	_	
196-29	39651-39659	multiple	_	
196-30	39660-39667	factors	_	
196-31	39668-39677	Decreased	_	
196-32	39678-39691	resting-state	_	
196-33	39692-39708	interhemispheric	_	
196-34	39709-39719	functional	_	
196-35	39720-39732	connectivity	_	
196-36	39733-39743	correlated	_	
196-37	39744-39748	with	_	
196-38	39749-39763	neurocognitive	_	
196-39	39764-39772	deficits	_	
196-40	39773-39775	in	_	
196-41	39776-39786	drug-naive	_	
196-42	39787-39800	first-episode	_	
196-43	39801-39817	adolescent-onset	_	
196-44	39818-39831	schizophrenia	_	
196-45	39832-39840	Impaired	_	
196-46	39841-39852	hemispheric	_	
196-47	39853-39866	communication	_	
196-48	39867-39869	in	_	
196-49	39870-39883	schizophrenia	_	
196-50	39883-39884	:	_	
196-51	39885-39886	a	_	
196-52	39887-39892	study	_	
196-53	39893-39898	using	_	
196-54	39899-39902	the	_	
196-55	39903-39928	consonant–vowel–consonant	_	
196-56	39929-39933	task	_	
196-57	39934-39941	Imaging	_	
196-58	39942-39949	genetic	_	
196-59	39950-39959	liability	_	
196-60	39960-39962	to	_	
196-61	39963-39976	schizophrenia	_	
196-62	39976-39977	:	_	
196-63	39978-39988	systematic	_	
196-64	39989-39995	review	_	
196-65	39996-39998	of	_	
196-66	39999-40003	fMRI	_	
196-67	40004-40011	studies	_	
196-68	40012-40014	of	_	
196-69	40015-40023	patients	_	
196-70	40023-40024	'	_	
196-71	40025-40037	nonpsychotic	_	
196-72	40038-40047	relatives	_	
196-73	40048-40057	Decreased	_	
196-74	40058-40064	volume	_	
196-75	40065-40067	of	_	
196-76	40068-40072	left	_	
196-77	40073-40076	and	_	
196-78	40077-40082	total	_	
196-79	40083-40091	anterior	_	
196-80	40092-40099	insular	_	
196-81	40100-40106	lobule	_	
196-82	40107-40109	in	_	
196-83	40110-40123	schizophrenia	_	
196-84	40125-40129	From	_	
196-85	40130-40139	sensation	_	
196-86	40140-40142	to	_	
196-87	40143-40152	cognition	_	
196-88	40153-40161	Abnormal	_	
196-89	40162-40171	asymmetry	_	
196-90	40172-40174	of	_	
196-91	40175-40180	white	_	
196-92	40181-40187	matter	_	
196-93	40188-40197	integrity	_	
196-94	40198-40200	in	_	
196-95	40201-40214	schizophrenia	_	
196-96	40215-40223	revealed	_	
196-97	40224-40226	by	_	
196-98	40227-40236	voxelwise	_	
196-99	40237-40246	diffusion	_	
196-100	40247-40253	tensor	_	
196-101	40254-40261	imaging	_	
196-102	40262-40278	Interhemispheric	_	
196-103	40279-40290	cooperation	_	
196-104	40291-40297	during	_	
196-105	40298-40302	word	_	
196-106	40303-40313	processing	_	
196-107	40313-40314	:	_	
196-108	40315-40323	evidence	_	
196-109	40324-40327	for	_	
196-110	40328-40336	callosal	_	
196-111	40337-40345	transfer	_	
196-112	40346-40357	dysfunction	_	
196-113	40358-40360	in	_	
196-114	40361-40374	schizophrenic	_	
196-115	40375-40383	patients	_	
196-116	40384-40395	Hemispheric	_	
196-117	40396-40409	cooperation-a	_	
196-118	40410-40417	crucial	_	
196-119	40418-40424	factor	_	
196-120	40425-40427	in	_	
196-121	40428-40441	schizophrenia	_	
196-122	40441-40442	?	_	

#Text=Neurophysiological evidence
#Text=A family affair: brain abnormalities in siblings of patients with schizophrenia
#Text=Abnormalities in hemispheric specialization of caudate nucleus connectivity in schizophrenia
#Text=Auditory hallucinations and reduced language lateralization in schizophrenia: a meta-analysis of dichotic listening studies
#Text=Reduced laterality as a trait marker of schizophrenia--evidence from structural and functional neuroimaging
#Text=Cerebral asymmetry in schizophrenia
#Text=Reduced functional connectivity and asymmetry of the planum temporale in patients with schizophrenia and first-degree relatives
#Text=Association between symptoms of psychosis and reduced functional connectivity of auditory cortex
#Text=Neuroimaging findings from childhood onset schizophrenia patients and their non-psychotic siblings
#Text=A meta-analysis of diffusion tensor imaging studies of the corpus callosum in schizophrenia
#Text=Schizophrenia: a disease of heteromodal association cortex?
197-1	40443-40461	Neurophysiological	_	
197-2	40462-40470	evidence	_	
197-3	40471-40472	A	_	
197-4	40473-40479	family	_	
197-5	40480-40486	affair	_	
197-6	40486-40487	:	_	
197-7	40488-40493	brain	_	
197-8	40494-40507	abnormalities	_	
197-9	40508-40510	in	_	
197-10	40511-40519	siblings	_	
197-11	40520-40522	of	_	
197-12	40523-40531	patients	_	
197-13	40532-40536	with	_	
197-14	40537-40550	schizophrenia	_	
197-15	40551-40564	Abnormalities	_	
197-16	40565-40567	in	_	
197-17	40568-40579	hemispheric	_	
197-18	40580-40594	specialization	_	
197-19	40595-40597	of	_	
197-20	40598-40605	caudate	_	
197-21	40606-40613	nucleus	_	
197-22	40614-40626	connectivity	_	
197-23	40627-40629	in	_	
197-24	40630-40643	schizophrenia	_	
197-25	40644-40652	Auditory	_	
197-26	40653-40667	hallucinations	_	
197-27	40668-40671	and	_	
197-28	40672-40679	reduced	_	
197-29	40680-40688	language	_	
197-30	40689-40703	lateralization	_	
197-31	40704-40706	in	_	
197-32	40707-40720	schizophrenia	_	
197-33	40720-40721	:	_	
197-34	40722-40723	a	_	
197-35	40724-40737	meta-analysis	_	
197-36	40738-40740	of	_	
197-37	40741-40749	dichotic	_	
197-38	40750-40759	listening	_	
197-39	40760-40767	studies	_	
197-40	40768-40775	Reduced	_	
197-41	40776-40786	laterality	_	
197-42	40787-40789	as	_	
197-43	40790-40791	a	_	
197-44	40792-40797	trait	_	
197-45	40798-40804	marker	_	
197-46	40805-40807	of	_	
197-47	40808-40821	schizophrenia	_	
197-48	40821-40822	-	_	
197-49	40822-40823	-	_	
197-50	40823-40831	evidence	_	
197-51	40832-40836	from	_	
197-52	40837-40847	structural	_	
197-53	40848-40851	and	_	
197-54	40852-40862	functional	_	
197-55	40863-40875	neuroimaging	_	
197-56	40876-40884	Cerebral	_	
197-57	40885-40894	asymmetry	_	
197-58	40895-40897	in	_	
197-59	40898-40911	schizophrenia	_	
197-60	40912-40919	Reduced	_	
197-61	40920-40930	functional	_	
197-62	40931-40943	connectivity	_	
197-63	40944-40947	and	_	
197-64	40948-40957	asymmetry	_	
197-65	40958-40960	of	_	
197-66	40961-40964	the	_	
197-67	40965-40971	planum	_	
197-68	40972-40981	temporale	_	
197-69	40982-40984	in	_	
197-70	40985-40993	patients	_	
197-71	40994-40998	with	_	
197-72	40999-41012	schizophrenia	_	
197-73	41013-41016	and	_	
197-74	41017-41029	first-degree	_	
197-75	41030-41039	relatives	_	
197-76	41040-41051	Association	_	
197-77	41052-41059	between	_	
197-78	41060-41068	symptoms	_	
197-79	41069-41071	of	_	
197-80	41072-41081	psychosis	_	
197-81	41082-41085	and	_	
197-82	41086-41093	reduced	_	
197-83	41094-41104	functional	_	
197-84	41105-41117	connectivity	_	
197-85	41118-41120	of	_	
197-86	41121-41129	auditory	_	
197-87	41130-41136	cortex	_	
197-88	41137-41149	Neuroimaging	_	
197-89	41150-41158	findings	_	
197-90	41159-41163	from	_	
197-91	41164-41173	childhood	_	
197-92	41174-41179	onset	_	
197-93	41180-41193	schizophrenia	_	
197-94	41194-41202	patients	_	
197-95	41203-41206	and	_	
197-96	41207-41212	their	_	
197-97	41213-41226	non-psychotic	_	
197-98	41227-41235	siblings	_	
197-99	41236-41237	A	_	
197-100	41238-41251	meta-analysis	_	
197-101	41252-41254	of	_	
197-102	41255-41264	diffusion	_	
197-103	41265-41271	tensor	_	
197-104	41272-41279	imaging	_	
197-105	41280-41287	studies	_	
197-106	41288-41290	of	_	
197-107	41291-41294	the	_	
197-108	41295-41301	corpus	_	
197-109	41302-41310	callosum	_	
197-110	41311-41313	in	_	
197-111	41314-41327	schizophrenia	_	
197-112	41328-41341	Schizophrenia	_	
197-113	41341-41342	:	_	
197-114	41343-41344	a	_	
197-115	41345-41352	disease	_	
197-116	41353-41355	of	_	
197-117	41356-41367	heteromodal	_	
197-118	41368-41379	association	_	
197-119	41380-41386	cortex	_	
197-120	41386-41387	?	_	

#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
#Text=Brain Network Connectivity in individuals with Schizophrenia and their Siblings
#Text=Abnormal brain lateralization and connectivity in Schizophrenia
#Text=Abnormal asymmetry of brain connectivity in schizophrenia
#Text=Resting-state functional network correlates of psychotic symptoms in schizophrenia
#Text=An improved framework for confound regression and filtering for control of motion artifact in the preprocessing of resting-state functional connectivity data
#Text=Dynamics of hemispheric specialization and integration in the context of motor control
#Text=Handedness, language lateralisation and anatomical asymmetry in schizophrenia
#Text=Language lateralization in monozygotic twins discordant and concordant for schizophrenia.
198-1	41388-41396	Spurious	_	
198-2	41397-41400	but	_	
198-3	41401-41411	systematic	_	
198-4	41412-41424	correlations	_	
198-5	41425-41427	in	_	
198-6	41428-41438	functional	_	
198-7	41439-41451	connectivity	_	
198-8	41452-41455	MRI	_	
198-9	41456-41464	networks	_	
198-10	41465-41470	arise	_	
198-11	41471-41475	from	_	
198-12	41476-41483	subject	_	
198-13	41484-41490	motion	_	
198-14	41491-41496	Brain	_	
198-15	41497-41504	Network	_	
198-16	41505-41517	Connectivity	_	
198-17	41518-41520	in	_	
198-18	41521-41532	individuals	_	
198-19	41533-41537	with	_	
198-20	41538-41551	Schizophrenia	_	
198-21	41552-41555	and	_	
198-22	41556-41561	their	_	
198-23	41562-41570	Siblings	_	
198-24	41571-41579	Abnormal	_	
198-25	41580-41585	brain	_	
198-26	41586-41600	lateralization	_	
198-27	41601-41604	and	_	
198-28	41605-41617	connectivity	_	
198-29	41618-41620	in	_	
198-30	41621-41634	Schizophrenia	_	
198-31	41635-41643	Abnormal	_	
198-32	41644-41653	asymmetry	_	
198-33	41654-41656	of	_	
198-34	41657-41662	brain	_	
198-35	41663-41675	connectivity	_	
198-36	41676-41678	in	_	
198-37	41679-41692	schizophrenia	_	
198-38	41693-41706	Resting-state	_	
198-39	41707-41717	functional	_	
198-40	41718-41725	network	_	
198-41	41726-41736	correlates	_	
198-42	41737-41739	of	_	
198-43	41740-41749	psychotic	_	
198-44	41750-41758	symptoms	_	
198-45	41759-41761	in	_	
198-46	41762-41775	schizophrenia	_	
198-47	41776-41778	An	_	
198-48	41779-41787	improved	_	
198-49	41788-41797	framework	_	
198-50	41798-41801	for	_	
198-51	41802-41810	confound	_	
198-52	41811-41821	regression	_	
198-53	41822-41825	and	_	
198-54	41826-41835	filtering	_	
198-55	41836-41839	for	_	
198-56	41840-41847	control	_	
198-57	41848-41850	of	_	
198-58	41851-41857	motion	_	
198-59	41858-41866	artifact	_	
198-60	41867-41869	in	_	
198-61	41870-41873	the	_	
198-62	41874-41887	preprocessing	_	
198-63	41888-41890	of	_	
198-64	41891-41904	resting-state	_	
198-65	41905-41915	functional	_	
198-66	41916-41928	connectivity	_	
198-67	41929-41933	data	_	
198-68	41934-41942	Dynamics	_	
198-69	41943-41945	of	_	
198-70	41946-41957	hemispheric	_	
198-71	41958-41972	specialization	_	
198-72	41973-41976	and	_	
198-73	41977-41988	integration	_	
198-74	41989-41991	in	_	
198-75	41992-41995	the	_	
198-76	41996-42003	context	_	
198-77	42004-42006	of	_	
198-78	42007-42012	motor	_	
198-79	42013-42020	control	_	
198-80	42021-42031	Handedness	_	
198-81	42031-42032	,	_	
198-82	42033-42041	language	_	
198-83	42042-42056	lateralisation	_	
198-84	42057-42060	and	_	
198-85	42061-42071	anatomical	_	
198-86	42072-42081	asymmetry	_	
198-87	42082-42084	in	_	
198-88	42085-42098	schizophrenia	_	
198-89	42099-42107	Language	_	
198-90	42108-42122	lateralization	_	
198-91	42123-42125	in	_	
198-92	42126-42137	monozygotic	_	
198-93	42138-42143	twins	_	
198-94	42144-42154	discordant	_	
198-95	42155-42158	and	_	
198-96	42159-42169	concordant	_	
198-97	42170-42173	for	_	
198-98	42174-42187	schizophrenia	_	
198-99	42187-42188	.	_	

#Text=A functional MRI pilot study
#Text=Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison
#Text=Regional variation in interhemispheric coordination of intrinsic hemodynamic fluctuations
#Text=Mechanisms of hemispheric specialization: insights from analyses of connectivity
#Text=Lateralization of auditory-cortex functions
#Text=Mapping brain asymmetry
#Text=Abnormal rich club organization and functional brain dynamics in schizophrenia
#Text=Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age
#Text=Functional specialization in the human brain estimated by intrinsic hemispheric interaction
#Text=Modulation of interhemispheric functional coordination in electroconvulsive therapy for depression
#Text=Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia
#Text=Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia
#Text=A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics
#Text=DPABI: Data processing & analysis for (resting-state) brain imaging
#Text=Disrupted axonal fiber connectivity in schizophrenia
#Text=Delayed development of brain connectivity in adolescents with schizophrenia and their unaffected siblings
#Text=Developmental changes in topological asymmetry between hemispheric brain white matter networks from adolescence to young adulthood
#Text=Functional homotopic changes in multiple sclerosis with resting-state functional MR imaging
#Text=Growing together and growing apart: regional and sex differences in the lifespan developmental trajectories of functional homotopy
199-1	42189-42190	A	_	
199-2	42191-42201	functional	_	
199-3	42202-42205	MRI	_	
199-4	42206-42211	pilot	_	
199-5	42212-42217	study	_	
199-6	42218-42226	Cortical	_	
199-7	42227-42236	thickness	_	
199-8	42237-42239	in	_	
199-9	42240-42253	first-episode	_	
199-10	42254-42267	schizophrenia	_	
199-11	42268-42276	patients	_	
199-12	42277-42280	and	_	
199-13	42281-42292	individuals	_	
199-14	42293-42295	at	_	
199-15	42296-42300	high	_	
199-16	42301-42309	familial	_	
199-17	42310-42314	risk	_	
199-18	42314-42315	:	_	
199-19	42316-42317	a	_	
199-20	42318-42333	cross-sectional	_	
199-21	42334-42344	comparison	_	
199-22	42345-42353	Regional	_	
199-23	42354-42363	variation	_	
199-24	42364-42366	in	_	
199-25	42367-42383	interhemispheric	_	
199-26	42384-42396	coordination	_	
199-27	42397-42399	of	_	
199-28	42400-42409	intrinsic	_	
199-29	42410-42421	hemodynamic	_	
199-30	42422-42434	fluctuations	_	
199-31	42435-42445	Mechanisms	_	
199-32	42446-42448	of	_	
199-33	42449-42460	hemispheric	_	
199-34	42461-42475	specialization	_	
199-35	42475-42476	:	_	
199-36	42477-42485	insights	_	
199-37	42486-42490	from	_	
199-38	42491-42499	analyses	_	
199-39	42500-42502	of	_	
199-40	42503-42515	connectivity	_	
199-41	42516-42530	Lateralization	_	
199-42	42531-42533	of	_	
199-43	42534-42549	auditory-cortex	_	
199-44	42550-42559	functions	_	
199-45	42560-42567	Mapping	_	
199-46	42568-42573	brain	_	
199-47	42574-42583	asymmetry	_	
199-48	42584-42592	Abnormal	_	
199-49	42593-42597	rich	_	
199-50	42598-42602	club	_	
199-51	42603-42615	organization	_	
199-52	42616-42619	and	_	
199-53	42620-42630	functional	_	
199-54	42631-42636	brain	_	
199-55	42637-42645	dynamics	_	
199-56	42646-42648	in	_	
199-57	42649-42662	schizophrenia	_	
199-58	42663-42672	Asymmetry	_	
199-59	42673-42675	in	_	
199-60	42676-42684	dopamine	_	
199-61	42685-42687	D2	_	
199-62	42687-42688	/	_	
199-63	42688-42689	3	_	
199-64	42690-42699	receptors	_	
199-65	42700-42702	of	_	
199-66	42703-42710	caudate	_	
199-67	42711-42718	nucleus	_	
199-68	42719-42721	is	_	
199-69	42722-42726	lost	_	
199-70	42727-42731	with	_	
199-71	42732-42735	age	_	
199-72	42736-42746	Functional	_	
199-73	42747-42761	specialization	_	
199-74	42762-42764	in	_	
199-75	42765-42768	the	_	
199-76	42769-42774	human	_	
199-77	42775-42780	brain	_	
199-78	42781-42790	estimated	_	
199-79	42791-42793	by	_	
199-80	42794-42803	intrinsic	_	
199-81	42804-42815	hemispheric	_	
199-82	42816-42827	interaction	_	
199-83	42828-42838	Modulation	_	
199-84	42839-42841	of	_	
199-85	42842-42858	interhemispheric	_	
199-86	42859-42869	functional	_	
199-87	42870-42882	coordination	_	
199-88	42883-42885	in	_	
199-89	42886-42903	electroconvulsive	_	
199-90	42904-42911	therapy	_	
199-91	42912-42915	for	_	
199-92	42916-42926	depression	_	
199-93	42927-42940	Hyperactivity	_	
199-94	42941-42944	and	_	
199-95	42945-42962	hyperconnectivity	_	
199-96	42963-42965	of	_	
199-97	42966-42969	the	_	
199-98	42970-42977	default	_	
199-99	42978-42985	network	_	
199-100	42986-42988	in	_	
199-101	42989-43002	schizophrenia	_	
199-102	43003-43006	and	_	
199-103	43007-43009	in	_	
199-104	43010-43022	first-degree	_	
199-105	43023-43032	relatives	_	
199-106	43033-43035	of	_	
199-107	43036-43043	persons	_	
199-108	43044-43048	with	_	
199-109	43049-43062	schizophrenia	_	
199-110	43063-43071	Abnormal	_	
199-111	43072-43082	prefrontal	_	
199-112	43083-43091	cortical	_	
199-113	43092-43100	activity	_	
199-114	43101-43104	and	_	
199-115	43105-43117	connectivity	_	
199-116	43118-43124	during	_	
199-117	43125-43133	response	_	
199-118	43134-43143	selection	_	
199-119	43144-43146	in	_	
199-120	43147-43152	first	_	
199-121	43153-43160	episode	_	
199-122	43161-43170	psychosis	_	
199-123	43170-43171	,	_	
199-124	43172-43179	chronic	_	
199-125	43180-43193	schizophrenia	_	
199-126	43193-43194	,	_	
199-127	43195-43198	and	_	
199-128	43199-43209	unaffected	_	
199-129	43210-43218	siblings	_	
199-130	43219-43221	of	_	
199-131	43222-43233	individuals	_	
199-132	43234-43238	with	_	
199-133	43239-43252	schizophrenia	_	
199-134	43253-43254	A	_	
199-135	43255-43268	comprehensive	_	
199-136	43269-43279	assessment	_	
199-137	43280-43282	of	_	
199-138	43283-43291	regional	_	
199-139	43292-43301	variation	_	
199-140	43302-43304	in	_	
199-141	43305-43308	the	_	
199-142	43309-43315	impact	_	
199-143	43316-43318	of	_	
199-144	43319-43323	head	_	
199-145	43324-43338	micromovements	_	
199-146	43339-43341	on	_	
199-147	43342-43352	functional	_	
199-148	43353-43365	connectomics	_	
199-149	43366-43371	DPABI	_	
199-150	43371-43372	:	_	
199-151	43373-43377	Data	_	
199-152	43378-43388	processing	_	
199-153	43389-43390	&	_	
199-154	43391-43399	analysis	_	
199-155	43400-43403	for	_	
199-156	43404-43405	(	_	
199-157	43405-43418	resting-state	_	
199-158	43418-43419	)	_	
199-159	43420-43425	brain	_	
199-160	43426-43433	imaging	_	
199-161	43434-43443	Disrupted	_	
199-162	43444-43450	axonal	_	
199-163	43451-43456	fiber	_	
199-164	43457-43469	connectivity	_	
199-165	43470-43472	in	_	
199-166	43473-43486	schizophrenia	_	
199-167	43487-43494	Delayed	_	
199-168	43495-43506	development	_	
199-169	43507-43509	of	_	
199-170	43510-43515	brain	_	
199-171	43516-43528	connectivity	_	
199-172	43529-43531	in	_	
199-173	43532-43543	adolescents	_	
199-174	43544-43548	with	_	
199-175	43549-43562	schizophrenia	_	
199-176	43563-43566	and	_	
199-177	43567-43572	their	_	
199-178	43573-43583	unaffected	_	
199-179	43584-43592	siblings	_	
199-180	43593-43606	Developmental	_	
199-181	43607-43614	changes	_	
199-182	43615-43617	in	_	
199-183	43618-43629	topological	_	
199-184	43630-43639	asymmetry	_	
199-185	43640-43647	between	_	
199-186	43648-43659	hemispheric	_	
199-187	43660-43665	brain	_	
199-188	43666-43671	white	_	
199-189	43672-43678	matter	_	
199-190	43679-43687	networks	_	
199-191	43688-43692	from	_	
199-192	43693-43704	adolescence	_	
199-193	43705-43707	to	_	
199-194	43708-43713	young	_	
199-195	43714-43723	adulthood	_	
199-196	43724-43734	Functional	_	
199-197	43735-43744	homotopic	_	
199-198	43745-43752	changes	_	
199-199	43753-43755	in	_	
199-200	43756-43764	multiple	_	
199-201	43765-43774	sclerosis	_	
199-202	43775-43779	with	_	
199-203	43780-43793	resting-state	_	
199-204	43794-43804	functional	_	
199-205	43805-43807	MR	_	
199-206	43808-43815	imaging	_	
199-207	43816-43823	Growing	_	
199-208	43824-43832	together	_	
199-209	43833-43836	and	_	
199-210	43837-43844	growing	_	
199-211	43845-43850	apart	_	
199-212	43850-43851	:	_	
199-213	43852-43860	regional	_	
199-214	43861-43864	and	_	
199-215	43865-43868	sex	_	
199-216	43869-43880	differences	_	
199-217	43881-43883	in	_	
199-218	43884-43887	the	_	
199-219	43888-43896	lifespan	_	
199-220	43897-43910	developmental	_	
199-221	43911-43923	trajectories	_	
199-222	43924-43926	of	_	
199-223	43927-43937	functional	_	
199-224	43938-43946	homotopy	_	
